Processing 00000000.tx.1: Cell Itinerary and Metabolic Fate of Proinsulin in Rat Liver: In Vivo and in Vitro Studies Bernard Desbuquois, Genevive Chauvet, Mostafa Kouach and Franois Authier Institut National de la Sant et de la Recherche Mdicale U567 and Centre National de la Recherche Scientifique Unite Mixte de Recherche 8104 (B.D.), Dpartement dEndocrinologie, Institut Cochin, 75014 Paris, France; 

Phrase: "Cell Itinerary"

Phrase: "and"

Phrase: "Metabolic Fate of Proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1539479:FATE [Gene or Genome]

Phrase: "in Rat Liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: ":"

Phrase: "In Vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in Vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "Bernard Desbuquois,"

Phrase: "Genevive Chauvet,"

Phrase: "Mostafa Kouach"

Phrase: "and"

Phrase: "Franois Authier Institut National de la Sant et de la Recherche Mdicale U567"

Phrase: "and"

Phrase: "Centre National de la Recherche Scientifique"

Phrase: "Unite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0166872:unite [Biomedical or Dental Material]

Phrase: "Mixte de Recherche 8104"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0011198:DE [Geographic Area]
   812   C0017480:DE [Geographic Area]
   812   C3541240:DE [Idea or Concept]

Phrase: "(B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D."

Phrase: ")"

Phrase: ","

Phrase: "Dpartement dEndocrinologie,"

Phrase: "Institut Cochin,"

Phrase: "75014 Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030561:Paris [Geographic Area]
   861   C0331677:Paris [Plant]
   861   C1824032:PARIS [Gene or Genome]
   827 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ";"
Processing 00000000.tx.2: Institut National de la Sant et de la Recherche Mdicale U530 (G.C.), Universit Ren Descartes, Unit de Formation et de Recherche Biomdicale des Saints-Pres, 75007 Paris, France; 

Phrase: "Institut National de la Sant et de la Recherche Mdicale U530"

Phrase: "(G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "C."

Phrase: ")"

Phrase: ","

Phrase: "Universit Ren Descartes,"

Phrase: "Unit de Formation et de Recherche Biomdicale des Saints-Pres,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0033095:Pres [Phenomenon or Process]
   790   C1822756:PRES [Gene or Genome]
   790   C3160858:PRES [Disease or Syndrome]
   756 E C0332152:Pre [Temporal Concept]
   756 E C0740175:Pre [Qualitative Concept]
   756 E C2257086:PRE [Genetic Function]

Phrase: "75007 Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030561:Paris [Geographic Area]
   861   C0331677:Paris [Plant]
   861   C1824032:PARIS [Gene or Genome]
   827 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ";"
Processing 00000000.tx.3: Laboratoire de Spectromtrie de Masse (M.K.), Facult de Mdecine, 59000 Lille, France; 

Phrase: "Laboratoire de Spectromtrie de Masse"

Phrase: "(M.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Facult de Mdecine,"

Phrase: "59000 Lille,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ";"
Processing 00000000.tx.4: and Institut National de la Sant et de la Recherche Mdicale U510 (F.A.), Facult de Pharmacie Paris XI, 92296 Chtenay-Malabry, France Address all correspondence and requests for reprints to: Bernard Desbuquois, Dpartement dEndocrinologie, Institut Cochin, 24 rue du Faubourg Saint-Jacques, 75014 Paris, France. 

Phrase: "and"

Phrase: "Institut National de la Sant et de la Recherche Mdicale U510"

Phrase: "(F.A."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: ")"

Phrase: ","

Phrase: "Facult de Pharmacie Paris XI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1720296:Xi [Intellectual Product]

Phrase: "92296 Chtenay-Malabry,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Bernard Desbuquois,"

Phrase: "Dpartement dEndocrinologie,"

Phrase: "Institut Cochin,"

Phrase: "24 rue du Faubourg Saint-Jacques,"

Phrase: "75014 Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030561:Paris [Geographic Area]
   861   C0331677:Paris [Plant]
   861   C1824032:PARIS [Gene or Genome]
   827 E C1824369:PARI [Gene or Genome]

Phrase: "France."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]
Processing 00000000.tx.5: E-mail: desbuquois{at}cochin.inserm.fr .  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Proinsulin, the insulin precursor in pancreatic -cells, displays a slower hepatic clearance than insulin and exerts a more prolonged metabolic effect on liver in vivo. 

Phrase: "E-mail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "desbuquois{at}cochin.inserm.fr .  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the insulin precursor in pancreatic -cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0018956:cells precursor [Cell]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a slower hepatic clearance than insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "a more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "prolonged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439590:Prolonged [Temporal Concept]

Phrase: "metabolic effect on liver"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.6: To elucidate the mechanisms underlying these differences, the cellular itinerary and processing of proinsulin and insulin in rat liver have been comparatively studied using cell fractionation. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "these differences,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "the cellular itinerary"

Phrase: "and"

Phrase: "processing of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "insulin in rat liver"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "comparatively"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cell fractionation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007593:Cell Fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.7: As [125I]-insulin, [125I]-proinsulin taken up into liver in vivo was internalized and accumulated in endosomes, in which it underwent dissociation from the insulin receptor and degradation in a pH- and ATP-dependent manner. 

Phrase: "As [125I"

Phrase: "]-insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "into liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "was"

Phrase: "internalized"

Phrase: "and"

Phrase: "accumulated in endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034850:Endosomes [Cell Component]

Phrase: "in which"

Phrase: "it"

Phrase: "underwent"

Phrase: "dissociation from the insulin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "degradation in a pH-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "ATP-dependent manner."
Processing 00000000.tx.8: However, relative to [125I]-insulin, [125I]-proinsulin showed a delayed and prolonged in vivo association with endosomes, a slower in vivo and cell-free endosomal processing, and a higher cell-free endosome-lysosome transfer. 

Phrase: "However,"

Phrase: "relative to [125I"

Phrase: "]-insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a delayed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205421:Delayed [Temporal Concept]
  1000   C3272602:Delayed [Qualitative Concept]

Phrase: "and"

Phrase: "prolonged in vivo association with endosomes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "a slower in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "cell-free endosomal processing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0230625:cell processing [Cell Component]
   812   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "a higher cell-free endosome-lysosome transfer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0040671:Transfer [Mental Process]
   799   C1705822:Transfer [Activity]
Processing 00000000.tx.9: Endosomal extracts degraded to a lesser extent proinsulin than insulin at acidic pH; 

Phrase: "Endosomal extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "degraded to a lesser extent proinsulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439792:Extent [Spatial Concept]
   753   C0547044:Lesser [Qualitative Concept]
   753   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "than insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "at acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ";"
Processing 00000000.tx.10: so did, and even proportionally less, at neutral pH, plasma membrane and cytosolic fractions. 

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "did"

Phrase: ","

Phrase: "and"

Phrase: "even proportionally less,"

Phrase: "at neutral pH,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "cytosolic fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.11: Proinsulin degradation products generated by soluble endosomal extracts were isolated by HPLC and characterized by mass spectrometry. 

Phrase: "Proinsulin degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "generated by soluble endosomal extracts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
   760   C3146294:Generated [Activity]
   726   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "isolated by HPLC"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "characterized by mass spectrometry."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C1880022:Characterized [Activity]
   770   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.12: Under conditions resulting in multiple cleavages in insulin, proinsulin was cleaved at eight bonds in the C peptide but only at the Phe24-Phe25 bond in the insulin moiety. 

Phrase: "Under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "resulting in multiple cleavages"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0332294:Resulting in [Functional Concept]
   770   C0439064:Multiple [Quantitative Concept]
   770   C0678226:resulting [Functional Concept]
   737   C0010813:cleavage [Cell Function]
   737   C0596311:Cleavage [Phenomenon or Process]
   737 E C1274040:Result [Functional Concept]
   737   C1330957:cleavage [Cell Function]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "in insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "cleaved at eight bonds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205242:Cleaved [Spatial Concept]
   770   C0205454:Eight [Quantitative Concept]
   770   C0333853:Cleaved [Cell]

Phrase: "in the C peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "but"

Phrase: "only at the Phe24-Phe25 bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205171:Only [Quantitative Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "in the insulin moiety."
Processing 00000000.tx.13: As native insulin, native proinsulin induced a dose- and time-dependent endocytosis and tyrosine phosphorylation of the insulin receptor; 

Phrase: "As native insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "native proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a dose-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "time-dependent endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014139:Endocytosis [Cell Function]
   827   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "tyrosine phosphorylation of the insulin receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: ";"
Processing 00000000.tx.14: but at an inframaximal dose, proinsulin effects on these processes were of longer duration. 

Phrase: "but at an inframaximal dose,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0178602:Dose [Quantitative Concept]
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]

Phrase: "proinsulin effects on these processes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "were of longer duration."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   816   C0439591:Long duration [Qualitative Concept]
   770   C0449238:Duration [Temporal Concept]
   770   C2926735:Duration [Pharmacologic Substance]
   737   C0205166:Long [Qualitative Concept]
   737   C1706317:Long [Qualitative Concept]
Processing 00000000.tx.15: We conclude that a reduced proteolysis of proinsulin in endosomes, and probably also at the plasma membrane, accounts for its slower hepatic clearance and prolonged effects on insulin receptor endocytosis and tyrosine phosphorylation.  

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "a reduced proteolysis of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597304:Proteolysis [Molecular Function]

Phrase: "in endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "and"

Phrase: "probably also at the plasma membrane,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0007603:Plasma membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0032105:Plasma [Body Substance]
   753   C0596901:Membrane [Cell Component]
   753   C0750492:Probably [Idea or Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "accounts for its slower hepatic clearance"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205054:Hepatic [Body Location or Region]
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]
   753   C2981730:Account [Classification]
   719   C0439834:Slow [Qualitative Concept]

Phrase: "and"

Phrase: "prolonged effects on insulin receptor endocytosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "tyrosine phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.16: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  FIRST IDENTIFIED BY Steiner and Oyer (1), proinsulin, the insulin precursor in pancreatic -cells, is a single-chain polypeptide in which the carboxyl terminus of the B-chain is linked via a C peptide to the amino terminus of the A-chain. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "FIRST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "IDENTIFIED BY Steiner"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "Oyer"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the insulin precursor in pancreatic -cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0018956:cells precursor [Cell]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "a single-chain polypeptide in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "the carboxyl terminus of the B-chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596260:Carboxyl [Organic Chemical]

Phrase: "is"

Phrase: "linked via a C peptide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "to the amino terminus"

Phrase: "of the A-chain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.17: The conversion of proinsulin to insulin involves endoproteolytic cleavages on the carboxyl side of two pairs of basic residues at the B-chain C peptide (Arg31-Arg32) and A-chain C peptide (Lys64-Arg65) junctions, catalyzed by the proprotein convertases PC3 and PC2; 

Phrase: "The conversion of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439836:Conversion [Functional Concept]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "involves"

Phrase: "endoproteolytic cleavages on the carboxyl side of two pairs of basic residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   703   C0010813:cleavage [Cell Function]
   703   C0596311:Cleavage [Phenomenon or Process]
   703   C1330957:cleavage [Cell Function]

Phrase: "at the B-chain C peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(Arg31-Arg32"

Phrase: ")"

Phrase: "and"

Phrase: "A-chain C peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(Lys64-Arg65"

Phrase: ")"

Phrase: "junctions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205144:Junction [Spatial Concept]
   966   C1706311:Junction [Medical Device]

Phrase: "catalyzed by the proprotein convertases PC3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1100660:Proprotein Convertases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0379214:pro protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709708:Proprotein [Amino Acid, Peptide, or Protein]
   753   C2677316:PC-3 [Gene or Genome]

Phrase: "and"

Phrase: "PC2"

Phrase: ";"
Processing 00000000.tx.18: the remaining C-terminal basic residues are then removed by carboxypeptidase H (reviewed in Refs. 2 and 3). 

Phrase: "the remaining C-terminal basic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "removed by carboxypeptidase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0007075:Carboxypeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0849355:Removed [Qualitative Concept]
   790   C3265462:Carboxypeptidase [Pharmacologic Substance]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "H ("
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "reviewed in Refs. 2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: During this process, incompletely cleaved intermediates are formed, in particular des-[64, 65], and des-[31, 32] proinsulins. 

Phrase: "During this process,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "incompletely cleaved intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "are"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: ","

Phrase: "in particular des-[64,"

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "],"

Phrase: "and"

Phrase: "des-[31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: "] proinsulins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.20: Minor amounts of intact proinsulin and proinsulin intermediates are released from -cells in the blood circulation, in which they account for 1030% of insulin immunoreactivity in the fasting state. 

Phrase: "Minor amounts of intact proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "proinsulin intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "are"

Phrase: "released from -cells"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in the blood circulation,"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
  1000   C0005775:Blood Circulation [Physiologic Function]
           Circulation
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C1516559:Circulation [Organism Function]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "in which"

Phrase: "they"

Phrase: "account for 1030% of insulin immunoreactivity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0597879:immunoreactivity [Molecular Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1551359:account [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "in the fasting state."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015663:Fasting state [Finding]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]
Processing 00000000.tx.21: This percentage is increased in pathological conditions such as insulinomas, familial hyperproinsulinemias, and non-insulin-dependent diabetes (2, 3). 

Phrase: "This percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439165:Percentage [Quantitative Concept]
  1000   C1549488:Percentage [Idea or Concept]
  1000   C1561533:Percentage [Idea or Concept]

Phrase: "is"

Phrase: "increased in pathological conditions"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   770   C0030664:Pathological [Biomedical Occupation or Discipline]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1521733:Pathological [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "such as insulinomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021670:Insulinomas [Neoplastic Process]

Phrase: "familial hyperproinsulinemias,"

Phrase: "and"

Phrase: "non-insulin-dependent diabetes"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011860:Non-Insulin Dependent Diabetes [Disease or Syndrome]
   923   C0011854:Insulin Dependent Diabetes [Disease or Syndrome]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1518422:Non [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.22: Proinsulin binds to the insulin receptor and elicits acute insulin-like metabolic effects in adipocytes and hepatocytes, albeit with a 10- to 100-fold-lower binding affinity and biological potency (reviewed in Ref. 4). 

Phrase: "Proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to the insulin receptor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   806   C1334133:INSULIN RECEPTOR [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "acute insulin-like metabolic effects in adipocytes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C2945675:metabolic effects [Physiologic Function]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "hepatocytes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "albeit with a 10-"

Phrase: "to 100-fold-lower binding affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "biological potency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   745   C3245505:Potential [Qualitative Concept]

Phrase: "("

Phrase: "reviewed in Ref. 4"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.23: Remarkably, in vivo, the ability of proinsulin to suppress hepatic glucose production is less reduced than its ability to stimulate glucose disposal (5, 6). 

Phrase: "Remarkably,"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the ability of proinsulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "hepatic glucose production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0033268:production [Occupational Activity]
   827   C0205054:Hepatic [Body Location or Region]

Phrase: "is"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "reduced than its ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C0392756:Reduced [Qualitative Concept]

Phrase: "stimulate"

Phrase: "glucose disposal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707797:Disposal [Activity]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.24: In addition, relative to insulin, in vivo effects of proinsulin develop more slowly and are more prolonged after hormone withdrawal; 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "relative to insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "in vivo effects of proinsulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "develop"

Phrase: "more slowly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0439834:Slowly [Qualitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "prolonged after hormone withdrawal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019932:Hormone [Hormone]
   770   C0439590:Prolonged [Temporal Concept]
   770   C2349954:Withdrawal [Activity]
   770   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.25: most long-lasting is suppression of hepatic glucose production (7). 

Phrase: "most long-lasting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205166:Long [Qualitative Concept]
   827   C1706317:Long [Qualitative Concept]

Phrase: "is"

Phrase: "suppression of hepatic glucose production"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.26: Proinsulin also exerts potent growth-promoting effects in chick embryo fibroblasts (8), IM-9 lymphoblasts (9), and small intestinal crypt cells (10). 

Phrase: "Proinsulin also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "potent growth-promoting effects in chick embryo fibroblasts"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0018270:'growth' NOS [Organism Function]
   744   C0033414:Promoting [Activity]
   744   C0220844:growth [Physiologic Function]
   744   C1280500:effects [Qualitative Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2911660:Growth [Activity]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "IM-9 lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0229613:Lymphoblasts [Cell]
   827   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "small intestinal crypt cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   858   C0814997:Intestinal cell [Cell]
   844   C0677646:crypt cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.27: However, the latter effects are mediated by incompletely characterized receptors, which show a greater affinity for proinsulin than for insulin. 

Phrase: "However,"

Phrase: "the latter effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "mediated by incompletely characterized receptors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1880022:Characterized [Activity]

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a greater affinity for proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "than"

Phrase: "for insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.28: As expected from its low affinity for the liver insulin receptor (11, 12), proinsulin displays a reduced extraction by the isolated perfused liver (13, 14) and liver in vivo (15, 16), which accounts for its prolonged half-life in serum. 

Phrase: "As"

Phrase: "expected from its low affinity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205251:low [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1517001:Expected [Idea or Concept]
   760   C1550472:low [Idea or Concept]

Phrase: "for the liver insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(11,"

Phrase: "12"

Phrase: ")"

Phrase: ","

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a reduced extraction by the isolated perfused liver"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0185115:Extraction [Therapeutic or Preventive Procedure]
   744   C0684295:extraction [Laboratory Procedure]

Phrase: "(13,"

Phrase: "14"

Phrase: ")"

Phrase: "and"

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(15,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "accounts for its prolonged half-life"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0018517:Half-Life [Temporal Concept]
   753   C0376558:Life [Idea or Concept]
   753   C0439590:Prolonged [Temporal Concept]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2825407:Half [Quantitative Concept]
   753   C2981730:Account [Classification]

Phrase: "in serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]
Processing 00000000.tx.29: Furthermore, after in vivo uptake into the liver, proinsulin is more slowly cleared than insulin, suggesting a slower intracellular processing (15, 16). 

Phrase: "Furthermore,"

Phrase: "after"

Phrase: "in vivo uptake into the liver,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "more slowly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0439834:Slowly [Qualitative Concept]

Phrase: "cleared than insulin,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0521097:cleared [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C2963144:Clear [Qualitative Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a slower intracellular processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709694:Processing [Activity]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.30: However, although proinsulin has been shown to be less efficiently degraded than insulin by isolated liver subcellular fractions (11, 17) and purified liver insulin-degrading enzyme (IDE) (18), studies on proinsulin processing in intact cells have been limited to adipocytes (19) and fibroblasts overexpressing the insulin receptor (20). 

Phrase: "However,"

Phrase: "although"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "less efficiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]

Phrase: "degraded than insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1881707:DEGRADED [Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by isolated liver subcellular fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0038528:Subcellular Fractions [Cell Component]
   858   C0982262:LIVER FRACTION [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "(11,"

Phrase: "17"

Phrase: ")"

Phrase: "and"

Phrase: "purified liver insulin-degrading enzyme (IDE)"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   875   C0443764:Liver enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   847 E C0428321:hepatic enzyme [Laboratory Procedure]
   833 E C1287351:liver enzymes [Laboratory or Test Result]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "studies on proinsulin processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1709694:Processing [Activity]
   770   C2603343:Study [Research Activity]

Phrase: "in intact cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "limited to adipocytes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0206131:Adipocytes [Cell]
   790   C0439801:Limited [Functional Concept]
   790   C3542948:Limited [Intellectual Product]
   756 E C1549649:Limit [Idea or Concept]
   756 E C2349209:Limit [Conceptual Entity]

Phrase: "(19"

Phrase: ")"

Phrase: "and"

Phrase: "fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.31: In the latter cells, proinsulin was found to be less efficiently degraded than insulin and, in part, released intact from the cell via a retroendocytotic pathway; 

Phrase: "In the latter cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "less efficiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]

Phrase: "degraded than insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1881707:DEGRADED [Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "intact from the cell"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0682538:intact cell [Cell]
   770   C0205266:Intact [Qualitative Concept]
   770   C1554187:Intact [Idea or Concept]

Phrase: "via a retroendocytotic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.32: this observation was suggested to account for the prolonged biological activity of proinsulin in vivo (20). 

Phrase: "this observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "account for the prolonged biological activity of proinsulin"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0005532:Biological [Biomedical Occupation or Discipline]
   744   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205177:Activity [Functional Concept]
   744   C0205460:biological [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0439590:Prolonged [Temporal Concept]
   744   C0441655:Activity [Activity]
   744   C1551359:account [Idea or Concept]
   744   C1561536:*Activity [Idea or Concept]
   744   C2741673:Account # [Clinical Attribute]
   744   C2981730:Account [Classification]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.33: In the present study, the cell itinerary and metabolic fate of proinsulin in rat liver have been analyzed using cell fractionation, and the results have been compared with those obtained with insulin. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the cell itinerary"

Phrase: "and"

Phrase: "metabolic fate of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1539479:FATE [Gene or Genome]

Phrase: "in rat liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "have"

Phrase: "been"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cell fractionation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007593:Cell Fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "compared with those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "obtained with insulin."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   811   C0020459:INSULIN INCREASE [Disease or Syndrome]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1301820:Obtained [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1706701:Obtain [Activity]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   718 E C1517378:Gain [Quantitative Concept]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.34: Particular attention has been paid to the subcellular distribution of [125I]-proinsulin taken up by rat liver in vivo, the fate of in vivo internalized [125I]-proinsulin in liver cell-free systems, and the in vitro degradation of proinsulin by liver subcellular fractions. 

Phrase: "Particular attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004268:Attention [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "paid to the subcellular distribution of [125I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]
   714   C0871051:pay [Quantitative Concept]

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "by rat liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the fate of in vivo internalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1539479:FATE [Gene or Genome]

Phrase: "[125I"

Phrase: "]-proinsulin in liver cell-free systems,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the in vitro degradation of proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "by liver subcellular fractions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0038528:Subcellular Fractions [Cell Component]
   896   C0982262:LIVER FRACTION [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.35: Proinsulin degradation intermediates, generated on incubation with soluble endosomal extracts, have been isolated by RP-HPLC and characterized by mass spectrometry. 

Phrase: "Proinsulin degradation intermediates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "generated on incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "with soluble endosomal extracts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "have"

Phrase: "been"

Phrase: "isolated by RP-HPLC"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1555029:Reverse [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "characterized by mass spectrometry."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C1880022:Characterized [Activity]
   770   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.36: Finally, the abilities of native proinsulin and insulin to induce the endocytosis and tyrosine phosphorylation of the insulin receptor in vivo have been compared.  

Phrase: "Finally,"

Phrase: "the abilities of native proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Abilities [Organism Attribute]

Phrase: "and"

Phrase: "insulin to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "tyrosine phosphorylation of the insulin receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "have"

Phrase: "been"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.37: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Materials Porcine insulin and recombinant human insulin were purchased from Novo Nordisk (Bagsvaerd, Denmark). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials Porcine insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0724601:Porcine Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C0770206:Porcine insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0039005:porcine [Mammal]
   827   C1135183:Porcine, NOS [Mammal]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "recombinant human insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C1533581:Recombinant Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Insulin
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C1514798:recombinant [Organism]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Novo Nordisk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0331875:Novo Nordisk [Health Care Related Organization]
   770   C0869011:purchased [Activity]

Phrase: "(Bagsvaerd,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")."
Processing 00000000.tx.38: Porcine proinsulin, recombinant human proinsulin, des-[64, 65] human proinsulin, and split-[3233] human proinsulin were generously supplied by Eli Lilly Research Laboratories (Indianapolis, IN). 

Phrase: "Porcine proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "recombinant human proinsulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0086418:Human [Human]

Phrase: "des-[64,"

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "] human proinsulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0086418:Human [Human]

Phrase: "and"

Phrase: "split-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1534709:Split [Functional Concept]
  1000   C1881714:SPLIT [Phenomenon or Process]

Phrase: "[3233"

Phrase: "] human proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0086418:Human [Human]

Phrase: "were"

Phrase: "generously"

Phrase: "supplied by Eli Lilly Research Laboratories"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   790   C0331851:Eli Lilly [Health Care Related Organization]
   783   C0022886:laboratories research [Research Activity]
   753   C0022877:Laboratories [Manufactured Object,Organization]
   753   C0035168:research [Research Activity]
   753   C0242481:Research [Research Activity]
   753   C1619828:Laboratories [Intellectual Product]
   753   C1999230:Supplied [Activity]
   719 E C0243163:supply [Idea or Concept]
   719 E C0699914:supply [Quantitative Concept]
   719 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   719 E C1561604:supply [Functional Concept]
   719 E C1875802:SUPPLY [Medical Device]
   719 E C3244292:laboratory [Functional Concept]

Phrase: "(Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.39: Polyclonal guinea pig antiserum to porcine insulin was obtained from Sigma-Aldrich (St. Quentin Fallavier, France); 

Phrase: "Polyclonal guinea pig antiserum to porcine insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "obtained from Sigma-Aldrich"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1301820:Obtained [Functional Concept]
   770   C1719918:Sigma [Intellectual Product]
   737 E C1706701:Obtain [Activity]

Phrase: "(St. Quentin Fallavier,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.40: goat antiserum to human proinsulin, from Linco Research (St. Charles, MO); 

Phrase: "goat antiserum to human proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "from Linco Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "(St. Charles,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.41: and polyclonal IgG against the human insulin receptor -subunit and mouse monoclonal antiphosphotyrosine antibody (clone 4G10), from UBI (Euromedex, Souffelweyersheim, France). 

Phrase: "and"

Phrase: "polyclonal IgG against the human insulin receptor -subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C2702333:Human IgG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "mouse monoclonal antiphosphotyrosine antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   875   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(clone 4G10"

Phrase: ")"

Phrase: ","

Phrase: "from UBI"

Phrase: "(Euromedex,"

Phrase: "Souffelweyersheim,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")."
Processing 00000000.tx.42: Nitrocellulose membranes and the enhanced chemiluminescence detection kit were purchased from Amersham Biosciences (Little Chalfont, Buckinghamshire, UK). 

Phrase: "Nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "the enhanced chemiluminescence detection kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "were"

Phrase: "purchased from Amersham Biosciences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0869011:purchased [Activity]

Phrase: "(Little Chalfont,"

Phrase: "Buckinghamshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454842:Buckinghamshire [Geographic Area]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.43: HPLC grade acetonitrile and trifluoroacetic acid were obtained from Baker Chemical Co (Fisher Bioblock, Illkirch, France). 

Phrase: "HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "grade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441800:Grade [Classification]
  1000   C0919553:Grade [Classification]
  1000   C3244287:grade [Finding]

Phrase: "acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]

Phrase: "and"

Phrase: "trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040982:Trifluoroacetic Acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "obtained from Baker Chemical Co (Fisher Bioblock,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0220806:Chemical [Chemical]
   748   C0238749:Baker [Professional or Occupational Group]
   748   C0325045:Fisher [Mammal]
   748   C1301820:Obtained [Functional Concept]
   748   C3272558:Chemical [Intellectual Product]
   714 E C1706701:Obtain [Activity]

Phrase: "Illkirch,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")."
Processing 00000000.tx.44: Other chemicals were obtained commercially and were of reagent grade. 

Phrase: "Other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "commercially"

Phrase: "and"

Phrase: "were of reagent grade."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   770   C0441800:Grade [Classification]
   770   C0919553:Grade [Classification]
   770   C3244287:grade [Finding]
Processing 00000000.tx.45: Preparation and characterization of [125I]-labeled peptides Porcine and human [125I]-proinsulin and [125I]-insulin (about 0.62.2 mCi/nmol; 0.20.5 125I atom per molecule) were prepared using chloramine T and purified by gel-filtration on Sephadex G-50 (21, 22). 

Phrase: "Preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "characterization of [125I"

Phrase: "]-labeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "Porcine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039005:porcine [Mammal]
  1000   C1135183:Porcine, NOS [Mammal]

Phrase: "and"

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(about 0.62.2 mCi/nmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439191:NMOLE [Quantitative Concept]

Phrase: "; 0.20.5 125I atom per molecule"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0567415:Atom [Element, Ion, or Isotope]
   748   C1706222:Atom [Conceptual Entity]

Phrase: ")"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "chloramine T"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0055332:Chloramin T [Organic Chemical,Pharmacologic Substance]
   861   C0008164:Chloramine [Organic Chemical]
   861   C0025033:Chloramin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0055330:chloramine [Inorganic Chemical]

Phrase: "and"

Phrase: "purified by gel-filtration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008559:Gel Filtration [Laboratory Procedure]
   770   C0016107:filtration [Laboratory Procedure]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C1382104:Gel [Substance]
   770   C1998793:Purified [Functional Concept]

Phrase: "on Sephadex G-50"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1120001:sephadex G 50 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   901   C1119999:sephadex G [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0074343:sephadex [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0439267:g% [Quantitative Concept]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.46: To identify the tyrosine(s) residues iodinated, [125I]-proinsulin was quantitatively converted to [125I]-insulin by enzymatic digestion (19, 23), and both digested [125I]-proinsulin and [125I]-insulin were subjected to reverse-phase HPLC (RP-HPLC) (24, 25). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "("

Phrase: "s)"

Phrase: "residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "iodinated"

Phrase: ","

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "quantitatively"

Phrase: "converted"

Phrase: "to [125I"

Phrase: "]-insulin by enzymatic digestion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(19,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "both"

Phrase: "digested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digested [Physiologic Function]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to reverse-phase HPLC (RP-HPLC) (24,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0008562:HPLC [Laboratory Procedure]
   804   C0205390:Phase [Temporal Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C1883351:To [Qualitative Concept]

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.47: Based on the elution profile of the radioactivity, iodination was found to occur mainly (70%) at tyrosines A14 in [125I]-insulin and A83 (the equivalent of tyrosine A14) in [125I]-proinsulin (results not shown). 

Phrase: "Based on the elution profile of the radioactivity,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   744   C0034553:Radioactivity [Natural Phenomenon or Process]
   744   C1441565:Elution [Laboratory Procedure]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   744   C1979963:Profile [Laboratory Procedure]
   744   C2003903:Profile [Functional Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "iodination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0430302:Iodination [Laboratory Procedure]
  1000   C0542502:Iodination [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "mainly"

Phrase: "(70%"

Phrase: ")"

Phrase: "at tyrosines A14 in [125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "A83"

Phrase: "("

Phrase: "the equivalent of tyrosine A14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205163:Equivalent [Qualitative Concept]
   760   C0439185:equivalent [Quantitative Concept]

Phrase: ")"

Phrase: "in [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.48: However, a minor population of molecules labeled at tyrosine A19 or equivalent was also identified. 

Phrase: "However,"

Phrase: "a minor population of molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]

Phrase: "labeled at tyrosine A19"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1549870:A19 [Intellectual Product]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "or"

Phrase: "equivalent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205163:Equivalent [Qualitative Concept]
  1000   C0439185:equivalent [Quantitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.49: The ability of [125I]-proinsulin to bind to the liver insulin receptor at pH 78 was about 811% that of [125I]-insulin. 

Phrase: "The ability of [125I"

Phrase: "]-proinsulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind to the liver insulin receptor"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   790   C1334133:INSULIN RECEPTOR [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2346688:LIVER [Food]

Phrase: "at pH 78"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "about 811%"

Phrase: "that of [125I"

Phrase: "]-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.50: Animals and peptide injections In vivo procedures were approved by the institutional committee for use and care of experimental animals. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "peptide injections In vivo procedures"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   858   C0021485:injection procedures [Therapeutic or Preventive Procedure]
   842 E C1533685:Injection procedure [Therapeutic or Preventive Procedure]
   842 E C1828121:Injection Procedure [Functional Concept]
   804   C0025664:procedures [Intellectual Product]
   804   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   804   C2700391:procedures [Activity]
   771 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   771 E C3274430:PROCEDURE [Health Care Activity]
   771 E C3538935:Procedure [Idea or Concept]
   771 E C3539779:Procedure [Intellectual Product]

Phrase: "were"

Phrase: "approved by the institutional committee"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205540:Approved [Qualitative Concept]
   760   C2699414:Committee [Group]

Phrase: "for use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "care of experimental animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0178478:animals care [Occupation or Discipline]
   770   C1947933:Care [Activity]
Processing 00000000.tx.51: Male Sprague Dawley rats, weighing 200  20 g, were obtained from Charles River (St. Aubin les Elbeufs, France) and Elevage Janvier (Le Genest-St-Isle, France) and were fasted for 16 h before killing. 

Phrase: "Male Sprague Dawley rats,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034715:Rats, Sprague-Dawley [Mammal]
   861   C2699239:Sprague-Dawley [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "weighing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305866:Weighing [Diagnostic Procedure]

Phrase: "200  20 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "obtained from Charles River"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0337050:River [Natural Phenomenon or Process]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(St. Aubin les Elbeufs,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "Elevage Janvier"

Phrase: "(Le Genest-St-Isle,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "fasted for 16 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0015663:Fast [Finding]
   737   C0456962:Fast [Qualitative Concept]

Phrase: "before"

Phrase: "killing."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]
Processing 00000000.tx.52: When indicated, porcine [125I]-labeled peptides (1525 Ci; 2030 pmol) or native human peptides (0.0613 nmol), diluted into 0.5 ml 0.15-M NaCl, were rapidly injected into the penis vein under ether or pentobarbital anesthesia. 

Phrase: "When"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "porcine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039005:porcine [Mammal]
  1000   C1135183:Porcine, NOS [Mammal]

Phrase: "[125I"

Phrase: "]-labeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(1525 Ci"

Phrase: "; 2030 pmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439192:pmol [Quantitative Concept]

Phrase: "or"

Phrase: "native human peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(0.0613 nmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439191:NMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "diluted into 0.5 ml 0.15-M NaCl,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0444499:0/5 [Quantitative Concept]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C0439526:/mL [Quantitative Concept]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C1959973:% NaCl [Quantitative Concept]
   708   C1720119:Dilute [Functional Concept]
   708   C1948037:Dilute [Functional Concept]

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "injected into the penis vein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030851:penis [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]
   760   C1280739:Penis [Body Part, Organ, or Organ Component]
   760   C1709494:PENIS [Tissue]
   726   C1720154:Inject [Functional Concept]

Phrase: "under ether"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014994:Ether [Organic Chemical,Pharmacologic Substance]
  1000   C0014996:Ether, NOS [Organic Chemical,Pharmacologic Substance]
  1000   C1161324:ether [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "pentobarbital anesthesia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   861   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   745 E C0002932:Anaesthetic [Pharmacologic Substance]
Processing 00000000.tx.53: At the time indicated, the liver was rapidly removed, minced in ice-cold 0.25 M sucrose, and immediately homogenized. 

Phrase: "At the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "minced in ice-cold 0.25 M sucrose,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0456963:Ice cold [Qualitative Concept]
   744   C0009264:Cold [Natural Phenomenon or Process]
   744   C0009443:Cold [Disease or Syndrome]
   744   C0020746:Ice [Inorganic Chemical]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0234192:Cold [Physiologic Function]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "homogenized."
Processing 00000000.tx.54: Liver subcellular fractionation Livers were homogenized in 5 vol of 0.25-M sucrose using a Dounce homogenizer (loose-fitting pestle). 

Phrase: "Liver subcellular fractionation Livers"

Phrase: "were"

Phrase: "homogenized in 5 vol of 0.25-M sucrose"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C0444499:0/5 [Quantitative Concept]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0449468:VOL [Quantitative Concept]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C0560268:vol% [Quantitative Concept]
   742   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   742   C1690016:% vol [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Dounce homogenizer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0181200:homogenizer [Medical Device]

Phrase: "(loose-fitting pestle"

Phrase: ")."
Processing 00000000.tx.55: When indicated, bacitracin (1 mg/ml), 1,10 phenanthroline (2.5 mM), and N-ethylmaleimide (1 mM) were included in the homogenization medium to reduce degradation of labeled peptides during fractionation. 

Phrase: "When"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "(1 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10 phenanthroline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "(2.5 mM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0450346:2 5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "N-ethylmaleimide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015101:Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(1 mM)"

Phrase: "were"

Phrase: "included in the homogenization medium to"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0009458:Medium [Intellectual Product]
   753   C0332257:included [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   753   C3538986:INCLUDED [Gene or Genome]
   719 E C1552866:include [Idea or Concept]
   719 E C2700399:Include [Activity]

Phrase: "reduce"

Phrase: "degradation of labeled peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1523817:peptide degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "during fractionation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016640:fractionation [Laboratory Procedure]
  1000   C0524811:fractionation [Therapeutic or Preventive Procedure]
  1000   C3161031:Fractionation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.56: Nuclear (N), heavy mitochondrial (M), light mitochondrial (L), microsomal (P), and soluble (S) fractions and, when indicated, total particulate (NMLP) or combined LPS fractions, were isolated from homogenates by differential centrifugation. 

Phrase: "Nuclear (N), heavy mitochondrial (M), light mitochondrial"

Phrase: "(L"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0521450:Lysosomal [Body Location or Region]
   928 E C0024369:Lysosome [Cell Component]
   928 E C2984253:Lysosome [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "microsomal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1979928:Microsomal [Qualitative Concept]
   928 E C0026029:Microsome [Cell Component]

Phrase: "(P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "soluble (S) fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: ","

Phrase: "when"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "total particulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457784:Particulate [Substance]

Phrase: "(NMLP"

Phrase: ")"

Phrase: "or"

Phrase: "combined LPS fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "isolated from homogenates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "by differential centrifugation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007703:Centrifugation [Laboratory Procedure]
   861   C0443199:Differential [Qualitative Concept]
   861   C1705242:Differential [Qualitative Concept]
Processing 00000000.tx.57: The plasma membrane (PM) fraction was isolated from the N fraction as described by Hubbard et al. 

Phrase: "The plasma membrane (PM) fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "was"

Phrase: "isolated from the N fraction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205409:Isolated [Functional Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1554103:Fraction [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "as"

Phrase: "described by Hubbard et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.58: (26). 

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.59: Two sets of three endosomal fractions were isolated from the L and P fractions, respectively, as described by Khan et al. 

Phrase: "Two sets of three endosomal fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036849:Set [Mental Process]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]

Phrase: "were"

Phrase: "isolated from the L"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205409:Isolated [Functional Concept]
   770   C0521450:Lysosomal [Body Location or Region]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "P fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "respectively,"

Phrase: "as"

Phrase: "described by Khan et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.60: (27); 

Phrase: "(27"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.61: they were designated(by increasing rank order of densities) as Ll, Li, and Lh (L subfractions) and GEl, GEi, and GEh (P subfractions). 

Phrase: "they"

Phrase: "were"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "("

Phrase: "by increasing rank order"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0699794:Rank [Intellectual Product]
   827   C1705175:Order [Intellectual Product]
   827   C1705176:Order [Qualitative Concept]
   827   C1705177:Order [Classification]
   827   C1705178:Order [Activity]
   827   C1882348:Order [Qualitative Concept]

Phrase: "of densities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:densities [Quantitative Concept]
   916 E C0439794:Dense [Qualitative Concept]

Phrase: ")"

Phrase: "as"

Phrase: "Ll,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Lh (L subfractions"

Phrase: ")"

Phrase: "and"

Phrase: "GEl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "GEi,"

Phrase: "and"

Phrase: "GEh (P subfractions"

Phrase: ")."
Processing 00000000.tx.62: In some experiments, the LPS, L, and P fractions were subfractionated by centrifugation on continuous Nycodenz density gradients (25, 28). 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the LPS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023810:LPS [Lipid]
  1000   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
  1000   C2697656:LPS [Gene or Genome]

Phrase: "L,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0521450:Lysosomal [Body Location or Region]
   928 E C0024369:Lysosome [Cell Component]
   928 E C2984253:Lysosome [Functional Concept]

Phrase: "and"

Phrase: "P fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "subfractionated by centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "on continuous Nycodenz density gradients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0178587:density [Quantitative Concept]
   812   C0812409:gradients [Quantitative Concept]
   779 E C0439182:% gradient [Quantitative Concept]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "(25,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.63: Hypotonic treatment of endosomal fractions and isolation of soluble endosomal extracts were achieved as described previously (24, 25, 29). 

Phrase: "Hypotonic treatment of endosomal fractions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "isolation of soluble endosomal extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0204727:Isolation [Therapeutic or Preventive Procedure]
   760   C0205409:Isolation [Functional Concept]
   760   C0220862:isolation [Laboratory Procedure]

Phrase: "were"

Phrase: "achieved"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(24,"

Phrase: "25,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.64: Cell fractions, isolated after injection of [125I]-labeled peptides, were analyzed for peptide content and integrity; 

Phrase: "Cell fractions,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0805525:Cell fractions [Cell Component]
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "isolated after injection of [125I"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C0205409:Isolated [Functional Concept]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1548221:Isolated [Idea or Concept]
   760   C1828121:Injection [Functional Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "]-labeled peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "analyzed for peptide content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]
   770   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205266:integrity [Qualitative Concept]
  1000   C0872403:integrity [Individual Behavior]
  1000   C1947912:Integrity [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.65: the latter was assessed by precipitation by 5% trichloroacetic acid (TCA) and gel-filtration on a Sephadex G-50 column (1 x 50 cm) equilibrated with 1 M acetic acid (21, 28). 

Phrase: "the latter"

Phrase: "was"

Phrase: "assessed by precipitation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1516048:Assessed [Activity]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "by 5% trichloroacetic acid (TCA)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "gel-filtration on a Sephadex G-50 column"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008559:Gel Filtration [Laboratory Procedure]
   744   C0016107:filtration [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C1382104:Gel [Substance]

Phrase: "(1 x 50 cm)"

Phrase: "equilibrated with 1 M acetic acid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0000985:Acetic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]

Phrase: "(21,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.66: Association of the labeled peptides with the insulin receptor was assessed by cross-linking with disuccinimidylsuberate followed by SDS-PAGE and autoradiography (28). 

Phrase: "Association of the labeled peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "assessed by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1516048:Assessed [Activity]

Phrase: "cross-linking with disuccinimidylsuberate"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332220:Cross-linking [Functional Concept]
   816 E C0178576:Cross link [Natural Phenomenon or Process]
   770   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "followed by SDS-PAGE"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "autoradiography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.67: Cell fractions, isolated after injection of native peptides, were analyzed for peptide content after extraction by 0.1 N HCl containing 0.5% BSA and 0.05% bacitracin. in vitro insulin binding activity, and insulin receptor -subunit expression and phosphorylation (see below). 

Phrase: "Cell fractions,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0805525:Cell fractions [Cell Component]
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "isolated after injection of native peptides,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   753   C0205409:Isolated [Functional Concept]
   753   C0302891:Native [Functional Concept]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1548221:Isolated [Idea or Concept]
   753   C1828121:Injection [Functional Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed for peptide content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]
   770   C0936012:Analyzed [Research Activity]

Phrase: "after extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185115:Extraction [Therapeutic or Preventive Procedure]
  1000   C0684295:extraction [Laboratory Procedure]

Phrase: "by 0.1 N HCl"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% BSA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "0.05% bacitracin. in vitro insulin binding activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   822   C1145751:insulin activity [Molecular Function]
   812   C2266866:Binding Activity [Molecular Function]
   793   C0205177:Activity [Functional Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "insulin receptor -subunit expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0597360:receptor expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.68: Fate of in vivo internalized [125I]-labeled and unlabeled peptides in liver cell-free systems Degradation, extraendosomal release, and intraendosomal dissociation of in vivo internalized [125I]-labeled peptides in intact cell-free endosomes were studied as described previously (21, 24). 

Phrase: "Fate of in vivo internalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1539479:FATE [Gene or Genome]

Phrase: "[125I"

Phrase: "]-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "unlabeled peptides in liver cell-free systems Degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1523817:peptide degradation [Molecular Function]
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "extraendosomal release,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "intraendosomal dissociation of in vivo internalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "[125I"

Phrase: "]-labeled peptides in intact cell-free endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(21,"

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.69: Briefly, a total, P-derived endosomal fraction was isolated after injection of [125I]-insulin (2 min) or [125I]-proinsulin (4 min) and resuspended in 0.125 M KCl buffered with 25 mM citrate-phosphate, at the indicated pH, for various lengths of time at 37 C. 

Phrase: "Briefly,"

Phrase: "a total,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "P-derived endosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1264633:Fraction [Quantitative Concept]
   812   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "isolated after injection of [125I"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C0205409:Isolated [Functional Concept]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1548221:Isolated [Idea or Concept]
   760   C1828121:Injection [Functional Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2 min) or [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "resuspended in 0.125 M KCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026237:Mitochondrial [Cell Component]
   753   C0521451:Mitochondrial [Functional Concept]

Phrase: "buffered with 25 mM citrate-phosphate,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   783   C1553427:Buffered Citrate [Intellectual Product]
   767 E C3256468:citrate buffer [Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0008857:Citrate [Organic Chemical]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "at the indicated pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "for various lengths"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C1444754:Lengths [Quantitative Concept]
   827 E C1706316:LENGTH [Research Activity]
   777 E C0205166:Long [Qualitative Concept]
   777 E C1522425:Longest [Qualitative Concept]
   777 E C1706317:Long [Qualitative Concept]

Phrase: "of time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "at 37 C."
Processing 00000000.tx.70: Peptide degradation was assessed by TCA-precipitation; 

Phrase: "Peptide degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1523817:peptide degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "assessed by TCA-precipitation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1516048:Assessed [Activity]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.71: extraendosomal peptide release and intraendosomal peptide dissociation from the insulin receptor were assessed by polyethyleneglycol (PEG) precipitation in the absence and presence of 0.1% Brij-35, respectively. 

Phrase: "extraendosomal peptide release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "intraendosomal peptide dissociation from the insulin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "were"

Phrase: "assessed by polyethyleneglycol (PEG) precipitation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0444679:Polyethylene glycol precipitation [Laboratory Procedure]
   770   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0032931:Precipitation [Natural Phenomenon or Process]
   770   C0032932:Precipitation [Molecular Function]
   770   C1516048:Assessed [Activity]
   770   C1642401:% precipitation [Quantitative Concept]
   770   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "presence of 0.1% Brij-35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "respectively."
Processing 00000000.tx.72: Degradation of in vivo internalized native peptides in cell-free endosomes was studied in a comparable manner. 

Phrase: "Degradation of in vivo internalized native peptides in cell-free endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0243125:degradation [Functional Concept]
   738   C0699900:Degradation [Organism Function]
   737   C1523817:peptide degradation [Molecular Function]

Phrase: "was"

Phrase: "studied in a comparable manner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0557651:Study [Manufactured Object]
   726   C2603343:Study [Research Activity]
Processing 00000000.tx.73: Endosomes isolated after injection of insulin, proinsulin, des-[64, 65] proinsulin, or split-[3233] proinsulin (1, 5, 1.66, and 3.33 nmol, respectively), were incubated in 0.125 mM KCl and 25 mM citrate-phosphate, pH 6. 

Phrase: "Endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "isolated after injection of insulin,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   862   C0199782:Injection of insulin [Therapeutic or Preventive Procedure]
           Insulin injection
   797   C0586328:Insulin injection [Therapeutic or Preventive Procedure]
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205409:Isolated [Functional Concept]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1548221:Isolated [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1828121:Injection [Functional Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "des-[64,"

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "] proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "split-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1534709:Split [Functional Concept]
  1000   C1881714:SPLIT [Phenomenon or Process]

Phrase: "[3233"

Phrase: "] proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "1.66,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "3.33 nmol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439191:NMOLE [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "incubated in 0.125 mM KCl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "25 mM citrate-phosphate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.74: After various times at 37 C, peptides were extracted by 0.1 N HCl as described above, and their concentrations in the extracts were measured by RIA. 

Phrase: "After various times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "at 37 C,"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "extracted by 0.1 N HCl"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C1518434:Nuclear Extract [Biomedical or Dental Material]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0521447:Nuclear [Spatial Concept]
   753   C3541890:EXTRACTED [Finding]
   719 E C2828366:Extract [Substance]

Phrase: "as described above,"

Phrase: "and"

Phrase: "their concentrations in the extracts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0086045:Concentrations [Mental Process]
   739   C1720005:Concentrated extract [Biomedical or Dental Material]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "measured by RIA."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0034580:RIA [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.75: Cell-free endosome-lysosome transfer of in vivo internalized [125I]-labeled peptides was studied as described previously (25, 28). 

Phrase: "Cell-free endosome-lysosome transfer of in vivo internalized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0040671:Transfer [Mental Process]
   742   C1705822:Transfer [Activity]

Phrase: "[125I"

Phrase: "]-labeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(25,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.76: Aliquots (0.30.5 ml) of a LPS fraction, isolated 8 min after injection of [125I]-insulin or [125I]-proinsulin, were incubated at 4 C or 37 C with 1.5 mM ATP, 0.5 mg/ml creatine kinase, and 10 mM phosphocreatine. 

Phrase: "Aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "(0.30.5 ml) of a LPS fraction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439526:/mL [Quantitative Concept]

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "8 min after injection of [125I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: "]-insulin or [125I"

Phrase: "]-proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "incubated at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "37 C with 1.5 mM ATP,"

Phrase: "0.5 mg/ml creatine kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010287:Creatine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0010286:Creatine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "10 mM phosphocreatine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031634:Phosphocreatine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.77: After cooling to 4 C, incubation mixtures were subjected to centrifugation on linear Nycodenz gradients; 

Phrase: "After cooling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0678568:cooling [Natural Phenomenon or Process]
   966 E C1548792:Cool [Qualitative Concept]

Phrase: "to 4 C,"

Phrase: "incubation mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "subjected to centrifugation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "on linear Nycodenz gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0812409:gradients [Quantitative Concept]
   793 E C0439182:% gradient [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.78: and the distribution of radioactivity and N-acetyl--D-glucosaminidase activity among soluble, endosomal, and lysosomal components was determined. 

Phrase: "and"

Phrase: "the distribution of radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "N-acetyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase activity among soluble, endosomal,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "lysosomal components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.79: Assays for in vitro degradation of [125I]-labeled and unlabeled peptides by liver subcellular fractions 125I-labeled (0.1 nM) and unlabeled (10 nM) peptides were incubated with endosomal, PM, and cytosolic fractions in 50 mM citrate phosphate buffer containing 0.5% (wt/vol) BSA at 37 C; 

Phrase: "Assays for in vitro degradation of [125I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   788   C1515653:In Vitro Assay [Research Activity]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "]-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "unlabeled peptides by liver subcellular fractions 125I-labeled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(0.1 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "unlabeled"

Phrase: "(10 nM) peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "incubated with endosomal, PM,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007603:Plasma membrane [Cell Component]
   762   C1179907:endosome membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "cytosolic fractions in 50 mM citrate phosphate buffer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1264633:Fractions [Quantitative Concept]
   711 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "(wt/vol) BSA at 37 C"

Phrase: ";"
Processing 00000000.tx.80: specific conditions (time, medium pH, and concentration of cell fraction protein) are indicated in each particular experiment. 

Phrase: "specific conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "medium pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "concentration of cell fraction protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0427716:Protein concentration [Laboratory Procedure]
   797   C1304757:Protein concentration [Laboratory or Test Result]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "indicated in each particular experiment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0681814:Experiment [Research Activity]
   760   C1444656:Indicated [Finding]
   760   C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.81: Degradation of [125I]-labeled peptides was measured by TCA-precipitation and binding to excess antiinsulin antibody and degradation of native peptides by RIA. 

Phrase: "Degradation of [125I"

Phrase: "]-labeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "measured by TCA-precipitation"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "binding to excess antiinsulin antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "degradation of native peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1523817:peptide degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "by RIA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034580:RIA [Laboratory Procedure]
Processing 00000000.tx.82: Isolation and characterization of proinsulin degradation intermediates Degradation intermediates, generated on incubation of native proinsulin with soluble endosomal extracts, were isolated by RP-HPLC exactly as described for insulin intermediates (25). 

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "characterization of proinsulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "Degradation intermediates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "generated on incubation of native proinsulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0302891:Native [Functional Concept]
   753   C3146294:Generated [Activity]

Phrase: "with soluble endosomal extracts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "isolated by RP-HPLC exactly"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C0205409:Isolated [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C1555029:Reverse [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "as"

Phrase: "described for insulin intermediates"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1552738:described [Idea or Concept]
   770   C1579433:Insulin [Pharmacologic Substance]
   737   C0205103:Intermediate [Spatial Concept]
   737   C1550465:intermediate [Idea or Concept]
   737   C2827755:INTERMEDIATE [Laboratory or Test Result]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.83: Eluates were monitored on-line for absorbance at 214 nm, and resolved components were analyzed by ion spray mass spectrometry and HPLC coupled with ion spray ionization-mass spectrometry as described previously (25, 30). 

Phrase: "Eluates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0301870:Eluate [Body Substance]
   966   C1272724:Eluate [Substance]

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "on-line for absorbance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552960:Line [Quantitative Concept]
   770   C1720176:On [Functional Concept]
   770   C1720294:On [Intellectual Product]

Phrase: "at 214 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "resolved components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by ion spray mass spectrometry"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0037813:Mass Spectrometry [Laboratory Procedure]
   753   C0022023:Ion [Element, Ion, or Isotope]
   753   C0436196:Spectrometry [Laboratory Procedure]
   753   C0577559:Mass [Finding]
   753   C0936012:Analyzed [Research Activity]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1700702:ION [Functional Concept]
   753   C1704413:{Spray} [Quantitative Concept]
   753   C2003858:Spray [Functional Concept]
   753   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "coupled with ion spray ionization-mass spectrometry"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0037813:Mass Spectrometry [Laboratory Procedure]
   748   C0022023:Ion [Element, Ion, or Isotope]
   748   C0436196:Spectrometry [Laboratory Procedure]
   748   C0577559:Mass [Finding]
   748   C0596801:Ionization [Phenomenon or Process]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1700702:ION [Functional Concept]
   748   C1704413:{Spray} [Quantitative Concept]
   748   C1948027:Coupled [Functional Concept]
   748   C2003858:Spray [Functional Concept]
   748   C3152252:Mass [Quantitative Concept]
   714 E C0010222:couple [Family Group]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(25,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.84: Measurement of insulin binding activity and analysis of insulin receptor -subunit expression and tyrosine phosphorylation in liver cell fractions Insulin binding activity of PM and endosomal fractions was measured using [125I]-insulin as a ligand (31). 

Phrase: "Measurement of insulin binding activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0202098:Insulin measurement [Laboratory Procedure]
   760   C0242485:Measurement [Functional Concept]

Phrase: "and"

Phrase: "analysis of insulin receptor -subunit expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "tyrosine phosphorylation in liver cell fractions Insulin binding activity of PM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1519726:Tyrosine Phosphorylation [Molecular Function]
   736   C0031715:Phosphorylation [Molecular Function]
   736   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[125I"

Phrase: "]-insulin as a ligand"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.85: Insulin receptor -subunit expression and tyrosine phosphorylation in cell fractions were analyzed by Western immunoblotting using antibodies against the -subunit of the insulin receptor and phosphotyrosine, respectively (24, 28). 

Phrase: "Insulin receptor -subunit expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0597360:receptor expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "tyrosine phosphorylation in cell fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C0805525:Cell fractions [Cell Component]
   804   C1264633:Fractions [Quantitative Concept]
   771 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "analyzed by Western immunoblotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Immunoblotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Immunoblot [Laboratory Procedure]
   770   C0020985:Immunoblotting [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies against the -subunit of the insulin receptor"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   776   C0443876:Insulin receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0021644:Insulin Antibodies [Immunologic Factor]
   767   C0034805:antibodies receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "phosphotyrosine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "respectively"

Phrase: "(24,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.86: Cell fraction proteins, resolved by reducing SDS-PAGE electrophoresis, were electrotransferred to nitrocellulose membranes (0.45 m) for 1 h at 380 mA in transfer buffer (25 mM Tris, 192 mM glycine, pH 8.3). 

Phrase: "Cell fraction proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0805525:Cell Fraction [Cell Component]

Phrase: "resolved by reducing SDS-PAGE electrophoresis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0392756:Reducing [Qualitative Concept]
   753   C1514893:Resolved [Idea or Concept]
   753   C1704732:Page [Intellectual Product]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "were"

Phrase: "electrotransferred"

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "(0.45"

Phrase: "m) for 1 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   819   C2348952:H/m [Quantitative Concept]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "at 380 mA"

Phrase: "in transfer buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(25 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "192 mM glycine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0522461:Glycine [Plant]

Phrase: "pH 8.3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.87: After incubation for 3 h in blocking buffer (10 mM Tris-HCl, pH 7.5, 300 mM NaCl, 0.05% Tween-20) containing 5% skim milk (insulin receptor) or 2% BSA (phosphotyrosine), membranes were incubated with antibody to the insulin receptor -subunit (1:1000) or phosphotyrosine (1:2500) in the same buffer for 16 h at 4 C. 

Phrase: "After incubation"

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in blocking buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(10 mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "300 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.05% Tween-20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% skim milk"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0349375:Skim milk [Food]
   827   C0026131:Milk [Body Substance]
   827   C0349374:Milk [Food]
   827   C0444318:Milk [Substance]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]

Phrase: "(insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "2% BSA (phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "to the insulin receptor -subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1711351:Subunit [Quantitative Concept]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: "or"

Phrase: "phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2500"

Phrase: ")"

Phrase: "in the same buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.88: Membranes were then washed three times in blocking buffer containing 0.5% skim milk (insulin receptor) or 0.2% BSA (phosphotyrosine) over a period of 1 h and probed using horseradish-peroxidase-conjugated goat antirabbit IgG (insulin receptor) or antimouse IgG (phosphotyrosine). 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times in blocking buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% skim milk"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0349375:Skim milk [Food]
   812   C0026131:Milk [Body Substance]
   812   C0349374:Milk [Food]
   812   C0444318:Milk [Substance]
   812   C2825079:Milk [Food]
   756 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   756 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   741 E C0443260:Milky [Finding]

Phrase: "(insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "0.2% BSA (phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "over a period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0439531:/period [Temporal Concept]
  1000   C1948053:Period [Temporal Concept]
   928 E C0332182:Periodic [Temporal Concept]
   928 E C1706381:PERIODIC [Intellectual Product]
   900 E C0031084:Periodicities [Temporal Concept]

Phrase: "of 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "probed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0182400:Probe [Medical Device]
   966   C1704681:Probe [Gene or Genome]
   966   C2347609:Probe [Chemical Viewed Functionally]
   966   C3536729:Probe [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "horseradish-peroxidase-conjugated goat antirabbit IgG"

Phrase: "(insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "antimouse IgG (phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.89: Immune complexes were revealed using enhanced chemiluminescence reagents and autoradiography. 

Phrase: "Immune complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003313:Immune Complexes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439662:Immune [Functional Concept]
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "enhanced chemiluminescence reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "autoradiography."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.90: Measurement of insulin and proinsulin concentration Concentrations of insulin, proinsulin, and proinsulin intermediates in incubation mixtures and acid extracts of liver cell fractions were measured by RIA using [125I]-insulin and an anti-insulin antibody that reacts identically with insulin and proinsulin. 

Phrase: "Measurement of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0202098:Insulin measurement [Laboratory Procedure]
   790   C0242485:Measurement [Functional Concept]

Phrase: "and"

Phrase: "proinsulin concentration Concentrations of insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]

Phrase: "proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "intermediates in incubation mixtures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205103:Intermediate [Spatial Concept]
   770   C0439962:mixtures [Substance]
   770   C1550465:intermediate [Idea or Concept]
   770   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001128:Acid [Chemical]
  1000   C0202406:Acid [Laboratory Procedure]

Phrase: "extracts of liver cell fractions"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   806   C0227525:Liver cell [Cell]
   806   C0805525:Cell fractions [Cell Component]
   797   C0007592:Cell Extracts [Cell Component]
   797   C0023899:Liver Extract [Organic Chemical,Pharmacologic Substance]
   781   C0982262:LIVER FRACTION [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   781   C1264633:Fraction of [Quantitative Concept]
           Fractions
   760   C0007634:Cell [Cell]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1269647:Cell [Cell]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2346688:LIVER [Food]
   760   C2828366:Extract [Substance]
   751 E C2697585:Hepatocellular [Qualitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
   704 E C0205054:Hepatic [Body Location or Region]

Phrase: "were"

Phrase: "measured by RIA"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0034580:RIA [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "an anti-insulin antibody"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "that"

Phrase: "reacts"

Phrase: "identically with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proinsulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.91: Proinsulin concentrations were also measured with a RIA that uses [125I]-proinsulin and a specific antiproinsulin antibody (22); 

Phrase: "Proinsulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "also"

Phrase: "measured with a RIA"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0034580:RIA [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "that uses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0457083:uses [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "a specific antiproinsulin antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(22"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.92: the latter recognizes proinsulin and des-[31, 32] proinsulin but not des-[64, 65] proinsulin and insulin. 

Phrase: "the latter"

Phrase: "recognizes"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "des-[31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: "] proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "not des-[64,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "] proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.93: Samples were assayed at three to four different dilutions against appropriate standard curves, and antibody-bound ligand was separated from free ligand by PEG precipitation (32). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "assayed at three to four different dilutions"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0079240:dilutions [Laboratory Procedure]
   748   C0205449:Three [Quantitative Concept]
   748   C0205450:Four [Quantitative Concept]
   748   C1705242:Different [Qualitative Concept]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]
   714 E C1948037:Dilution [Functional Concept]

Phrase: "against appropriate standard curves,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205134:Curve [Spatial Concept]

Phrase: "and"

Phrase: "antibody-bound ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligand [Chemical]

Phrase: "was"

Phrase: "separated from free ligand"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023688:Ligand [Chemical]
   770   C0086972:Separated [Finding]
   770   C0332296:free [Functional Concept]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]

Phrase: "by PEG precipitation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0444679:Polyethylene glycol precipitation [Laboratory Procedure]
   861   C0032931:Precipitation [Natural Phenomenon or Process]
   861   C0032932:Precipitation [Molecular Function]
   861   C1642401:% precipitation [Quantitative Concept]
   861   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.94: Protein and enzyme assays Protein (33, 34), galactosyltransferase (35), and N-acetyl--D-glucosaminidase (35) activity in cell fractions were assayed using standard procedures.  

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "enzyme assays Protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C2717977:Enzyme Assays [Laboratory Procedure]

Phrase: "(33,"

Phrase: "34"

Phrase: ")"

Phrase: ","

Phrase: "galactosyltransferase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016964:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0702242:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "N-acetyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017724:Glucosaminidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(35"

Phrase: ")"

Phrase: "activity in cell fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0805525:Cell fractions [Cell Component]
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard procedures."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.95: Results Top Abstract Introduction Materials and Methods Results Discussion References  In vivo liver uptake of injected [125I]-proinsulin and [125I]-insulin After injection into rats, both [125I]-proinsulin and [125I]-insulin were retained, in part, by the liver and then lost from this organ in a time-dependent manner (Fig. 1A). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "In vivo liver uptake of injected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin After injection"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   858   C0199782:Insulin injection [Therapeutic or Preventive Procedure]
   858   C0586328:Insulin injection [Therapeutic or Preventive Procedure]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "into rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "both"

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "lost from this organ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178784:Organ [Body Part, Organ, or Organ Component]
   770   C0745777:Lost [Functional Concept]

Phrase: "in a time-dependent manner"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.96: Concurrently, a time-dependent decrease in TCA-precipitability of the peptides retained in the liver was observed (Fig. 1B). 

Phrase: "Concurrently,"

Phrase: "a time-dependent decrease in TCA-precipitability of the peptides"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0040223:Time [Temporal Concept]
   738   C0392756:Decrease [Qualitative Concept]
   738   C0547047:Decrease [Quantitative Concept]
   738   C0851827:Dependent [Qualitative Concept]
   738   C1701901:Dependent [Qualitative Concept]
   738   C3244310:dependent [Functional Concept]
   738   C3541383:Time [Temporal Concept]

Phrase: "retained in the liver"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0333118:Retained [Functional Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.97: In agreement with a previous report (15), the fate of injected [125I]-proinsulin differed from that of [125I]-insulin in three respects: first, a 3-fold-lower uptake of radioactivity at early postinjection times (maximum, 0.008% and 0.026% of the injected dose per milligram of protein, corresponding to 1.6% and 5.2% of injected dose per gram of liver, respectively); 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with a previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "the fate of injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1539479:FATE [Gene or Genome]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "differed from that of [125I"

Phrase: "]-insulin in three respects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ":"

Phrase: "first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a 3-fold-lower uptake of radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]

Phrase: "at early postinjection times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "(maximum,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0806909:Maximum [Quantitative Concept]
  1000   C1552615:maximum [Quantitative Concept]
  1000   C2826546:MAXIMUM [Quantitative Concept]
   928 E C0205289:Maximal [Qualitative Concept]

Phrase: "0.008%"

Phrase: "and"

Phrase: "0.026% of the injected dose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C2986768:Injected Dose [Functional Concept]
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   719   C1720154:Inject [Functional Concept]

Phrase: "per milligram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439210:milligram [Quantitative Concept]

Phrase: "of protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "corresponding to 1.6%"

Phrase: "and"

Phrase: "5.2% of injected dose"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C2986768:Injected Dose [Functional Concept]
   760   C0178602:Dose [Quantitative Concept]
   760   C0439084:>5 [Quantitative Concept]
   760   C0728893:+5 [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   726   C1720154:Inject [Functional Concept]

Phrase: "per gram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439208:gram [Quantitative Concept]

Phrase: "of liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "respectively"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.98: second, a slower loss of radioactivity from the liver after 4 min (apparent half-lives, about 30 and 6 min, respectively); 

Phrase: "second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "a slower loss of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "from the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "after 4 min (apparent half-lives,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0018517:Half-Life [Temporal Concept]
   804   C0595998:lives [Finding]
   804   C1548795:Live [Qualitative Concept]
   804   C1634625:% live [Qualitative Concept]
   804   C2825407:Half [Quantitative Concept]
   804   C2982691:Live [Activity]
   771 E C0376558:Life [Idea or Concept]

Phrase: "about 30"

Phrase: "and"

Phrase: "6 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.99: and third, a slower decrease in fractional TCA-precipitable radioactivity, which was most apparent before 8 min. 

Phrase: "and"

Phrase: "third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "a slower decrease in fractional TCA-precipitable radioactivity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "most apparent before 8 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.100: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.101: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.102: Kinetics of in vivo uptake of injected [125I]-proinsulin and [125I]-insulin into rat liver. 

Phrase: "Kinetics of in vivo uptake of injected"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0022702:Kinetics [Natural Phenomenon or Process]
   748   C0220865:kinetics [Functional Concept]
   748   C2825046:Kinetics [Occupation or Discipline]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin into rat liver."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.103: Liver homogenates were prepared from rats killed at the indicated time after iv injection of [125I]-proinsulin (closed squares) and [125I]-insulin (open squares). 

Phrase: "Liver homogenates"

Phrase: "were"

Phrase: "prepared from rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]
   756   C1521827:Prepare [Functional Concept]

Phrase: "killed at the indicated time"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0162388:killed [Social Behavior]
   760   C1444656:Indicated [Finding]
   760   C3541383:Time [Temporal Concept]
   726 E C0681205:Kill [Idea or Concept]
   726 E C1550555:kill [Functional Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "after iv injection of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(closed squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]

Phrase: ")"

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(open squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.104: Protease inhibitors were included in the homogenization medium. 

Phrase: "Protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "included in the homogenization medium."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0009458:Medium [Intellectual Product]
   760   C0332257:included [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]
Processing 00000000.tx.105: A, Radioactivity recovered. 

Phrase: "A,"

Phrase: "Radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "recovered."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]
Processing 00000000.tx.106: B, Percentage of radioactivity that is TCA-precipitable. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Percentage of radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439165:Percentage [Quantitative Concept]
   790   C1549488:Percentage [Idea or Concept]
   790   C1561533:Percentage [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "TCA-precipitable."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.107: Each point is the mean  SEM of four to seven separate determinations.  

Phrase: "Each point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "is"

Phrase: "the mean  SEM of four"

Phrase: "to seven separate determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.108: As expected from a receptor-mediated process, the in vivo uptake of [125I]-insulin and [125I]-proinsulin into liver homogenates was dose-dependently inhibited by the coinjection of native insulin (results not shown). 

Phrase: "As"

Phrase: "expected from a receptor-mediated process,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1517001:Expected [Idea or Concept]
   753   C1522240:Process [Phenomenon or Process]

Phrase: "the in vivo uptake of [125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-proinsulin into liver homogenates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "dose-dependently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0178602:Dose [Quantitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]

Phrase: "inhibited by the coinjection of native insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0302891:Native [Functional Concept]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.109: However, because of the contribution of blood radioactivity to liver radioactivity, this was more readily seen on particulate fractions, especially with [125I]-proinsulin. 

Phrase: "However,"

Phrase: "because of the contribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribution [Activity]

Phrase: "of blood radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "to liver radioactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "this"

Phrase: "was"

Phrase: "more readily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "seen on particulate fractions,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205397:Seen [Qualitative Concept]
   770   C0457784:Particulate [Substance]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1554103:Fraction [Idea or Concept]
   737 E C1947903:See [Activity]

Phrase: "especially with"

Phrase: "[125I"

Phrase: "]-proinsulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.110: At the maximal dose of native insulin tested (80 nmol), [125I]-insulin and [125I]-proinsulin uptake into the total particulate fraction was inhibited by 88%  3% and 55%  4% (mean  SEM, n = 4), respectively. 

Phrase: "At the maximal dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0178602:Dose [Quantitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]

Phrase: "of native insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(80 nmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439191:NMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-proinsulin uptake into the total particulate fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "inhibited by 88%  3%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "55%  4%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "(mean  SEM,"

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.111: When expressed as percentage of total counts per minute injected, the nondisplaceable radioactivity was the same whether [125I]-insulin or [125I]-proinsulin was used as ligand. 

Phrase: "When"

Phrase: "expressed as percentage of total counts"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0439157:counts [Quantitative Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]
   719 E C0750480:Count [Activity]
   719 E C1705566:Count [Quantitative Concept]

Phrase: "per minute"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439232:minute [Temporal Concept]
  1000   C0700321:minute [Quantitative Concept]
  1000   C0702093:/minute [Temporal Concept]
  1000   C1282918:Minute [Quantitative Concept]
  1000   C2347166:Minute [Quantitative Concept]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: ","

Phrase: "the nondisplaceable radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "whether"

Phrase: "[125I"

Phrase: "]-insulin or [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "used as ligand."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0023688:Ligand [Chemical]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.112: Subcellular distribution and characterization of [125I]-proinsulin and [125I]-insulin taken up into the liver The distribution of [125I]-labeled peptides into the N, M, L, P, and S fractions was first examined, with results expressed as percent of total recovered radioactivity (Fig. 2). 

Phrase: "Subcellular distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "characterization of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "into the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "The distribution of [125I"

Phrase: "]-labeled peptides into the N, M, L, P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1099798:peptide P [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "S fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "with results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "expressed as percent of total recovered radioactivity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   814   C0439175:percent of total [Quantitative Concept]
           % total
   774   C2827927:Percent Recovered [Quantitative Concept]
   748   C0034553:Radioactivity [Natural Phenomenon or Process]
   748   C0439165:Percent [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0521108:recovered [Qualitative Concept]
   714 E C2004454:recover [Organism Function]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.113: As shown previously (36), the P fraction was the locus of highest recovery of [125I]-insulin, with a maximum at 1.5 min (about 70%). 

Phrase: "As"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "the P fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "the locus of highest recovery of [125I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1708726:Locus [Gene or Genome]

Phrase: "]-insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with a maximum at 1.5 min (about 70%"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   795   C0702093:/min [Temporal Concept]
   795   C0806909:Maximum [Quantitative Concept]
   795   C1552615:maximum [Quantitative Concept]
   795   C2826546:MAXIMUM [Quantitative Concept]
   724 E C0205289:Maximal [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.114: However, at early times, some radioactivity was also present in the N fraction; 

Phrase: "However,"

Phrase: "at early times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "some radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "also"

Phrase: "present in the N fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.115: and at later times, the recovery of radioactivity decreased in the P fraction while concurrently increasing in the S fraction and, to a slight extent, in the M and L fractions. 

Phrase: "and at later times,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0040223:times [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   770   C1632851:Times [Quantitative Concept]
   737   C0205087:Late [Temporal Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "the recovery of radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237820:Recovery [Activity]
   770   C1555688:recovery [Idea or Concept]
   770   C2004454:Recovery [Organism Function]

Phrase: "decreased in the P fraction"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0057257:Fraction P [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "while"

Phrase: "concurrently"

Phrase: "increasing in the S fraction"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0442808:Increasing [Functional Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
   726 E C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "to a slight extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]

Phrase: "in the M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026237:Mitochondrial [Cell Component]
  1000   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "L fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.116: Regardless of the fraction, the percentage of TCA-soluble radioactivity (shown in black) increased with time but did so more rapidly and to a greater extent in the S fraction than in sedimentable fractions. 

Phrase: "Regardless of the fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "the percentage of TCA-soluble radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "("

Phrase: "shown in black"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0005680:Black [Population Group]
   790   C0027567:Black [Population Group]
   790   C0085756:Black [Population Group]
   790   C0439541:Black [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "increased with time"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0040223:Time [Temporal Concept]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   718 E C1517378:Gain [Quantitative Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "but"

Phrase: "did"

Phrase: "so more rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037640:SO [Geographic Area]
   827   C1637379:Rapidly [Qualitative Concept]

Phrase: "and to a greater extent"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1555603:Great extent [Qualitative Concept]
   760   C0439792:Extent [Spatial Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "in the S fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "than"

Phrase: "in sedimentable fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.117: View larger version (27K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.118: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.119: Distribution of homogenate radioactivity in N, M, L, P, and S fractions after injection of [125I]-proinsulin and [125I]-insulin. 

Phrase: "Distribution of homogenate radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "in N, M, L, P,"

Phrase: "and"

Phrase: "S fractions after injection of [125I"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1264633:Fraction of [Quantitative Concept]
           Fractions
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.120: Liver homogenates were prepared in the presence of protease inhibitors from rats killed at the indicated times after iv injection of [125I]-proinsulin and [125I]-insulin and fractionated by differential centrifugation. 

Phrase: "Liver homogenates"

Phrase: "were"

Phrase: "prepared in the presence of protease inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   748   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1947941:Protease [Enzyme]
   745 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   714   C1521827:Prepare [Functional Concept]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "from rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "killed at the indicated times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0162388:killed [Social Behavior]
   760   C1444656:Indicated [Finding]
   760   C1632851:Times [Quantitative Concept]
   726 E C0681205:Kill [Idea or Concept]
   726 E C1550555:kill [Functional Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "after iv injection of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "fractionated by differential centrifugation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C0443199:Differential [Qualitative Concept]
   770   C1705242:Differential [Qualitative Concept]
   770   C1979893:Fractionated [Qualitative Concept]
Processing 00000000.tx.121: Fractions are represented as histogram bars from left to right, with results expressed as the percentage of total recovered radioactivity (mean  SEM of three to seven determinations). 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "are"

Phrase: "represented as histogram"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2348974:Histogram [Manufactured Object]
   756   C1882932:Represent [Activity]

Phrase: "bars from left"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0205091:Left [Spatial Concept]
   790   C0687760:bar [Manufactured Object]
   790   C1551065:bar [Quantitative Concept]
   790   C1552822:left [Functional Concept]
   790   C1707156:BARS [Gene or Genome]
   790   C3274014:BARS [Intellectual Product]
   790   C3541345:BARS [Intellectual Product]

Phrase: "to right,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "with results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "expressed as the percentage of total recovered radioactivity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0034553:Radioactivity [Natural Phenomenon or Process]
   744   C0439165:Percentage [Quantitative Concept]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0521108:recovered [Qualitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   711 E C2004454:recover [Organism Function]

Phrase: "(mean  SEM of three to seven determinations"

Phrase: ")."
Processing 00000000.tx.122: The black area on each histogram bar represents the percentage of TCA-soluble radioactivity.  

Phrase: "The black area on each histogram bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the percentage of TCA-soluble radioactivity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
Processing 00000000.tx.123: Although, at intermediate times, [125I]-proinsulin was also mainly recovered in the P fraction, its distribution somewhat differed from that of [125I]-insulin. 

Phrase: "Although"

Phrase: ","

Phrase: "at intermediate times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also mainly"

Phrase: "recovered in the P fraction,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C0057257:Fraction P [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   760   C0521108:recovered [Qualitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   726 E C2004454:recover [Organism Function]

Phrase: "its distribution somewhat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "differed from that of [125I"

Phrase: "]-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.124: First, at early times, less radioactivity was recovered in sedimentable fractions; 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "at early times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "less radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "recovered in sedimentable fractions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0521108:recovered [Qualitative Concept]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C1554103:Fraction [Idea or Concept]
   737 E C2004454:recover [Organism Function]

Phrase: ";"
Processing 00000000.tx.125: and concurrently, more was recovered in the S fraction, reflecting a greater contribution of extracellular (blood) radioactivity to liver radioactivity. 

Phrase: "and"

Phrase: "concurrently,"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "was"

Phrase: "recovered in the S fraction,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0521108:recovered [Qualitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
   726 E C2004454:recover [Organism Function]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "a greater contribution of extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "(blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: ")"

Phrase: "radioactivity to liver radioactivity."
Processing 00000000.tx.126: Second, at late times, more radioactivity was recovered in the M and L fractions, especially in the latter (3-fold increase at 8 min). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "at late times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "more radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "recovered in the M"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521108:recovered [Qualitative Concept]
   770   C0521451:Mitochondrial [Functional Concept]
   737 E C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "L fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "especially in the latter"

Phrase: "(3-fold increase at 8 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]
Processing 00000000.tx.127: Third, the increase in TCA-soluble radioactivity occurred more slowly, especially in the S fraction, in which it did not exceed 25% of the total 8 min after injection. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "the increase in TCA-soluble radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "more slowly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0439834:Slowly [Qualitative Concept]

Phrase: "especially in the S fraction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "in which"

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exceed"

Phrase: "25% of the total 8 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0702093:/min [Temporal Concept]

Phrase: "after injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]
Processing 00000000.tx.128: The kinetics of uptake of [125I]-labeled peptides into PM and endosomal fractions was then studied (Fig. 3). 

Phrase: "The kinetics of uptake of [125I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022702:Kinetics [Natural Phenomenon or Process]
   753   C0220865:kinetics [Functional Concept]
   753   C2825046:Kinetics [Occupation or Discipline]

Phrase: "]-labeled peptides into PM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.129: In agreement with previous reports (24, 27, 36, 37), [125I]-insulin associated first with the plasma membrane and then with endosomes, with maximal enrichments of about 10-fold (plasma membrane), 40- to 80-fold (P-derived endosomes), and 100- to 300-fold (L-derived endosomes), respectively. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "(24,"

Phrase: "27,"

Phrase: "36,"

Phrase: "37"

Phrase: ")"

Phrase: ","

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "first with the plasma membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]

Phrase: "and"

Phrase: "then with endosomes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034850:Endosomes [Cell Component]
   790   C1883708:Then [Temporal Concept]

Phrase: "with maximal enrichments"

Phrase: "of about 10-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "40-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "to 80-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "(P-derived endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "100-"

Phrase: "to 300-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "(L-derived endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.130: In each of these fractions, the percentage of TCA-soluble radioactivity increased with time, especially in the PM and light endosomal fractions. 

Phrase: "In each"

Phrase: "of these fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "the percentage of TCA-soluble radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "increased with time,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0040223:Time [Temporal Concept]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   718 E C1517378:Gain [Quantitative Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "especially in the PM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "light endosomal fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.131: Although qualitatively comparable, the distribution of [125I]-proinsulin differed from that of [125I]-insulin by a less marked and prolonged association with the PM fraction, a delayed and prolonged association with endosomal fractions, and a reduced and slower increase in TCA-soluble radioactivity in both fractions. 

Phrase: "Although"

Phrase: "qualitatively comparable,"

Phrase: "the distribution of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "differed from that of [125I"

Phrase: "]-insulin by a less"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "and"

Phrase: "prolonged association with the PM fraction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "a delayed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205421:Delayed [Temporal Concept]
  1000   C3272602:Delayed [Qualitative Concept]

Phrase: "and"

Phrase: "prolonged association with endosomal fractions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "a reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "slower increase in TCA-soluble radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in both fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.132: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.133: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.134: Distribution of homogenate radioactivity in PM and endosomal fractions after injection of [125I]-proinsulin and [125I]-insulin. 

Phrase: "Distribution of homogenate radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "in PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "endosomal fractions after injection of [125I"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1264633:Fraction of [Quantitative Concept]
           Fractions
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.135: Liver homogenates were prepared from rats killed at the indicated times after iv injection of [125I]-proinsulin (white bars) and [125I]-insulin (black bars) and fractionated by differential centrifugation as shown in Fig. 

Phrase: "Liver homogenates"

Phrase: "were"

Phrase: "prepared from rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]
   756   C1521827:Prepare [Functional Concept]

Phrase: "killed at the indicated times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0162388:killed [Social Behavior]
   760   C1444656:Indicated [Finding]
   760   C1632851:Times [Quantitative Concept]
   726 E C0681205:Kill [Idea or Concept]
   726 E C1550555:kill [Functional Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "after iv injection of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(white bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(black bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "fractionated by differential centrifugation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C0443199:Differential [Qualitative Concept]
   770   C1705242:Differential [Qualitative Concept]
   770   C1979893:Fractionated [Qualitative Concept]

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.136: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.137: The PM fraction was isolated from the N fraction and two sets of three endosomal fractions were isolated from the L (Ll, Li, and Lh) and P (GEl, GEi, and GEh) fractions as described in Materials and Methods. 

Phrase: "The PM fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "was"

Phrase: "isolated from the N fraction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205409:Isolated [Functional Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1554103:Fraction [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "two sets of three endosomal fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036849:Set [Mental Process]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]

Phrase: "were"

Phrase: "isolated from the L"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205409:Isolated [Functional Concept]
   770   C0521450:Lysosomal [Body Location or Region]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(Ll,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Lh)"

Phrase: "and"

Phrase: "P (GEl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "GEi,"

Phrase: "and"

Phrase: "GEh) fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.138: Left, Radioactivity associated with each fraction, expressed relative to the radioactivity in the homogenate. 

Phrase: "Left,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "Radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "associated with each fraction,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1264633:Fraction [Quantitative Concept]
   770   C1554103:Fraction [Idea or Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "expressed"

Phrase: "relative to the radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "in the homogenate."
Processing 00000000.tx.139: Right, Percentage of radioactivity that is TCA-soluble. 

Phrase: "Right,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "Percentage of radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439165:Percentage [Quantitative Concept]
   790   C1549488:Percentage [Idea or Concept]
   790   C1561533:Percentage [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "TCA-soluble."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]
   734   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.140: Results are the mean  SEM of at least three determinations.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of"

Phrase: "at least three determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.141: Quantitative subfractionation of the P fraction on Nycodenz density gradients showed that, at 4 and 8 min, both [125I]-insulin and [125I]-proinsulin distributed as single components that peaked at the density of 1.09 g/ml, as did galactosyltransferase, a Golgi marker (results not shown). 

Phrase: "Quantitative subfractionation of the P fraction"

Phrase: "on Nycodenz density gradients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0178587:density [Quantitative Concept]
   827   C0812409:gradients [Quantitative Concept]
   793 E C0439182:% gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "at 4"

Phrase: "and"

Phrase: "8 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "both"

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "distributed as single components"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0037179:Single [Population Group]
   770   C0087136:single [Finding]
   770   C0205171:Single [Quantitative Concept]
   770   C0449432:Components [Manufactured Object]
   770   C1704711:Distributed [Functional Concept]
   737 E C1705248:Component [Conceptual Entity]

Phrase: "that"

Phrase: "peaked at the density of 1.09 g/ml,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C1300565:g/mL [Quantitative Concept]
   762   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   762 E C1637390:mL/g [Quantitative Concept]
   742   C0178587:density [Quantitative Concept]
   742   C0439267:g% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C0444505:peaked [Quantitative Concept]

Phrase: "as"

Phrase: "did"

Phrase: "galactosyltransferase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016964:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0702242:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a Golgi marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.142: In contrast, whereas [125I]-insulin associated with the L fraction also migrated as a single component at the density of 1.09 g/ml, [125I]-proinsulin distributed as two incompletely resolved components at densities of about 1.09 and 1.12 g/ml, respectively. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "whereas"

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "associated with the L fraction also"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0521450:Lysosomal [Body Location or Region]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "migrated as a single component"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0232902:Migrated [Functional Concept]
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "at the density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of 1.09 g/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "distributed as two incompletely resolved components"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0205448:Two [Quantitative Concept]
   753   C0449432:Components [Manufactured Object]
   753   C1514893:Resolved [Idea or Concept]
   753   C1704711:Distributed [Functional Concept]
   753   C2699488:Resolved [Conceptual Entity]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "at densities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:densities [Quantitative Concept]
   916 E C0439794:Dense [Qualitative Concept]

Phrase: "of about 1.09"

Phrase: "and"

Phrase: "1.12 g/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.143: The radioactivity associated with the component of highest density largely overlapped with N-acetyl--D-glucosaminidase, suggesting association of [125I]-proinsulin with lysosomes. 

Phrase: "The radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "associated with the component of highest density largely"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0178587:density [Quantitative Concept]
   744   C0449432:Component [Manufactured Object]
   744   C1522410:Highest [Qualitative Concept]
   744   C1705248:Component [Conceptual Entity]
   711 E C0205250:High [Qualitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1299351:High [Qualitative Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C2700149:HIGH [Intellectual Product]

Phrase: "overlapped with N-acetyl"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0185027:overlapped [Therapeutic or Preventive Procedure]
   770   C0521447:Nuclear [Spatial Concept]
   737 E C1948020:Overlap [Conceptual Entity]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017724:Glucosaminidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "association of [125I"

Phrase: "]-proinsulin with lysosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.144: To confirm the involvement of the insulin receptor in the in vivo uptake of [125I]-proinsulin, PM and endosomal fractions were subjected to reducing SDS-PAGE analysis after cross-linking of ligand-receptor complexes. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the involvement of the insulin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "in the in vivo uptake of [125I"

Phrase: "]-proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "PM"

Phrase: "and"

Phrase: "endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "subjected to reducing SDS-PAGE analysis"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0392756:Reducing [Qualitative Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1704732:Page [Intellectual Product]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "after"

Phrase: "cross-linking of ligand-receptor complexes."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0332220:Cross-linking [Functional Concept]
   783   C1621296:receptor ligand [Molecular Function]
   773 E C0178576:Cross link [Natural Phenomenon or Process]
   773   C1523873:receptor complex [Cell Component]
   753   C0023688:Ligand [Chemical]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   753   C2828360:Cross [Conceptual Entity]
   719 E C0439855:Complex [Qualitative Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]
Processing 00000000.tx.145: As with [125I]-insulin, a major band of molecular mass 135-kDa, the expected size of the -subunit of the insulin receptor, was identified (results not shown). 

Phrase: "As with"

Phrase: "[125I"

Phrase: "]-insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a major band of molecular mass 135-kDa,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0230715:A band [Cell Component]
   744   C0175723:Band [Medical Device]
   744   C0439645:Band [Spatial Concept]
   744   C1521913:band [Cell Component]

Phrase: "the expected size of the -subunit of the insulin receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0456389:size [Spatial Concept]

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.146: In time studies, the intensity of this band paralleled the radioactivity content of the fractions; 

Phrase: "In time studies,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
  1000   C0040227:Time Studies [Intellectual Product]
   861   C0040223:Time [Temporal Concept]
   861   C0947630:studies [Laboratory Procedure]
   861   C3541383:Time [Temporal Concept]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "the intensity of this band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "paralleled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C2348042:Parallel [Qualitative Concept]
   966   C2826345:PARALLEL [Research Activity]

Phrase: "the radioactivity content of the fractions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.147: but at any given time, it was at least three times lower than with [125I]-insulin. 

Phrase: "but at any given time,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0040223:Time [Temporal Concept]
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "it"

Phrase: "was at least three times"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0040223:times [Temporal Concept]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0205449:Three [Quantitative Concept]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0441994:Lower [Spatial Concept]
   833   C1548802:Lower [Body Location or Region]
   833   C2003888:Lower [Activity]

Phrase: "with"

Phrase: "[125I"

Phrase: "]-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.148: Gel filtration analysis of the radioactivity extracted from endosomal fractions showed that, in addition to the major proinsulin- and insulin-sized peaks, some radioactivity was eluted as high- and low-molecular-weight components (Fig. 4). 

Phrase: "Gel filtration analysis of the radioactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597748:radioactivity analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "extracted from endosomal fractions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C1264633:Fractions [Quantitative Concept]
   770   C3541890:EXTRACTED [Finding]
   737 E C1554103:Fraction [Idea or Concept]
   737 E C2828366:Extract [Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "in addition to the major proinsulin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "insulin-sized peaks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:peaks [Quantitative Concept]

Phrase: "some radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "eluted as high-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205250:High [Qualitative Concept]
   790   C1299351:High [Qualitative Concept]
   790   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "low-molecular-weight components"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0449432:Components [Manufactured Object]
   779 E C1705248:Component [Conceptual Entity]
   708   C0041667:Low weight [Finding]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.149: At 8 min, the low-molecular-weight components accounted for about 35% of the total eluted radioactivity after [125I]-insulin injection but only 10% after [125I]-proinsulin injection. 

Phrase: "At 8 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "the low-molecular-weight components"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0449432:Components [Manufactured Object]
   779 E C1705248:Component [Conceptual Entity]
   708   C0041667:Low weight [Finding]

Phrase: "accounted for about 35% of the total eluted radioactivity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0034553:Radioactivity [Natural Phenomenon or Process]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   708   C1551359:account [Idea or Concept]
   708   C2741673:Account # [Clinical Attribute]
   708   C2981730:Account [Classification]

Phrase: "after"

Phrase: "[125I"

Phrase: "]-insulin injection"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0199782:Insulin injection [Therapeutic or Preventive Procedure]
  1000   C0586328:Insulin injection [Therapeutic or Preventive Procedure]
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1828121:Injection [Functional Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "only 10%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "after"

Phrase: "[125I"

Phrase: "]-proinsulin injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]
Processing 00000000.tx.150: In addition, little or no radioactivity was eluted at the position of [125I]-insulin after [125I]-proinsulin injection. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "eluted at the position of [125I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "after"

Phrase: "[125I"

Phrase: "]-proinsulin injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]
Processing 00000000.tx.151: View larger version (16K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.152: 4. 

Phrase: "4."
Processing 00000000.tx.153: Gel-filtration elution profile of the radioactivity associated with endosomal fractions after injection of [125I]-proinsulin and [125I]-insulin. 

Phrase: "Gel-filtration elution profile of the radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1979963:Profile [Laboratory Procedure]
   748   C2003903:Profile [Functional Concept]

Phrase: "associated with endosomal fractions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1264633:Fractions [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1554103:Fraction [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "after injection of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.154: Endosomal fractions were isolated in the presence of protease inhibitors from liver homogenates of rats killed 8 min after iv injection of [125I]-proinsulin (A) and [125I]-insulin (B). 

Phrase: "Endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "isolated in the presence of protease inhibitors"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   778   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   748   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0205409:Isolated [Functional Concept]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1548221:Isolated [Idea or Concept]
   748   C1947941:Protease [Enzyme]
   745 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "from liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "homogenates of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "8 min after iv injection of [125I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0702093:/min [Temporal Concept]

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: ")"

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.155: The radioactivity was extracted by 4 M acetic acid and chromatographed on a 1 x 50-cm Sephadex G50 column equilibrated with 1 M acetic acid. 

Phrase: "The radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "extracted by 4 M acetic acid"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0000985:Acetic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   753   C3541890:EXTRACTED [Finding]
   719 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "chromatographed on a 1 x 50-cm Sephadex G50 column"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0078589:X 50 [Organic Chemical]
   739   C0074343:sephadex [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C1185738:Column [Body Part, Organ, or Organ Component]
   739   C1706132:Column [Idea or Concept]
   706   C0302647:chromatograph [Medical Device]

Phrase: "equilibrated with 1 M acetic acid."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0000985:Acetic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.156: Seventy fractions (0.3 ml each) were collected and analyzed for radioactivity. 

Phrase: "Seventy fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "(0.3 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "each"

Phrase: ")"

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "analyzed for radioactivity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034553:Radioactivity [Natural Phenomenon or Process]
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.157: Arrows indicate the elution position of intact [125I]-proinsulin (PI) and [125I]-insulin (I).  

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the elution position of intact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0733755:Position [Spatial Concept]

Phrase: "[125I"

Phrase: "]-proinsulin (PI)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin (I)."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.158: Degradation and dissociation of [125I]-labeled and unlabeled peptides within intact isolated endosomes Endosomal subfractions containing in vivo internalized [125I]-insulin have been shown to degrade this peptide in a pH- and ATP-dependent manner when incubated under conditions maintaining endosomal integrity (21, 24, 38, 39, 40, 41, 42). 

Phrase: "Degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "dissociation of [125I"

Phrase: "]-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "unlabeled peptides within intact isolated endosomes Endosomal subfractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "internalized"

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "this peptide in a pH-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "ATP-dependent manner"

Phrase: "when"

Phrase: "incubated under conditions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1439852:Incubated [Laboratory Procedure]
   756   C0012634:condition [Disease or Syndrome]
   756   C0348080:Condition [Qualitative Concept]
   756   C1705253:Condition [Conceptual Entity]
   706 E C0009647:Conditioned [Mental Process]
   706 E C1701901:Conditional [Qualitative Concept]
   706 E C1963686:Conditional [Functional Concept]

Phrase: "maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "endosomal integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "(21,"

Phrase: "24,"

Phrase: "38,"

Phrase: "39,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.159: Using the TCA-precipitation assay, we compared the degradation of [125I]-insulin and [125I]-proinsulin in this cell-free system (Fig. 5). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TCA-precipitation assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the degradation of [125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-proinsulin in this cell-free system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.160: As [125I]-insulin, [125I]-proinsulin was degraded in a time- and pH-dependent manner, with a maximum at pH 6, and addition of ATP shifted the pH for maximal degradation to about 7.5. 

Phrase: "As [125I"

Phrase: "]-insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "degraded in a time-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0040223:Time [Temporal Concept]
   770   C1881707:DEGRADED [Phenomenon or Process]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "pH-dependent manner,"

Phrase: "with a maximum"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0806909:Maximum [Quantitative Concept]
  1000   C1552615:maximum [Quantitative Concept]
  1000   C2826546:MAXIMUM [Quantitative Concept]
   928 E C0205289:Maximal [Qualitative Concept]

Phrase: "at pH 6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "addition of ATP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "shifted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0333051:shifted [Functional Concept]
   966 E C2347509:Shift [Phenomenon or Process]

Phrase: "the pH for maximal degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]

Phrase: "to about 7.5."
Processing 00000000.tx.161: However, at the optimum pH, the rate of proinsulin degradation was about three times lower than that of [125I]-insulin degradation (Table 1). 

Phrase: "However,"

Phrase: "at the optimum pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "the rate of proinsulin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "about three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "lower than that of [125I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "]-insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.162: Studies with endosomes isolated after coinjection of increasing doses of native proinsulin (up to 13.3 nmol) with [125I]-proinsulin showed that, as with insulin (21), the fractional degradation of [125I]-proinsulin decreased with increasing endosomal ligand content (results not shown). 

Phrase: "Studies with endosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "isolated after coinjection of increasing doses of native proinsulin"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   742   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0178602:Doses [Quantitative Concept]
   742   C0205409:Isolated [Functional Concept]
   742   C0302891:Native [Functional Concept]
   742   C0442808:Increasing [Functional Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C0869039:Dose [Quantitative Concept]
   708 E C1114758:Dose # [Clinical Attribute]
   708 E C1428722:DOS [Gene or Genome]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "("

Phrase: "up to 13.3 nmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439191:NMOLE [Quantitative Concept]

Phrase: "with"

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "as with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "the fractional degradation of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "decreased with increasing endosomal ligand content"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0023688:Ligand [Chemical]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0423896:Content [Mental Process]
   753   C0442797:decreased [Qualitative Concept]
   753   C0442808:Increasing [Functional Concept]
   753   C0456205:Content [Conceptual Entity]
   719 E C0442805:Increase [Functional Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.163: However, regardless of ligand content, [125I]-proinsulin was always degraded about three times less rapidly than [125I]-insulin. 

Phrase: "However,"

Phrase: "regardless of ligand content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "degraded about three times less rapidly"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0040223:times [Temporal Concept]
   753   C0205449:Three [Quantitative Concept]
   753   C1632851:Times [Quantitative Concept]
   753   C1637379:Rapidly [Qualitative Concept]
   753   C1881707:DEGRADED [Phenomenon or Process]
   719 E C3541383:Time [Temporal Concept]

Phrase: "than"

Phrase: "[125I"

Phrase: "]-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.164: View larger version (12K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.165: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.166: Degradation of in vivo internalized [125I]-proinsulin and [125I]-insulin in cell-free endosomes. 

Phrase: "Degradation of in vivo internalized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin in cell-free endosomes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0034850:Endosomes [Cell Component]
   708   C0487017:Insulin.free [Clinical Attribute]
Processing 00000000.tx.167: Endosomal fractions were isolated from liver homogenates of rats killed after iv injection of [125I]-proinsulin (4 min) and [125I]-insulin (2 min). 

Phrase: "Endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "isolated from liver"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0023884:Liver [Body Part, Organ, or Organ Component]
   790   C0205409:Isolated [Functional Concept]
   790   C0736268:LIVER [Body Part, Organ, or Organ Component]
   790   C1278929:Liver [Body Part, Organ, or Organ Component]
   790   C1548221:Isolated [Idea or Concept]
   790   C2346688:LIVER [Food]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]
   734 E C0205054:Hepatic [Body Location or Region]

Phrase: "homogenates of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]

Phrase: "killed after iv injection of [125I"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0021494:IV injection [Functional Concept]
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C0162388:killed [Social Behavior]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1828121:Injection [Functional Concept]
   719 E C0681205:Kill [Idea or Concept]
   719 E C1550555:kill [Functional Concept]

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.168: They were suspended in 125 mM KCl buffered with 25 mM citrate-phosphate and incubated, under various time and pH conditions, at 37 C. 

Phrase: "They"

Phrase: "were"

Phrase: "suspended in 125 mM KCl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1553389:suspended [Idea or Concept]
   760   C1553403:suspended [Idea or Concept]
   760   C1705537:Suspended [Functional Concept]

Phrase: "buffered with 25 mM citrate-phosphate"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   783   C1553427:Buffered Citrate [Intellectual Product]
   767 E C3256468:citrate buffer [Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0008857:Citrate [Organic Chemical]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "incubated,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "under various time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "pH conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "at 37 C."
Processing 00000000.tx.169: A, The medium was buffered to pH 6, and incubations were carried out for the indicated times, after which the TCA-soluble radioactivity released from [125I]-insulin (closed circles) and [125I]-proinsulin (open circles) was determined. 

Phrase: "A,"

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "buffered to pH 6,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C0492253:PH BUFFER [Medical Device]
   770   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "incubations"

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out for the indicated times,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   781   C0871938:out time [Mental Process]
   760   C0040223:times [Temporal Concept]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C1444656:Indicated [Finding]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "after"

Phrase: "which the TCA-soluble radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "released from"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   833   C0391871:Released [Functional Concept]
   833   C1283071:Released [Functional Concept]
   799 E C0030685:Release [Health Care Activity]
   799 E C0439180:% release [Quantitative Concept]
   799 E C0680255:release [Health Care Activity]
   799 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "and ["

Phrase: "125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(open circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.170: B, The medium was buffered to the indicated pH and supplemented (open symbols) or not (closed symbols) with 5 mM MgCl2 and 1 mM ATP; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "buffered to the indicated pH"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   781   C0492253:PH BUFFER [Medical Device]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "supplemented"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0242295:Supplement [Food]
   966   C1947943:Supplement [Intellectual Product]
   966   C2348609:Supplement [Functional Concept]

Phrase: "(open symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "not (closed symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0679214:symbols [Idea or Concept]
   793 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "with 5 mM MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1 mM ATP"

Phrase: ";"
Processing 00000000.tx.171: and, after incubation for 5 min, the TCA-soluble radioactivity released from [125I]-proinsulin (triangles) and [125I]-insulin (circles) was determined.  

Phrase: "and"

Phrase: ","

Phrase: "after"

Phrase: "incubation for 5 min,"

Phrase: "the TCA-soluble radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "released from"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   833   C0391871:Released [Functional Concept]
   833   C1283071:Released [Functional Concept]
   799 E C0030685:Release [Health Care Activity]
   799 E C0439180:% release [Quantitative Concept]
   799 E C0680255:release [Health Care Activity]
   799 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205119:triangles [Conceptual Entity]

Phrase: ")"

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1282913:Circle [Spatial Concept]
   966   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.172: View this table: [in this window] [in a new window]  TABLE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.173: Comparative degradation of 125I-labeled and unlabeled human insulin (HI), human proinsulin (HPI), and human proinsulin conversion intermediates within intact cell-free endosomes and by isolated endosomal, plasma membrane, and cytosolic fractions  Because the TCA-precipitation assay is known to underestimate [125I]-insulin degradation (43, 44, 45) and may potentially underestimate, to a greater extent, [125I]-proinsulin degradation, studies were also performed with intact cell-free endosomes loaded in vivo with native peptides and incubated at pH 6 (Table 1). 

Phrase: "Comparative degradation of 125I-labeled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "unlabeled human insulin (HI),"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "human proinsulin (HPI),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0086418:Human [Human]

Phrase: "and"

Phrase: "human proinsulin conversion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439836:Conversion [Functional Concept]

Phrase: "intermediates within intact cell-free endosomes"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0682538:intact cell [Cell]
   790   C1183428:cell free [Cell]
   753   C0007634:Cell [Cell]
   753   C0034850:Endosomes [Cell Component]
   753   C0205103:Intermediate [Spatial Concept]
   753   C0205266:Intact [Qualitative Concept]
   753   C0332296:free [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1550465:intermediate [Idea or Concept]
   753   C1554187:Intact [Idea or Concept]
   753   C1704653:Cell [Medical Device]
   753   C1880497:Free [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and by isolated endosomal, plasma membrane,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0007603:Plasma membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0032105:Plasma [Body Substance]
   753   C0205409:Isolated [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1515981:And [Idea or Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1706182:Membrane [Manufactured Object]
   748   C1179907:endosome membrane [Cell Component]
   748   C2247585:isolation membrane [Cell Component]

Phrase: "and"

Phrase: "cytosolic fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "Because"

Phrase: "the TCA-precipitation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "underestimate"

Phrase: "[125I"

Phrase: "]-insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "(43,"

Phrase: "44,"

Phrase: "45"

Phrase: ")"

Phrase: "and"

Phrase: "may"

Phrase: "potentially"

Phrase: "underestimate"

Phrase: ","

Phrase: "to a greater extent,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1555603:Great extent [Qualitative Concept]
   861   C0439792:Extent [Spatial Concept]

Phrase: "[125I"

Phrase: "]-proinsulin degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "also"

Phrase: "performed with intact cell-free endosomes"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0682538:intact cell [Cell]
   790   C1183428:cell free [Cell]
   753   C0007634:Cell [Cell]
   753   C0034850:Endosomes [Cell Component]
   753   C0205266:Intact [Qualitative Concept]
   753   C0332296:free [Functional Concept]
   753   C0884358:Performed [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1554187:Intact [Idea or Concept]
   753   C1704653:Cell [Medical Device]
   753   C1880497:Free [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: "in vivo with native peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "incubated at pH 6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.174: Under these conditions, the rate of proinsulin degradation, as measured by RIA using an anti-insulin serum, was decreased about 6-fold, relative to that for insulin (2% and 11.7% per min, respectively). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the rate of proinsulin degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "as"

Phrase: "measured by RIA"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0034580:RIA [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an anti-insulin serum,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   901   C0428357:Insulin - serum [Laboratory Procedure]
   901   C1261415:insulin serum [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0229671:Serum [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "decreased about 6-fold,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0332462:Fold [Spatial Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1880834:FOLD [Phenomenon or Process]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "relative to that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "for insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "11.7% per min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.175: Two proinsulin conversion intermediates, more slowly cleared from the liver than insulin, des-[64, 65]proinsulin and split-[3233]proinsulin, showed rates of endosomal degradation intermediate between those for insulin and proinsulin (8.3 and 4.7% per min, respectively). 

Phrase: "Two proinsulin conversion intermediates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0205103:Intermediate [Spatial Concept]
   779   C1550465:intermediate [Idea or Concept]
   779   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "more slowly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0439834:Slowly [Qualitative Concept]

Phrase: "cleared from the liver"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0521097:cleared [Functional Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   737 E C2963144:Clear [Qualitative Concept]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "than insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "des-[64,"

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "]proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "split-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1534709:Split [Functional Concept]
  1000   C1881714:SPLIT [Phenomenon or Process]

Phrase: "[3233"

Phrase: "]proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "rates of endosomal degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "intermediate between those for insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205103:Intermediate [Spatial Concept]
   760   C1550465:intermediate [Idea or Concept]
   760   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(8.3"

Phrase: "and"

Phrase: "4.7% per min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.176: The rate of proinsulin degradation was also decreased when estimated by a proinsulin-specific RIA but to a lesser extent (3.8% per min; Table 1). 

Phrase: "The rate of proinsulin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "when"

Phrase: "estimated by a proinsulin-specific RIA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0034580:RIA [Laboratory Procedure]
   753   C0205369:Specific [Qualitative Concept]
   753   C0750572:Estimated [Quantitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "but to a lesser extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]

Phrase: "(3.8% per min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439086:<3 [Quantitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2827736:3+ [Quantitative Concept]
   770   C2981702:3+ [Classification]

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.177: Because insulin degradation within endosomes requires its dissociation from the insulin receptor at the low endosomal pH, the possibility that the decreased degradation of [125I]-proinsulin resulted from its slower dissociation from the receptor was examined. 

Phrase: "Because"

Phrase: "insulin degradation within endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "requires"

Phrase: "its dissociation from the insulin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "at the low endosomal pH,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0728725:Low pH [Finding]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the decreased degradation of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulted from its slower dissociation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   726   C0439834:Slow [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "from the receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.178: To address this, the extraluminal release and intraluminal dissociation of [125I]-insulin and [125I]-proinsulin in intact cell-free endosomes, as a function of pH, were comparatively examined using a PEG-precipitation procedure (21, 24) (Fig. 6). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this,"

Phrase: "the extraluminal release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "intraluminal dissociation of [125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-proinsulin in intact cell-free endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "a function of pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "were"

Phrase: "comparatively"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PEG-precipitation procedure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]
   734   C0444679:Polyethylene glycol precipitation [Laboratory Procedure]

Phrase: "(21,"

Phrase: "24"

Phrase: ")"

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.179: As the generation of TCA-soluble radioactivity, the extraendosomal release of radioactivity (judged on the generation of PEG-soluble radioactivity in intact endosomes) was maximal at pH 6 but was about 2-fold lower for [125I]-proinsulin than for [125I]-insulin in the pH range 47 (Fig. 6A). 

Phrase: "As the generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of TCA-soluble radioactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "the extraendosomal release of radioactivity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "judged on the generation of PEG-soluble radioactivity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   744   C0034553:Radioactivity [Natural Phenomenon or Process]
   744   C0079411:Generation [Temporal Concept]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   744   C3146294:Generation [Activity]
   711   C0221191:Judge [Professional or Occupational Group]

Phrase: "in intact endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: "was"

Phrase: "maximal at pH 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205289:Maximal [Qualitative Concept]
   770   C0806909:Maximal [Quantitative Concept]

Phrase: "but"

Phrase: "was"

Phrase: "about 2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "lower for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0441994:Lower [Spatial Concept]
   833   C1548802:Lower [Body Location or Region]
   833   C2003888:Lower [Activity]

Phrase: "[125I"

Phrase: "]-proinsulin than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for"

Phrase: "[125I"

Phrase: "]-insulin in the pH range 47"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.180: This indicates that only TCA-soluble products diffuse out of endosomes. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that only TCA-soluble products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]

Phrase: "diffuse out of endosomes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034850:Endosomes [Cell Component]
   770   C0205219:Diffuse [Qualitative Concept]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.181: The intraendosomal dissociation of receptor-bound ligands (judged on the generation of PEG-soluble radioactivity in Brij-35-permeabilized endosomes) progressively decreased as the pH was increased, but was virtually identical for [125I]-proinsulin and [125I]-insulin (6075%) in the pH range 46.5 (Fig. 6B). 

Phrase: "The intraendosomal dissociation of receptor-bound ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "("

Phrase: "judged on the generation of PEG-soluble radioactivity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   744   C0034553:Radioactivity [Natural Phenomenon or Process]
   744   C0079411:Generation [Temporal Concept]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   744   C3146294:Generation [Activity]
   711   C0221191:Judge [Professional or Occupational Group]

Phrase: "in Brij-35-permeabilized endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: "progressively"

Phrase: "decreased as the pH"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   819   C0728725:decreased ph [Finding]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "but"

Phrase: "was"

Phrase: "virtually identical for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(6075%"

Phrase: ")"

Phrase: "in the pH range 46.5"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]
   812   C1514721:Range [Quantitative Concept]
   812   C2348147:Range [Quantitative Concept]
   812   C3542016:Range [Intellectual Product]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.182: Dissociation of [125I]-proinsulin even slightly exceeded that of [125I]-insulin at pH 7 and above, consistent with a previous report (11). 

Phrase: "Dissociation of [125I"

Phrase: "]-proinsulin even slightly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0750482:Slightly [Idea or Concept]

Phrase: "exceeded"

Phrase: "that of [125I"

Phrase: "]-insulin at pH 7"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "above, consistent with a previous report"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.183: Thus, a slower dissociation of [125I]-proinsulin from the internalized insulin receptor does not account for its reduced degradation in endosomes. 

Phrase: "Thus,"

Phrase: "a slower dissociation of [125I"

Phrase: "]-proinsulin from the internalized insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1718242:Proinsulin/Insulin [Quantitative Concept]
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "account for its reduced degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243125:degradation [Functional Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0699900:Degradation [Organism Function]
   760   C1551359:account [Idea or Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]

Phrase: "in endosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]
Processing 00000000.tx.184: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.185: 6. 

Phrase: "6."
Processing 00000000.tx.186: Dissociation of in vivo internalized [125I]-proinsulin and [125I]-insulin in cell-free endosomes, as a function of medium pH. 

Phrase: "Dissociation of in vivo internalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin in cell-free endosomes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0034850:Endosomes [Cell Component]
   708   C0487017:Insulin.free [Clinical Attribute]

Phrase: "as"

Phrase: "a function of medium pH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]
Processing 00000000.tx.187: Endosomal fractions were isolated from liver homogenates of rats killed after iv injection of [125I]-proinsulin (4 min) and [125I]-insulin (2 min). 

Phrase: "Endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "isolated from liver"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0023884:Liver [Body Part, Organ, or Organ Component]
   790   C0205409:Isolated [Functional Concept]
   790   C0736268:LIVER [Body Part, Organ, or Organ Component]
   790   C1278929:Liver [Body Part, Organ, or Organ Component]
   790   C1548221:Isolated [Idea or Concept]
   790   C2346688:LIVER [Food]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]
   734 E C0205054:Hepatic [Body Location or Region]

Phrase: "homogenates of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]

Phrase: "killed after iv injection of [125I"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0021494:IV injection [Functional Concept]
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C0162388:killed [Social Behavior]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1828121:Injection [Functional Concept]
   719 E C0681205:Kill [Idea or Concept]
   719 E C1550555:kill [Functional Concept]

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.188: They were suspended in 125 mM KCl buffered with 25 mM citrate-phosphate at the indicated pH and incubated for 5 min at 37 C. 

Phrase: "They"

Phrase: "were"

Phrase: "suspended in 125 mM KCl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1553389:suspended [Idea or Concept]
   760   C1553403:suspended [Idea or Concept]
   760   C1705537:Suspended [Functional Concept]

Phrase: "buffered with 25 mM citrate-phosphate"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   783   C1553427:Buffered Citrate [Intellectual Product]
   767 E C3256468:citrate buffer [Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0008857:Citrate [Organic Chemical]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "at the indicated pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "incubated for 5 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C."
Processing 00000000.tx.189: After a further incubation at 4 C, in the absence (A) or presence (B) of 0.1% Brij-35, the percentage of [125I]-proinsulin (open circles) and [125I]-insulin (closed circles) released out of endosomes (- Brij-35) and dissociated from the endosomal insulin receptor (+ Brij-35) was determined by PEG precipitation; 

Phrase: "After a further incubation"

Phrase: "at 4 C,"

Phrase: "in the absence (A)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(B) of 0.1% Brij-35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347469:/B [Quantitative Concept]

Phrase: "the percentage of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(open circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "released out of endosomes"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0034850:Endosomes [Cell Component]
   770   C0391871:Released [Functional Concept]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(- Brij-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0107162:Brij 35 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "dissociated from the endosomal insulin receptor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   790   C1334133:INSULIN RECEPTOR [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(+ Brij-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0107162:Brij 35 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "determined by PEG precipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0444679:Polyethylene glycol precipitation [Laboratory Procedure]
   770   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0032931:Precipitation [Natural Phenomenon or Process]
   770   C0032932:Precipitation [Molecular Function]
   770   C1642401:% precipitation [Quantitative Concept]
   770   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.190: it was expressed relative to total and endosome-associated radioactivity, respectively. 

Phrase: "it"

Phrase: "was"

Phrase: "expressed"

Phrase: "relative to total"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "endosome-associated radioactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "respectively."
Processing 00000000.tx.191: Results are the mean  SEM of four determinations on separate endosomal fractions.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of four determinations"

Phrase: "on separate endosomal fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.192: Cell-free endosome-lysosome transfer of internalized [125I]-labeled peptides Although not easily detectable in situ, an endosome-lysosome transfer of in vivo internalized [125I]-insulin occurs, under cell-free conditions, in the presence of cytosol and ATP (25, 28). 

Phrase: "Cell-free endosome-lysosome transfer of internalized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040671:Transfer [Mental Process]
   748   C1705822:Transfer [Activity]

Phrase: "[125I"

Phrase: "]-labeled peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "Although"

Phrase: "not easily detectable in situ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0444498:In situ [Spatial Concept]

Phrase: "an endosome-lysosome transfer of in vivo internalized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0040671:Transfer [Mental Process]
   744   C1705822:Transfer [Activity]

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "under cell-free conditions,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   734   C1183428:cell free [Cell]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "ATP"

Phrase: "(25,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.193: To compare [125I]-proinsulin and [125I]-insulin lysosomal transfer, LPS fractions, isolated after ligand injection, were incubated for various times, at 37 C, in the presence of ATP, after which the distribution of total and TCA-precipitable radioactivity on Nycodenz density gradients was analyzed (Fig. 7). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin lysosomal transfer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]

Phrase: "LPS fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "isolated after ligand injection,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0021485:injection [Therapeutic or Preventive Procedure]
   770   C0023688:Ligand [Chemical]
   770   C0205409:Isolated [Functional Concept]
   770   C1272883:Injection [Biomedical or Dental Material]
   770   C1533685:Injection [Therapeutic or Preventive Procedure]
   770   C1548221:Isolated [Idea or Concept]
   770   C1828121:Injection [Functional Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "incubated for various times,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0040223:times [Temporal Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "at 37 C,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of ATP,"

Phrase: "after"

Phrase: "which the distribution of total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "TCA-precipitable radioactivity on Nycodenz density gradients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.194: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.195: 7. 

Phrase: "7."
Processing 00000000.tx.196: Cell-free endosome lysosome transfer of in vivo internalized [125I]-proinsulin and [125I]-insulin. 

Phrase: "Cell-free endosome lysosome transfer of in vivo internalized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0040671:Transfer [Mental Process]
   742   C1705822:Transfer [Activity]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.197: LPS fractions were isolated from livers of rats killed 8 min after injection of [125I]-proinsulin (PI) or [125I]-insulin (I). 

Phrase: "LPS fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "isolated from livers of rats"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   764   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   760   C0023884:Livers [Body Part, Organ, or Organ Component]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   726 E C1278929:Liver [Body Part, Organ, or Organ Component]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C2346688:LIVER [Food]

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "8 min after injection of [125I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(PI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "or [125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(I"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.198: After incubation in the presence of ATP and an ATP-regenerating system at 4 C or 37 C, they were subfractionated by centrifugation on Nycodenz density gradients as described in Materials and Methods. 

Phrase: "After incubation"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of ATP"

Phrase: "and"

Phrase: "an ATP-regenerating system at 4 C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "or"

Phrase: "37 C,"

Phrase: "they"

Phrase: "were"

Phrase: "subfractionated by centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "on Nycodenz density gradients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0178587:density [Quantitative Concept]
   827   C0812409:gradients [Quantitative Concept]
   793 E C0439182:% gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.199: Twenty subfractions were collected and analyzed for density, total and TCA-precipitable radioactivity, and N-acetyl--D-glucosaminidase activity. 

Phrase: "Twenty subfractions"

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "analyzed for density,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0178587:density [Quantitative Concept]
   790   C0936012:Analyzed [Research Activity]
   718 E C0439794:Dense [Qualitative Concept]

Phrase: "total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "TCA-precipitable radioactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "N-acetyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.200: A, Representative distribution of the radioactivity as a function of density after incubation of LPS fractions for 10 min at 4 C (closed circles) or 37 C (open circles); 

Phrase: "A,"

Phrase: "Representative distribution of the radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "after incubation"

Phrase: "of LPS fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C (closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1282913:Circle [Spatial Concept]
   779   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "or"

Phrase: "37 C (open circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1282913:Circle [Spatial Concept]
   779   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.201: 85% of N-acetyl--D-glucosaminidase activity was recovered in the density interval 1.1101.145 g/ml, with a peak at d = 1.128 g/ml (not shown on the figure). 

Phrase: "85% of N-acetyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0521447:Nuclear [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "recovered in the density interval 1.1101.145 g/ml,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   760   C1300565:g/mL [Quantitative Concept]
   757   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   757 E C1637390:mL/g [Quantitative Concept]
   757   C3661266:ML-145 [Organic Chemical,Pharmacologic Substance]
   739   C0178587:density [Quantitative Concept]
   739   C0439267:g% [Quantitative Concept]
   739   C0439526:/mL [Quantitative Concept]
   739   C0521108:recovered [Qualitative Concept]
   739   C1272706:Interval [Temporal Concept]
   739   C1552654:Interval [Idea or Concept]
   739   C1552713:Interval [Intellectual Product]
   706 E C2004454:recover [Organism Function]

Phrase: "with a peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "at"

Phrase: "d ="

Phrase: "1.128 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "ml ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown on the figure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.202: B, Distribution of the radioactivity associated with soluble (S) (d < 1.065 g/ml), endosomal (E) (1.065 g/ml < d < 1.105 g/ml), and lysosomal (L) (1.110 g/ml < d < 1.150 g/ml) components after incubation of the LPS fractions for the indicated time at 37 C. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Distribution of the radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "associated with soluble"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1749467:soluble [Cell Component]
   790   C1948047:Soluble [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: ")"

Phrase: "("

Phrase: "d <"

Phrase: "1.065 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "endosomal (E)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0034850:Endosome [Cell Component]

Phrase: "(1.065 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "ml <"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "d <"

Phrase: "1.105 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "lysosomal (L)"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0521450:Lysosomal [Body Location or Region]
   928 E C0024369:Lysosome [Cell Component]
   928 E C2984253:Lysosome [Functional Concept]

Phrase: "(1.110 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "ml <"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "d <"

Phrase: "1.150 g/ml) components after incubation of the LPS fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0449432:Components [Manufactured Object]
   704 E C1705248:Component [Conceptual Entity]

Phrase: "for the indicated time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "at 37 C."
Processing 00000000.tx.203: The black area on each histogram bar indicates the fraction of radioactivity that is TCA-soluble. 

Phrase: "The black area on each histogram bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]

Phrase: "indicates"

Phrase: "the fraction of radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1264633:Fraction of [Quantitative Concept]
           Fraction
   770   C1554103:Fraction [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "TCA-soluble."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]
   734   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.204: Results are the mean  SD of three determinations on separate LPS fractions.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SD of three determinations"

Phrase: "on separate LPS fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.205: In freshly isolated LPS fractions, about 70% of [125I]-insulin and 60% of [125I]-proinsulin migrated as a broad, partially TCA-precipitable peak at the endosomal position (densities, 1.071.11 g/ml); 

Phrase: "In freshly isolated LPS fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "about 70% of [125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "60% of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "migrated as a broad, partially TCA-precipitable peak"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0232902:Migrated [Functional Concept]
   742   C0332464:Broad [Spatial Concept]
   742   C0444505:Peak [Quantitative Concept]

Phrase: "at the endosomal position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "(densities,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:densities [Quantitative Concept]
   916 E C0439794:Dense [Qualitative Concept]

Phrase: "1.071.11 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1300565:g/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.206: most of the remainder was recovered as TCA-soluble radioactivity on top of the gradient. 

Phrase: "most of the remainder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205393:Most [Quantitative Concept]

Phrase: "was"

Phrase: "recovered as TCA-soluble radioactivity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0034553:Radioactivity [Natural Phenomenon or Process]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0521108:recovered [Qualitative Concept]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   719 E C2004454:recover [Organism Function]

Phrase: "on top of the gradient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]
Processing 00000000.tx.207: Although no additional peak was seen at the lysosomal position (densities, 1.111.13 g/ml), the proportion of radioactivity recovered therein was about 2-fold higher with [125I]-proinsulin than with [125I]-insulin, suggesting that some lysosomal association of internalized [125I]-proinsulin had already occurred in vivo. 

Phrase: "Although"

Phrase: "no additional peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "was"

Phrase: "seen at the lysosomal position"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205397:Seen [Qualitative Concept]
   760   C0521450:Lysosomal [Body Location or Region]
   760   C0733755:Position [Spatial Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "(densities,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:densities [Quantitative Concept]
   916 E C0439794:Dense [Qualitative Concept]

Phrase: "1.111.13 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1300565:g/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the proportion of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709707:Proportion [Quantitative Concept]

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "therein"

Phrase: "was"

Phrase: "about 2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0205250:High [Qualitative Concept]
   799   C1299351:High [Qualitative Concept]
   799   C2700149:HIGH [Intellectual Product]
   750 E C0489786:Height [Organism Attribute]

Phrase: "[125I"

Phrase: "]-proinsulin than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with"

Phrase: "[125I"

Phrase: "]-insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "some lysosomal association of internalized"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "already"

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.208: Incubation of the LPS fraction at 37 C resulted in a time-dependent decrease in the radioactivity at the endosomal position, along with an increase in the radioactivity migrating at the lysosomal position and remaining on top of the gradient (Fig. 7A). 

Phrase: "Incubation of the LPS fraction"

Phrase: "at 37 C"

Phrase: "resulted in a time-dependent decrease"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0040223:Time [Temporal Concept]
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   753   C3541383:Time [Temporal Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "in the radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "at the endosomal position,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "along with an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in the radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "migrating at the lysosomal position"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0232902:migrating [Functional Concept]
   760   C0521450:Lysosomal [Body Location or Region]
   760   C0733755:Position [Spatial Concept]

Phrase: "and"

Phrase: "remaining on top of the gradient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1527428:Remaining [Qualitative Concept]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.209: However, whereas the lysosomal association of [125I]-insulin was maximal at 15 min and did not exceed 16% of the total recovered, that of [125I]-proinsulin was maintained up to 30 min and reached 30% (Fig. 7B). 

Phrase: "However,"

Phrase: "whereas"

Phrase: "the lysosomal association of [125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "maximal at 15 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205289:Maximal [Qualitative Concept]
   770   C0806909:Maximal [Quantitative Concept]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exceed"

Phrase: "16% of the total recovered,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0521108:recovered [Qualitative Concept]
   726 E C2004454:recover [Organism Function]

Phrase: "that of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "maintained up to 30 min"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0456693:/30 min [Temporal Concept]
   806   C1442458:30 min [Temporal Concept]
   760   C0702093:/min [Temporal Concept]
   760   C1314677:Maintained [Functional Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "30%"

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.210: In vitro degradation of [125I]-labeled and native peptides by isolated liver subcellular fractions The results described above suggest that the reduced degradation of proinsulin in endosomes results from its lower sensitivity to endosomal acidic proteases. 

Phrase: "In vitro degradation of [125I"

Phrase: "]-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "native peptides by isolated liver subcellular fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the reduced degradation of proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "in endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "results from its lower sensitivity"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C0441994:Lower [Spatial Concept]
   760   C1274040:Result [Functional Concept]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]
   760   C2825142:Result [Finding]

Phrase: "to endosomal acidic proteases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Proteases [Enzyme]
Processing 00000000.tx.211: To address this, the in vitro degradation of [125I]-insulin and [125I]-proinsulin by hypotonically disrupted endosomes as a function of pH was comparatively examined using the TCA-precipitation assay (Fig. 8B and Table 1). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this,"

Phrase: "the in vitro degradation of [125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-proinsulin by hypotonically disrupted endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "comparatively"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TCA-precipitation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: "and"

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.212: Both peptides were degraded with a pH optimum of 4.5; 

Phrase: "Both peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "degraded with a pH optimum of 4.5"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C2678549:PH-4 [Gene or Genome]
   744   C0020283:[pH] [Quantitative Concept]
   744   C0450407:ph+ [Finding]
   744   C0450408:ph++ [Finding]
   744   C0450409:ph+++ [Finding]
   744   C1881707:DEGRADED [Phenomenon or Process]
   744   C2698651:Optimum [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.213: but throughout the pH range, [125I]-proinsulin degradation was at least 2-fold lower than [125I]-insulin degradation. 

Phrase: "but throughout the pH range,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "[125I"

Phrase: "]-proinsulin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was at least 2-fold"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332462:Fold [Spatial Concept]
   760   C1421478:WAS [Gene or Genome]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0441994:Lower [Spatial Concept]
   833   C1548802:Lower [Body Location or Region]
   833   C2003888:Lower [Activity]

Phrase: "[125I"

Phrase: "]-insulin degradation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.214: Because about 90% of the insulin-degrading activity of hypotonically disrupted endosomes is soluble (29), results were similar whether a total extract or a soluble extract was used (results not shown). 

Phrase: "Because"

Phrase: "about 90% of the insulin-degrading activity of hypotonically disrupted endosomes"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   754   C1145751:insulin activity [Molecular Function]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0034850:Endosomes [Cell Component]
   738   C0205177:Activity [Functional Concept]
   738   C0332454:Disrupted [Qualitative Concept]
   738   C0439083:>90 [Quantitative Concept]
   738   C0439087:<90 [Quantitative Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1561536:*Activity [Idea or Concept]
   738   C1579433:Insulin [Pharmacologic Substance]

Phrase: "is"

Phrase: "soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "whether"

Phrase: "a total extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]

Phrase: "or"

Phrase: "a soluble extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.215: However, because of the selective extraction of endosomal proteases, the degrading activity in the soluble extract was concentrated by about 12- to 15-fold, when related to protein (Table 1). 

Phrase: "However,"

Phrase: "because of the selective extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]

Phrase: "of endosomal proteases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "the degrading activity in the soluble extract"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "concentrated by about 12-"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1880165:Concentrated [Biomedical or Dental Material]
   737 E C1880310:Concentrate [Manufactured Object]
   737 E C2003864:Concentrate [Substance]

Phrase: "to 15-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "when"

Phrase: "related to protein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.216: [125I]-proinsulin was also less degraded than [125I]-insulin when this was assessed by binding to excess anti-insulin antibody (Table 1). 

Phrase: "[125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also less"

Phrase: "degraded than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "when"

Phrase: "this"

Phrase: "was"

Phrase: "assessed by binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   790   C1516048:Assessed [Activity]

Phrase: "to excess anti-insulin antibody"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.217: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.218: 8. 

Phrase: "8."
Processing 00000000.tx.219: In vitro degradation of unlabeled (A) and [125I]-labeled (B) human proinsulin and insulin by a soluble endosomal extract as a function of medium pH. 

Phrase: "In vitro degradation of unlabeled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "(A"

Phrase: ")"

Phrase: "and ["

Phrase: "125I"

Phrase: "]-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(B) human proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0086418:Human [Human]

Phrase: "and"

Phrase: "insulin by a soluble endosomal extract"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0021641:Soluble Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Insulin
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "as a function of medium pH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]
Processing 00000000.tx.220: A, Native insulin and proinsulin (10 nM) were incubated with a soluble endosomal extract (2 g protein) at 37 C in 0.15 ml of 50-mM citrate-phosphate at the indicated pH. 

Phrase: "A,"

Phrase: "Native insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(10 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "were"

Phrase: "incubated with a soluble endosomal extract"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   753   C2828366:Extract [Substance]

Phrase: "(2 g protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "at 37 C in 0.15 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439526:/mL [Quantitative Concept]

Phrase: "of 50-mM citrate-phosphate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "at the indicated pH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.221: At various times (1060 min for insulin, 15120 min for proinsulin), incubation mixtures were cooled to 4 C and diluted at least 5-fold with 0.1 M Tris HCl containing 2.5 mM 1,10-phenanthroline, 0.5 mg/ml bacitracin, and 10 g/ml pepstatin-A. 

Phrase: "At various times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "(1060 min for insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "15120 min for proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "incubation mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "cooled to 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1548792:Cool [Qualitative Concept]

Phrase: "and"

Phrase: "diluted at least 5-fold"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "with 0.1 M Tris HCl"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2.5 mM 1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0450346:2 5 [Quantitative Concept]
   861   C1418486:MM-1 [Gene or Genome]
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "0.5 mg/ml bacitracin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "and"

Phrase: "10 g/ml pepstatin-A."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332197:absence [Quantitative Concept]
   804   C1689985:Absence [Anatomical Abnormality]
   733 E C2699517:ABSENT [Finding]
Processing 00000000.tx.222: The concentration of the peptides remaining in the incubation mixtures was determined by RIA using anti-insulin antiserum; 

Phrase: "The concentration of the peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "remaining in the incubation mixtures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439962:mixtures [Substance]
   760   C1527428:Remaining [Qualitative Concept]

Phrase: "was"

Phrase: "determined by RIA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034580:RIA [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-insulin antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.223: and, based on semilog plots of the concentration against time, initial rates of degradation (expressed as percent per minute) were determined. 

Phrase: "and"

Phrase: ","

Phrase: "based on semilog"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "plots of the concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "against time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "initial rates of degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205265:Initial [Temporal Concept]
   770   C1279901:Initial [Qualitative Concept]
   770   C1555582:Initial [Idea or Concept]
   770   C1705685:INITIAL [Functional Concept]
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "("

Phrase: "expressed as percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439165:Percent [Quantitative Concept]

Phrase: "per minute"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439232:minute [Temporal Concept]
  1000   C0700321:minute [Quantitative Concept]
  1000   C0702093:/minute [Temporal Concept]
  1000   C1282918:Minute [Quantitative Concept]
  1000   C2347166:Minute [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "determined."
Processing 00000000.tx.224: In B, [125I]-labeled insulin and proinsulin (0.1 nM) were incubated with the soluble endosomal extract under the same buffer conditions as above. 

Phrase: "In B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "[125I"

Phrase: "]-labeled insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(0.1 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "were"

Phrase: "incubated with the soluble endosomal extract"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   753   C2828366:Extract [Substance]

Phrase: "under the same buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "conditions as above."
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   790   C0012634:condition [Disease or Syndrome]
   790   C0348080:Condition [Qualitative Concept]
   790   C1705253:Condition [Conceptual Entity]
   734 E C0040607:Training [Educational Activity]
   734 E C0220931:Training [Educational Activity]
   734 E C0336809:Train [Manufactured Object]
   734 E C1552514:Train [Manufactured Object]
   734 E C2673163:training [Qualitative Concept]
   706 E C0009647:Conditioned [Mental Process]
Processing 00000000.tx.225: After 1 h at 37 C, the percentage of TCA-soluble radioactivity released was determined. 

Phrase: "After 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37 C,"

Phrase: "the percentage of TCA-soluble radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.226: The results shown have been reproduced in three separate experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "reproduced in three separate experiments."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205449:Three [Quantitative Concept]
   760   C0443299:Separate [Spatial Concept]
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.227: Comparable results (not shown) have been obtained using [125I]-labeled and unlabeled porcine peptides as substrates.  

Phrase: "Comparable results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[125I"

Phrase: "]-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "unlabeled porcine peptides as substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.228: In vitro degradation studies were also performed using unlabeled peptides as substrates (Fig. 8A and Table 1). 

Phrase: "In vitro degradation studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   906   C0681828:in vitro study [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "also"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "unlabeled peptides as substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: "and"

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.229: Under these conditions, peptide degradation, as judged on the loss of insulin and proinsulin immunoreactivity, was maximal at pH 4; 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "peptide degradation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1523817:peptide degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "as"

Phrase: "judged on the loss of insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1517945:Loss [Quantitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719   C0221191:Judge [Professional or Occupational Group]

Phrase: "and"

Phrase: "proinsulin immunoreactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "maximal at pH 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205289:Maximal [Qualitative Concept]
   770   C0806909:Maximal [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.230: and within the pH range 3.54.5 proinsulin was degraded two to four times less rapidly than insulin. 

Phrase: "and within the pH range 3.54.5 proinsulin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   762   C0601906:PH 3 [Pharmacologic Substance]
   742   C0020283:[pH] [Quantitative Concept]
   742   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0450407:ph+ [Finding]
   742   C0450408:ph++ [Finding]
   742   C0450409:ph+++ [Finding]
   742   C1514721:Range [Quantitative Concept]
   742   C1515981:And [Idea or Concept]
   742   C2348147:Range [Quantitative Concept]
   742   C3542016:Range [Intellectual Product]

Phrase: "was"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "two to four times less rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1948050:Two Times [Quantitative Concept]
   753   C0205448:Two [Quantitative Concept]

Phrase: "than insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.231: It is noteworthy that the rate of degradation of native peptides as measured by RIA was about twenty times higher than that of radiolabeled peptides using the TCA-precipitation assay. 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that"

Phrase: "the rate of degradation of native peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "as"

Phrase: "measured by RIA"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0034580:RIA [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "was"

Phrase: "about twenty times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "higher than that of radiolabeled peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TCA-precipitation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.232: As with intact cell-free endosomes, the rates of degradation of des-[64, 65]proinsulin and split-[3233]proinsulin by soluble endosomal extracts were intermediate between those of insulin and proinsulin (insulin > des-[64, 65]proinsulin > split-[3233]proinsulin > intact proinsulin). 

Phrase: "As with intact cell-free endosomes,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0682538:intact cell [Cell]
   790   C1183428:cell free [Cell]
   753   C0007634:Cell [Cell]
   753   C0034850:Endosomes [Cell Component]
   753   C0205266:Intact [Qualitative Concept]
   753   C0332296:free [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1554187:Intact [Idea or Concept]
   753   C1704653:Cell [Medical Device]
   753   C1880497:Free [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]
   753   C1996904:Free [Qualitative Concept]

Phrase: "the rates of degradation of des-[64,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "]proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "split-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1534709:Split [Functional Concept]
  1000   C1881714:SPLIT [Phenomenon or Process]

Phrase: "[3233"

Phrase: "]proinsulin by soluble endosomal extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "intermediate between those of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205103:Intermediate [Spatial Concept]
   760   C1550465:intermediate [Idea or Concept]
   760   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "> des-[64,"

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "]proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "> split-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1534709:Split [Functional Concept]
  1000   C1881714:SPLIT [Phenomenon or Process]

Phrase: "[3233"

Phrase: "]proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "> intact proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.233: Because plasma membranes and cytosol degrade insulin in vitro and have been suggested to be potential sites of insulin degradation in intact cells (43, 44, 45), their ability to degrade proinsulin and proinsulin conversion intermediates was examined (Table 1). 

Phrase: "Because"

Phrase: "plasma membranes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0007603:Plasma Membranes [Cell Component]
   861   C0025255:Membranes [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "degrade"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "potential sites of insulin degradation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C2945843:Site of [Qualitative Concept]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "in intact cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(43,"

Phrase: "44,"

Phrase: "45"

Phrase: ")"

Phrase: ","

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "degrade"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "proinsulin conversion intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.234: PM and cytosolic fractions degraded [125I]-proinsulin about 2040 times less rapidly than [125I]-insulin; 

Phrase: "PM"

Phrase: "and"

Phrase: "cytosolic fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "[125I"

Phrase: "]-proinsulin about 2040 times less rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "than"

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.235: and with the cytosolic fraction, comparable results were observed when native peptides were used as substrates. 

Phrase: "and with the cytosolic fraction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1264633:Fraction [Quantitative Concept]
   760   C1383501:Cytosolic [Cell Component]
   760   C1515981:And [Idea or Concept]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "comparable results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "native peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "used as substrates."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1710236:Substrate [Manufactured Object]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.236: As with endosomes, the rates of degradation of des-[64, 65]proinsulin and split-[3233]proinsulin by cytosol were intermediate between those for insulin and intact proinsulin. 

Phrase: "As with endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034850:Endosomes [Cell Component]

Phrase: "the rates of degradation of des-[64,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "]proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "split-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1534709:Split [Functional Concept]
  1000   C1881714:SPLIT [Phenomenon or Process]

Phrase: "[3233"

Phrase: "]proinsulin by cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "intermediate between those for insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205103:Intermediate [Spatial Concept]
   760   C1550465:intermediate [Idea or Concept]
   760   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "intact proinsulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.237: Selected protease inhibitors, including pepstatin-A (an aspartic protease inhibitor), leupeptin and E64 (two cysteine protease inhibitors), N-ethylmaleimide (a thiol blocking reagent), 1,10-phenanthroline (a metalloprotease inhibitor), and bacitracin (a nonspecific protease inhibitor) were tested for their ability to inhibit insulin and proinsulin degradation in isolated cell fractions. 

Phrase: "Selected protease inhibitors,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "pepstatin-A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "("

Phrase: "an aspartic protease inhibitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   901   C2717969:Aspartic Protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "leupeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "E64"

Phrase: "(two cysteine protease inhibitors"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0010658:Cysteine Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   861   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   861   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   812   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   812   C1947941:Protease [Enzyme]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "N-ethylmaleimide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015101:Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "("

Phrase: "a thiol blocking reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: ","

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10-phenanthroline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "("

Phrase: "a metalloprotease inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1152589:metalloprotease inhibitor [Molecular Function]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "("

Phrase: "a nonspecific protease inhibitor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   901   C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "tested for their ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proinsulin degradation in isolated cell fractions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.238: Consistent with previous reports (29, 30), endosomal degradation of [125I]-insulin as estimated by TCA-precipitation and binding to excess anti-insulin antibody, was totally inhibited by pepstatin-A (10 g/ml) and bacitracin (5 mg/ml), partially inhibited by 1,10-phenanthroline (1 mM), but little affected by other inhibitors (results not shown). 

Phrase: "Consistent with previous reports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(29,"

Phrase: "30"

Phrase: ")"

Phrase: ","

Phrase: "endosomal degradation of [125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as"

Phrase: "estimated by TCA-precipitation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0750572:Estimated [Quantitative Concept]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "binding to excess anti-insulin antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1623517:insulin binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "totally"

Phrase: "inhibited by pepstatin-A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(10 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "(5 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "partially"

Phrase: "inhibited by 1,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "10-phenanthroline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "(1 mM"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "affected by other inhibitors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.239: Pepstatin-A also totally blocked native insulin and proinsulin degradation by soluble endosomal extracts. 

Phrase: "Pepstatin-A also totally"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332197:absence [Quantitative Concept]
   812   C1689985:Absence [Anatomical Abnormality]
   741 E C2699517:ABSENT [Finding]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "native insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proinsulin degradation by soluble endosomal extracts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.240: In contrast, degradation of [125I]-labeled insulin by PM and cytosolic fractions was effectively suppressed by 1,10-phenanthroline, N-ethylmaleimide, and bacitracin but unaffected by pepstatin-A. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "degradation of [125I"

Phrase: "]-labeled insulin by PM"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C0857690:plasma insulin [Laboratory Procedure]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "cytosolic fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "effectively"

Phrase: "suppressed by 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1260953:Suppressed [Functional Concept]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "N-ethylmaleimide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015101:Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "but"

Phrase: "unaffected by pepstatin-A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.241: Characterization of proinsulin intermediates generated upon incubation with a soluble endosomal extract Incubation of native insulin with a soluble endosomal extract has been shown to result in the generation of a number of degradation intermediates that can be resolved by RP-HPLC (25). 

Phrase: "Characterization of proinsulin intermediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "generated upon incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "with a soluble endosomal extract Incubation"

Phrase: "of native insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with a soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in the generation of a number of degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0079411:Generation [Temporal Concept]
   742   C0237753:*Number [Quantitative Concept]
   742   C0243125:degradation [Functional Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C0699900:Degradation [Organism Function]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]
   742   C3146294:Generation [Activity]

Phrase: "intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "resolved by RP-HPLC (25"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C1514893:Resolved [Idea or Concept]
   753   C1555029:Reverse [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.242: Based on mass spectrometry analysis, the structure of these intermediates has been elucidated and cleavage sites in the A- and B-chains localized. 

Phrase: "Based on mass spectrometry analysis,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1524024:analysis [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C3152252:Mass [Quantitative Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "the structure of these intermediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678594:Structure [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "elucidated"

Phrase: "and"

Phrase: "cleavage sites in the A-"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "B-chains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:chains [Manufactured Object]
   861   C1524075:Chains [Idea or Concept]

Phrase: "localized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]
Processing 00000000.tx.243: We therefore used this strategy to isolate and characterize proinsulin degradation intermediates generated upon incubation with a soluble endosomal extract. 

Phrase: "We therefore"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this strategy to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "characterize"

Phrase: "proinsulin degradation intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "generated upon incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "with a soluble endosomal extract."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]
Processing 00000000.tx.244: On RP-HPLC, human insulin and proinsulin eluted as single peaks with retention times of 34 min (results not shown) and 37 min (Fig. 9), respectively. 

Phrase: "On RP-HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: "human insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "eluted as single peaks"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037179:Single [Population Group]
   770   C0087136:single [Finding]
   770   C0205171:Single [Quantitative Concept]
   770   C0444505:peaks [Quantitative Concept]

Phrase: "with retention times"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0035280:Retention [Mental Process]
   861   C0040223:times [Temporal Concept]
   861   C0333117:Retention [Functional Concept]
   861   C1632851:Times [Quantitative Concept]
   861   C1753315:retention [Cell Function]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "of 34 min (results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "37 min (Fig. 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0349966:Fig [Food]
   812   C0702093:/min [Temporal Concept]
   812   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.245: Incubation of both peptides with a soluble endosomal extract at pH 4 and 5 resulted in the time-dependent disappearance of these peaks, along with the appearance of multiple, less hydrophobic peaks. 

Phrase: "Incubation of both peptides"

Phrase: "with a soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "at pH 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "resulted in the time-dependent disappearance of these peaks,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0040223:Time [Temporal Concept]
   742   C0444505:peaks [Quantitative Concept]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C3244310:dependent [Functional Concept]
   742   C3541383:Time [Temporal Concept]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "along with the appearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233426:Appearance [Organism Attribute]
  1000   C0700364:Appearance [Qualitative Concept]

Phrase: "of multiple, less hydrophobic peaks."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0444505:peaks [Quantitative Concept]
Processing 00000000.tx.246: Quantitation of peak areas confirmed that, at pH 4 and 37 C, human proinsulin was degraded less rapidly than human insulin (percent degraded at 30 and 60 min: proinsulin, 40% and 75%; 

Phrase: "Quantitation of peak areas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that,"

Phrase: "at pH 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "37 C,"

Phrase: "human proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0086418:Human [Human]

Phrase: "was"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "less rapidly than human insulin"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   797   C0439092:Less Than [Intellectual Product]
           less
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086418:Human [Human]
   760   C0547044:Less [Qualitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1637379:Rapidly [Qualitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439165:Percent [Quantitative Concept]

Phrase: "degraded at 30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "and"

Phrase: "60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: ":"

Phrase: "proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "75%"

Phrase: ";"
Processing 00000000.tx.247: insulin, 60 and 90%, respectively) (Fig. 9, and results not shown). 

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "60"

Phrase: "and"

Phrase: "90%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "(Fig. 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.248: View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.249: 9. 

Phrase: "9."
Processing 00000000.tx.250: HPLC elution profiles of intact proinsulin and degradation products resulting from the incubation of proinsulin with a soluble endosomal extract. 

Phrase: "HPLC elution profiles of intact proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "resulting from the incubation of proinsulin"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0678226:resulting [Functional Concept]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "with a soluble endosomal extract."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]
Processing 00000000.tx.251: A soluble endosomal extract (ENs) (1 g protein) prepared from hypotonically disrupted endosomes was incubated with 5 M human proinsulin (PI) in 0.1 ml of 25-mM citrate-phosphate buffer (pH 5) for 2 h at 37 C. 

Phrase: "A soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2828366:Extract [Substance]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: ")"

Phrase: "(1 g protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "prepared from hypotonically disrupted endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034850:Endosomes [Cell Component]
   760   C0332454:Disrupted [Qualitative Concept]
   726   C1521827:Prepare [Functional Concept]

Phrase: "was"

Phrase: "incubated with 5 M human proinsulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0026237:Mitochondrial [Cell Component]
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086418:Human [Human]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "(PI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "in 0.1 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "of 25-mM citrate-phosphate buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C3256468:citrate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37 C."
Processing 00000000.tx.252: The reaction was stopped with acetic acid (15%), and the incubation mixture was analyzed by RP-HPLC (lower panel) as described in Materials and Methods. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped with acetic acid"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   770   C1272691:stopped [Qualitative Concept]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the incubation mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "analyzed by RP-HPLC (lower panel"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205390:Phase [Temporal Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C0936012:Analyzed [Research Activity]
   748   C1548802:Lower [Body Location or Region]
   748   C1555029:Reverse [Idea or Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C2003888:Lower [Activity]
   748   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.253: Intact proinsulin had an elution time of 37 min (upper panel). 

Phrase: "Intact proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "an elution time of 37 min (upper panel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0040223:Time [Temporal Concept]
   744   C3541383:Time [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.254: The endosomal proteins alone did not give any detectable peak (results not shown). 

Phrase: "The endosomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "any detectable peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.255: The major peptide pools, numbered sequentially 18, were collected and subjected to mass spectrometry analyses (see Table 2).  

Phrase: "The major peptide pools,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0337051:pools [Geographic Area]
   793 E C1509144:pool [Clinical Attribute]
   793 E C2349200:Pool [Functional Concept]

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "sequentially 18,"

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "subjected to mass spectrometry analyses (see Table 2)."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0681850:Subject [Group]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.256: The eight HPLC pools, isolated after incubation of proinsulin with a soluble endosomal extract at pH 5, were characterized by mass spectrometry (Table 2). 

Phrase: "The eight HPLC pools,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0337051:pools [Geographic Area]
   793 E C1509144:pool [Clinical Attribute]
   793 E C2349200:Pool [Functional Concept]

Phrase: "isolated after incubation of proinsulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "with a soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "at pH 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "were"

Phrase: "characterized by mass spectrometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C1880022:Characterized [Activity]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.257: Among these pools, five (1, 3, 5, 7, 8) were heterogeneous, and each contained two proinsulin intermediates. 

Phrase: "Among these pools,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0337051:pools [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]
   966 E C2349200:Pool [Functional Concept]

Phrase: "five"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205451:Five [Quantitative Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "8"

Phrase: ")"

Phrase: "were"

Phrase: "heterogeneous,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneous [Qualitative Concept]

Phrase: "and"

Phrase: "each contained two proinsulin intermediates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0205103:Intermediate [Spatial Concept]
   779   C1550465:intermediate [Idea or Concept]
   779   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.258: In addition to intact proinsulin, 12 proinsulin intermediates were identified. 

Phrase: "In addition to intact proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "12 proinsulin intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "were"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.259: Eight intermediates (components 15) were single-chain peptides in which the C-terminal sequence Phe25-Thr30 of the B chain remained linked to N-terminal sequences of the C peptide of various lengths, three intermediates (pools 6 and 7) were two-chain peptides in which the N-terminal sequence Phe1-Phe24 of the B chain was connected via disulfide bridges to the A-chain linked to C-terminal sequences of the C peptide of various lengths, and one intermediate (pool 8b) was intact proinsulin with an internal peptide bond cleaved. 

Phrase: "Eight intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "(components 15"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: ")"

Phrase: "were"

Phrase: "single-chain peptides in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "the C-terminal sequence Phe25-Thr30 of the B chain"

Phrase: "remained"

Phrase: "linked to N-terminal sequences of the C peptide of various lengths,"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   753   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   736   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   736   C0162326:Sequences [Nucleotide Sequence]
   736   C0205088:Terminal [Temporal Concept]
   736   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   736   C0521447:Nuclear [Spatial Concept]
   736   C1444754:Lengths [Quantitative Concept]
   736   C1705314:Terminal [Manufactured Object]
   736   C1705315:Terminal [Spatial Concept]
   734   C0920679:peptide sequence [Amino Acid Sequence]
   703 E C0004793:Sequence [Nucleotide Sequence]
   703 E C0162327:Sequence [Nucleotide Sequence]
   703   C1517892:Link [Intellectual Product]
   703 E C1519249:Sequence [Functional Concept]
   703   C1704666:Link [Intellectual Product]
   703 E C1706316:LENGTH [Research Activity]

Phrase: "three intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "(pools 6"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0337051:pools [Geographic Area]
   827 E C1509144:pool [Clinical Attribute]
   827 E C2349200:Pool [Functional Concept]

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: "were"

Phrase: "two-chain peptides in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "the N-terminal sequence Phe1-Phe24 of the B chain"

Phrase: "was"

Phrase: "connected via disulfide bridges"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012771:disulfide [Chemical Viewed Structurally]
   770   C0456378:bridges [Medical Device]
   737   C2986575:Connect [Activity]

Phrase: "to the A-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "linked to C-terminal sequences of the C peptide of various lengths,"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   753   C1707271:C-Terminal [Amino Acid Sequence]
   751   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0071642:peptide C [Amino Acid, Peptide, or Protein]
   736   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   736   C0162326:Sequences [Nucleotide Sequence]
   736   C0205088:Terminal [Temporal Concept]
   736   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   736   C1444754:Lengths [Quantitative Concept]
   736   C1705314:Terminal [Manufactured Object]
   736   C1705315:Terminal [Spatial Concept]
   734   C0920679:peptide sequence [Amino Acid Sequence]
   703 E C0004793:Sequence [Nucleotide Sequence]
   703 E C0162327:Sequence [Nucleotide Sequence]
   703   C1517892:Link [Intellectual Product]
   703 E C1519249:Sequence [Functional Concept]
   703   C1704666:Link [Intellectual Product]
   703 E C1706316:LENGTH [Research Activity]

Phrase: "and"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "(pool 8b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "intact proinsulin with an internal peptide bond"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cleaved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]
Processing 00000000.tx.260: From these data, it can be deduced that human proinsulin is cleaved by soluble endosomal proteases at nine distinct sites; 

Phrase: "From these data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "it"

Phrase: "can"

Phrase: "be"

Phrase: "deduced"

Phrase: "that human proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0086418:Human [Human]

Phrase: "is"

Phrase: "cleaved by soluble endosomal proteases"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]
   760   C1749467:soluble [Cell Component]
   760   C1947941:Proteases [Enzyme]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "at nine distinct sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.261: of these, eight affect the C peptide (Ala34-Glu35, Asp36-Leu37, Gln38-Val39, Gly40-Gln41, Glu43-Leu44, Ala57-Leu58, Glu59-Gly60, and Gly60-Ser61) but only one the B-chain (Phe24-Phe25). 

Phrase: "of these,"

Phrase: "eight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205454:Eight [Quantitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the C peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(Ala34-Glu35,"

Phrase: "Asp36-Leu37,"

Phrase: "Gln38-Val39,"

Phrase: "Gly40-Gln41,"

Phrase: "Glu43-Leu44,"

Phrase: "Ala57-Leu58,"

Phrase: "Glu59-Gly60,"

Phrase: "and"

Phrase: "Gly60-Ser61"

Phrase: ")"

Phrase: "but"

Phrase: "only one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "the B-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "(Phe24-Phe25"

Phrase: ")."
Processing 00000000.tx.262: In addition, because the generation of all intermediates involves a cleavage at the Phe24-Phe25 bond, the latter must be, as for insulin, the initial proteolytic event in proinsulin. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "because"

Phrase: "the generation of all intermediates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "involves"

Phrase: "a cleavage at the Phe24-Phe25 bond,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "the latter"

Phrase: "must"

Phrase: "be"

Phrase: ","

Phrase: "as for insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the initial proteolytic event in proinsulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441471:Event [Event]
Processing 00000000.tx.263: Cleavages of bonds in the C-peptide region adjacent to the A-chain-C-peptide junction and of the Phe24-Phe25 bond would be expected to affect the recognition of proinsulin by, respectively, the antiproinsulin and anti-insulin antibodies used in this study. 

Phrase: "Cleavages of bonds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0010813:cleavage [Cell Function]
   756   C0596311:Cleavage [Phenomenon or Process]
   756   C1330957:cleavage [Cell Function]

Phrase: "in the C-peptide region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "adjacent to the A-chain-C-peptide junction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "and of the Phe24-Phe25 bond"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515981:And [Idea or Concept]

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the recognition of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0524637:Recognition [Mental Process]

Phrase: "by,"

Phrase: "respectively,"

Phrase: "the antiproinsulin"

Phrase: "and"

Phrase: "anti-insulin antibodies"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C0021644:anti insulin antibodies [Immunologic Factor]
           Insulin Antibodies
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.264: View this table: [in this window] [in a new window]  TABLE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.265: Masses and assigned structures of the cleavage products generated from human proinsulin by a soluble endosomal extract  Insulin- and proinsulin-induced changes in insulin receptor content and tyrosine phosphorylation state in PM and endosomal fractions In vivo insulin treatment has been shown to induce a time- and dose-dependent endocytosis of the liver insulin receptor, along with an increase in -subunit tyrosine autophosphorylation (24, 31, 46). 

Phrase: "Masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0577559:Mass [Finding]
   966   C1306372:*Mass [Quantitative Concept]
   966   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "assigned structures of the cleavage products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "generated from human proinsulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0086418:Human [Human]
   770   C3146294:Generated [Activity]

Phrase: "by a soluble endosomal extract  Insulin-"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   902   C0021641:Soluble Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Insulin
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proinsulin-induced changes in insulin receptor content"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "tyrosine phosphorylation state in PM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "endosomal fractions In vivo insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   799   C0039798:treatment [Functional Concept]
   799   C0087111:Treatment [Therapeutic or Preventive Procedure]
   799   C1522326:Treatment [Functional Concept]
   799   C1533734:Treatment [Therapeutic or Preventive Procedure]
   799   C1705169:Treatment [Conceptual Entity]
   799   C3538994:TREATMENT [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a time-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "dose-dependent endocytosis of the liver insulin receptor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C3271695:insulin receptor endocytosis [Cell Function]
   744   C0014139:Endocytosis [Cell Function]
   744   C2984285:Endocytosis [Functional Concept]

Phrase: "along with an increase in -subunit tyrosine autophosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C3271785:tyrosine autophosphorylation [Molecular Function]
   804   C0813988:autophosphorylation [Molecular Function]

Phrase: "(24,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.266: Accordingly, PM and endosomal fractions of proinsulin- and insulin-treated rats were comparatively analyzed for insulin binding activity, expression of the -subunit of the insulin receptor, and tyrosine phosphorylation of the -subunit (Table 3 and Fig. 10). 

Phrase: "Accordingly,"

Phrase: "PM"

Phrase: "and"

Phrase: "endosomal fractions of proinsulin-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   816   C1264633:Fraction of [Quantitative Concept]
           Fractions
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "insulin-treated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "comparatively"

Phrase: "analyzed for insulin binding activity,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   806   C1623517:insulin binding [Molecular Function]
   806   C2266866:Binding Activity [Molecular Function]
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0243122:binding [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0936012:Analyzed [Research Activity]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "expression of the -subunit of the insulin receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "tyrosine phosphorylation of the -subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1519726:Tyrosine Phosphorylation [Molecular Function]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.267: In addition, the concentration of immunoreactive proinsulin and insulin in acidic extracts of these fractions was measured (Table 3). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the concentration of immunoreactive proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "insulin in acidic extracts of these fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.268: View this table: [in this window] [in a new window]  TABLE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.269: Insulin binding activity and peptide content of plasma membranes and endosomal fractions isolated at various times after insulin and proinsulin injection.  

Phrase: "Insulin binding activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C1145751:insulin activity [Molecular Function]
   901   C2266866:Binding Activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C1623517:insulin binding [Molecular Function]

Phrase: "and"

Phrase: "peptide content of plasma membranes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "isolated at various times"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0040223:times [Temporal Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1548221:Isolated [Idea or Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C3541383:Time [Temporal Concept]

Phrase: "after insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proinsulin injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]
Processing 00000000.tx.270: View larger version (46K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.271: 10. 

Phrase: "10."
Processing 00000000.tx.272: Proinsulin- and insulin-induced changes in the content and tyrosine phosphorylation state of the insulin receptor in liver PM and endosomal fractions. 

Phrase: "Proinsulin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "insulin-induced changes in the content"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "tyrosine phosphorylation state of the insulin receptor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1519726:Tyrosine Phosphorylation [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]

Phrase: "in liver PM"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   901   C0007603:Plasma membrane [Cell Component]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0025255:Membrane [Tissue]
   827   C0032105:Plasma [Body Substance]
   827   C0596901:Membrane [Cell Component]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1706182:Membrane [Manufactured Object]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "endosomal fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.273: Endosomal fractions were prepared from rats killed 10 min after injection of human insulin and proinsulin at the indicated dose (A) or at the indicated time after injection of 0.33 nmol (2 g) insulin or 4.4 nmol (40 g) proinsulin (B). 

Phrase: "Endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "prepared from rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]
   756   C1521827:Prepare [Functional Concept]

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "10 min after injection of human insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0456692:/10 min [Temporal Concept]
   748   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "proinsulin at the indicated dose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: ")"

Phrase: "or at the indicated time"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0040223:Time [Temporal Concept]
   760   C1444656:Indicated [Finding]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "after injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of 0.33 nmol (2 g) insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "4.4 nmol (40 g) proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.274: Plasma membrane fractions were prepared at the indicated time after injection of 0.33 nmol of insulin or 4.4 nmol of proinsulin (C). 

Phrase: "Plasma membrane fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "were"

Phrase: "prepared at the indicated time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C1444656:Indicated [Finding]
   760   C3541383:Time [Temporal Concept]
   726   C1521827:Prepare [Functional Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "after injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of 0.33 nmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439191:NMOLE [Quantitative Concept]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "4.4 nmol of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439191:NMOLE [Quantitative Concept]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.275: The expression (upper blots) and tyrosine phosphorylation state (lower blots) of the insulin receptor -subunit were assessed by immunoblotting using antibodies against the insulin receptor -subunit (-IR) and phosphotyrosine (-PY), respectively. 

Phrase: "The expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(upper blots"

Phrase: ")"

Phrase: "and"

Phrase: "tyrosine phosphorylation state"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1519726:Tyrosine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "(lower blots"

Phrase: ")"

Phrase: "of the insulin receptor -subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1711351:Subunit [Quantitative Concept]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "were"

Phrase: "assessed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies against the insulin receptor -subunit"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0443876:Insulin receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0021644:Insulin Antibodies [Immunologic Factor]
   783   C0034805:antibodies receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(-IR)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022065:IR [Geographic Area]
  1000   C0022071:Ir [Element, Ion, or Isotope]
  1000   C0034818:IR [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "and"

Phrase: "phosphotyrosine (-PY),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "respectively."
Processing 00000000.tx.276: About 1030 g of cell fraction protein were loaded on each lane. 

Phrase: "About 1030 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of cell fraction protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0805525:Cell Fraction [Cell Component]

Phrase: "were"

Phrase: "loaded on each lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.277: Arrows on the left indicate the mobility of the -subunit of the insulin receptor (94-kDa). 

Phrase: "Arrows on the left"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the mobility of the -subunit of the insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0425245:Mobility [Finding]
   742   C0449580:Mobility [Qualitative Concept]

Phrase: "(94-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.278: The ligand content (measured by insulin RIA) of endosomal fractions of hormone-treated rats in A was, from left to right, <0.1, 0.12, 0.66, 3.65, and 4.46 pmol/mg protein (insulin) and 0.11, 0.34, 1.18, 5.42, and 9.81 pmol/mg protein (proinsulin). 

Phrase: "The ligand content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "("

Phrase: "measured by insulin RIA) of endosomal fractions of hormone-treated rats"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   738   C0019932:Hormone [Hormone]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0034580:RIA [Laboratory Procedure]
   738   C0034693:rats [Mammal]
   738   C0034721:Rats [Mammal]
   738   C0332293:treated [Therapeutic or Preventive Procedure]
   738   C0444706:Measured [Qualitative Concept]
   738   C1264633:Fractions [Quantitative Concept]
           Fraction of
   738   C1522326:Treated [Functional Concept]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]
   738   C3541902:MEASURED [Diagnostic Procedure]
   704 E C0079809:Measure [Quantitative Concept]
   704 E C0242485:Measure [Functional Concept]
   704 E C1292734:TREAT [Functional Concept]
   704 E C1554103:Fraction [Idea or Concept]

Phrase: "in A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "was"

Phrase: ","

Phrase: "from left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "to right,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "<0.1,"

Phrase: "0.12,"

Phrase: "0.66,"

Phrase: "3.65,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439086:<3 [Quantitative Concept]
   861   C0450385:65 [Intellectual Product]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4.46 pmol/mg protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "0.11,"

Phrase: "0.34,"

Phrase: "1.18,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "5.42,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "9.81 pmol/mg protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0651569:9-MG [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.279: The ligand content of subcellular fractions of hormone-treated rats in B and C is shown in Table 3.  

Phrase: "The ligand content of subcellular fractions of hormone-treated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0423896:Content [Mental Process]
   739   C0456205:Content [Conceptual Entity]

Phrase: "in B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C"

Phrase: "is"

Phrase: "shown in Table 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.280: Endosomal fractions were first isolated 10 min after injection of increasing doses of insulin and proinsulin (Fig. 10A). 

Phrase: "Endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "10 min after injection of increasing doses of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0456692:/10 min [Temporal Concept]
   742   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 10A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553642:10a [Medical Device]

Phrase: ")."
Processing 00000000.tx.281: These doses had previously been shown to gradually inhibit the in vivo hepatic uptake of coinjected [125I]-insulin (data not shown). 

Phrase: "These doses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0178602:Doses [Quantitative Concept]
   966 E C0869039:Dose [Quantitative Concept]
   966 E C1114758:Dose # [Clinical Attribute]
   966 E C1428722:DOS [Gene or Genome]

Phrase: "had"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to gradually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the in vivo hepatic uptake of coinjected"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205054:Hepatic [Body Location or Region]
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.282: Although both peptides led to a dose-dependent increase in insulin receptor -subunit content and tyrosine phosphorylation, proinsulin was at least 10 times less potent than insulin in this respect; 

Phrase: "Although"

Phrase: "both peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "led to a dose-dependent increase"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   790   C1512045:Dose-dependent [Quantitative Concept]
   753   C0178602:Dose [Quantitative Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1708698:LED [Manufactured Object]
   753   C3244310:dependent [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in insulin receptor -subunit content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "tyrosine phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was at least 10 times"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0040223:times [Temporal Concept]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "less potent than insulin"

Phrase: "in this respect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679133:respect [Social Behavior]

Phrase: ";"
Processing 00000000.tx.283: and at the highest dose of proinsulin tested (13.3 nmol), maximal effects were not achieved. 

Phrase: "and at the highest dose of proinsulin"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   762   C0444956:High dose [Quantitative Concept]
   748   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1515981:And [Idea or Concept]
   748   C1522410:Highest [Qualitative Concept]
   714 E C0205250:High [Qualitative Concept]
   714 E C1299351:High [Qualitative Concept]
   714 E C2700149:HIGH [Intellectual Product]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(13.3 nmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439191:NMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "maximal effects"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0205289:Maximal [Qualitative Concept]
   861   C0806909:Maximal [Quantitative Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
   789 E C1552615:maximum [Quantitative Concept]
   789 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "achieved."
Processing 00000000.tx.284: These results are consistent with the 20-fold-lower in vivo affinity of proinsulin for the insulin receptor (dose required for 50% of inhibition of in vivo [125I]-insulin uptake, about 0.66 nmol insulin and 13 nmol proinsulin). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the 20-fold-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "in vivo affinity of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "required for 50% of inhibition of in vivo"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1515655:In Vivo [Spatial Concept]
           vivo
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1514873:Required [Functional Concept]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "[125I"

Phrase: "]-insulin uptake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "about 0.66 nmol insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "13 nmol proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.285: Interestingly, based on endosomal ligand content (shown in legend to Fig. 10) proinsulin was also approximately 1020 times less potent than insulin in increasing -subunit expression and autophosphorylation. 

Phrase: "Interestingly,"

Phrase: "based on endosomal ligand content"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0023688:Ligand [Chemical]
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "("

Phrase: "shown in legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2729544:Legend [Pharmacologic Substance]
   756   C1547282:Show [Intellectual Product]

Phrase: "to Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also approximately 1020 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0040223:times [Temporal Concept]
   812   C1632851:Times [Quantitative Concept]
   779 E C3541383:Time [Temporal Concept]
   741 E C0442043:Temporal [Spatial Concept]
   741 E C2362314:Temporal [Temporal Concept]

Phrase: "less potent than insulin"

Phrase: "in increasing -subunit expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "autophosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813988:autophosphorylation [Molecular Function]
Processing 00000000.tx.286: Plasma membrane and endosomal fractions were then isolated at various times after injection of 0.33 nmol insulin and 4.4 nmol of proinsulin (Fig. 10, B and C; and Table 3). 

Phrase: "Plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "isolated at various times"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0040223:times [Temporal Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1548221:Isolated [Idea or Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C3541383:Time [Temporal Concept]

Phrase: "after injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of 0.33 nmol insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "4.4 nmol of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439191:NMOLE [Quantitative Concept]

Phrase: "(Fig. 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C"

Phrase: ";"

Phrase: "and"

Phrase: "Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.287: At these doses, a comparable degree of insulin receptor occupancy was achieved, as judged on the inhibition of in vivo [125I]-insulin uptake (2025%). 

Phrase: "At these doses,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0178602:Doses [Quantitative Concept]
   966 E C0869039:Dose [Quantitative Concept]
   966 E C1114758:Dose # [Clinical Attribute]
   966 E C1428722:DOS [Gene or Genome]

Phrase: "a comparable degree of insulin receptor occupancy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0441889:Degree [Qualitative Concept]
   748   C0449286:Degree [Quantitative Concept]
   748   C0542560:Degree [Intellectual Product]
   748   C1561545:degree [Quantitative Concept]
   748   C2348088:Degree [Quantitative Concept]

Phrase: "was"

Phrase: "achieved"

Phrase: ","

Phrase: "as"

Phrase: "judged on the inhibition of in vivo"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1515655:In Vivo [Spatial Concept]
           vivo
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]
   714   C0221191:Judge [Professional or Occupational Group]

Phrase: "[125I"

Phrase: "]-insulin uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "(2025%"

Phrase: ")."
Processing 00000000.tx.288: Insulin treatment caused three major changes: first, a marked increase in insulin binding activity and expression of the -subunit of the insulin receptor in the endosomal fraction; 

Phrase: "Insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "three major changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: ":"

Phrase: "first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a marked increase in insulin binding activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0020459:INSULIN INCREASE [Disease or Syndrome]
   748   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "expression of the -subunit of the insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the endosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.289: second, a slight decrease in insulin binding activity and -subunit expression in the PM fraction; 

Phrase: "second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "a slight decrease in insulin binding activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "and -"

Phrase: "subunit expression in the PM fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.290: and third, an increase in tyrosine phosphorylation of the -subunit in both fractions. 

Phrase: "and"

Phrase: "third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "an increase in tyrosine phosphorylation of the -subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "in both fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.291: These changes achieved a maximum at 2 min but rapidly declined after 10 min, being no longer detectable after 20 min. 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "achieved"

Phrase: "a maximum at 2 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]

Phrase: "but"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "declined after 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "being"

Phrase: "no longer detectable after 20 min."
Processing 00000000.tx.292: Although of comparable magnitude, the changes induced by proinsulin differed from those induced by insulin in two respects: first, a slower and more prolonged increase in insulin binding activity, insulin receptor -subunit expression, and -subunit tyrosine phosphorylation in the endosomal fraction, which was maximal at 10 min and was still well detectable at 20 min (4590 min for insulin binding activity); 

Phrase: "Although of comparable magnitude,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449286:magnitude [Quantitative Concept]
   770   C1704240:Magnitude [Quantitative Concept]

Phrase: "the changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "induced by proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "differed from those"

Phrase: "induced by insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in two respects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679133:respects [Social Behavior]

Phrase: ":"

Phrase: "first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a slower"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439834:Slow [Qualitative Concept]

Phrase: "and"

Phrase: "more prolonged increase in insulin binding activity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0020459:INSULIN INCREASE [Disease or Syndrome]
   748   C0442805:Increase [Functional Concept]

Phrase: "insulin receptor -subunit expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0597360:receptor expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "subunit tyrosine phosphorylation in the endosomal fraction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1519726:Tyrosine Phosphorylation [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "which"

Phrase: "was"

Phrase: "maximal at 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205289:Maximal [Qualitative Concept]
   770   C0806909:Maximal [Quantitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "still well detectable at 20 min (4590 min"

Phrase: "for insulin binding activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C1145751:insulin activity [Molecular Function]
   901   C2266866:Binding Activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C1623517:insulin binding [Molecular Function]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.293: and second, a more prolonged increase in insulin receptor -subunit tyrosine phosphorylation in the PM fraction. 

Phrase: "and"

Phrase: "second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "a more prolonged increase in insulin receptor -subunit tyrosine phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0020459:INSULIN INCREASE [Disease or Syndrome]
   739   C0442805:Increase [Functional Concept]

Phrase: "in the PM fraction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]
Processing 00000000.tx.294: In agreement with results obtained with [125I]-labeled peptides, injected insulin and proinsulin were rapidly taken up into PM and endosomal fractions and were subsequently cleared from these fractions (Table 3). 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained with"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   833   C1301820:Obtained [Functional Concept]
   799 E C1706701:Obtain [Activity]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0205217:Increased [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442805:Increase [Functional Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "[125I"

Phrase: "]-labeled peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "injected insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   964   C0199782:injection insulin [Therapeutic or Preventive Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "into PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "were"

Phrase: "subsequently"

Phrase: "cleared from these fractions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0521097:cleared [Functional Concept]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C1554103:Fraction [Idea or Concept]
   737 E C2963144:Clear [Qualitative Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.295: The association of both peptides with the plasma membrane was maximal at 2 min, but the translocation of proinsulin to endosomes was delayed, relative to that of insulin (maximum, 10 and 5 min, respectively). 

Phrase: "The association of both peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "maximal at 2 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]

Phrase: "but"

Phrase: "the translocation of proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040715:Translocation [Cell or Molecular Dysfunction]
   770   C2987521:Translocation [Activity]

Phrase: "to endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "was"

Phrase: "delayed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205421:Delayed [Temporal Concept]
  1000   C3272602:Delayed [Qualitative Concept]

Phrase: ","

Phrase: "relative to that of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "(maximum,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0806909:Maximum [Quantitative Concept]
  1000   C1552615:maximum [Quantitative Concept]
  1000   C2826546:MAXIMUM [Quantitative Concept]
   928 E C0205289:Maximal [Qualitative Concept]

Phrase: "10"

Phrase: "and"

Phrase: "5 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.296: In addition, as expected from the slower clearance of proinsulin from blood plasma (4) and from the decreased processing of proinsulin in endosomes, injected proinsulin was cleared more slowly than insulin from both PM and endosomal fractions. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "as"

Phrase: "expected from the slower clearance of proinsulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0449297:Clearance [Qualitative Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C1517001:Expected [Idea or Concept]
   748   C2825073:Clearance [Natural Phenomenon or Process]
   714   C0439834:Slow [Qualitative Concept]

Phrase: "from blood plasma"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
  1000   C0032105:Blood Plasma [Body Substance]
           Plasma
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "(4"

Phrase: ")"

Phrase: "and from the decreased processing of proinsulin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C1709694:Processing [Activity]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "in endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "injected proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "cleared"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521097:cleared [Functional Concept]
   966 E C2963144:Clear [Qualitative Concept]

Phrase: "more slowly than insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0205172:More [Functional Concept]
   770   C0439834:Slowly [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from both PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "endosomal fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.297: Consequently, proinsulin concentrations achieved at 20 min and later in these fractions were at least 6- and 15-fold higher than insulin concentrations, respectively.  

Phrase: "Consequently,"

Phrase: "proinsulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "achieved at 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "later in these fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0205087:Late [Temporal Concept]

Phrase: "were at least 6-"

Phrase: "and"

Phrase: "15-fold higher than insulin concentrations,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0020459:high insulin [Disease or Syndrome]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "respectively."
Processing 00000000.tx.298: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  The subcellular distribution and metabolic fate of proinsulin and insulin in rat liver have been comparatively studied using both [125I]-labeled and unlabeled peptides as ligands of the insulin receptor and substrates of insulin-degrading activity. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The subcellular distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "metabolic fate of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1539479:FATE [Gene or Genome]

Phrase: "and"

Phrase: "insulin in rat liver"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "comparatively"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both"

Phrase: "[125I"

Phrase: "]-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "unlabeled peptides as ligands of the insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0206473:Peptide Receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "substrates of insulin-degrading activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.299: Our results show that proinsulin taken up into liver in vivo displays a slower and prolonged association with plasma membrane and endosomes, a slower in vivo and cell-free endosomal processing, and a higher and more sustained cell-free endosome-lysosome transfer. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "into liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a slower"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439834:Slow [Qualitative Concept]

Phrase: "and"

Phrase: "prolonged association with plasma membrane"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "a slower in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "cell-free endosomal processing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0230625:cell processing [Cell Component]
   812   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "a higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "and"

Phrase: "more sustained cell-free endosome-lysosome transfer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0040671:Transfer [Mental Process]
   795   C1705822:Transfer [Activity]
Processing 00000000.tx.300: When incubated with endosomal extracts at acidic pH and with PM and cytosolic fractions at neutral pH, proinsulin was degraded more slowly than insulin; 

Phrase: "When"

Phrase: "incubated with endosomal extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1439852:Incubated [Laboratory Procedure]
   737   C2828366:Extract [Substance]

Phrase: "at acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and with PM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0007603:Plasma membrane [Cell Component]
   770   C0025255:Membrane [Tissue]
   770   C0032105:Plasma [Body Substance]
   770   C0596901:Membrane [Cell Component]
   770   C1515981:And [Idea or Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "cytosolic fractions at neutral pH,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "more slowly than insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0205172:More [Functional Concept]
   770   C0439834:Slowly [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.301: and under conditions resulting in multiple cleavages in insulin, only the Phe 24-Phe25 bond in the insulin moiety of proinsulin was cleaved by soluble endosomal proteases. 

Phrase: "and under conditions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1515981:And [Idea or Concept]
   756   C0012634:condition [Disease or Syndrome]
   756   C0348080:Condition [Qualitative Concept]
   756   C1705253:Condition [Conceptual Entity]
   706 E C0009647:Conditioned [Mental Process]
   706 E C1701901:Conditional [Qualitative Concept]
   706 E C1963686:Conditional [Functional Concept]

Phrase: "resulting in multiple cleavages"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0332294:Resulting in [Functional Concept]
   770   C0439064:Multiple [Quantitative Concept]
   770   C0678226:resulting [Functional Concept]
   737   C0010813:cleavage [Cell Function]
   737   C0596311:Cleavage [Phenomenon or Process]
   737 E C1274040:Result [Functional Concept]
   737   C1330957:cleavage [Cell Function]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "in insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the Phe 24-Phe25 bond in the insulin moiety of proinsulin"

Phrase: "was"

Phrase: "cleaved by soluble endosomal proteases."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]
   760   C1749467:soluble [Cell Component]
   760   C1947941:Proteases [Enzyme]
   760   C1948047:Soluble [Qualitative Concept]
Processing 00000000.tx.302: Finally, relative to insulin, in vivo-administered proinsulin induced a more prolonged endocytosis and tyrosine phosphorylation of the insulin receptor. 

Phrase: "Finally,"

Phrase: "relative to insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "in vivo-administered proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a more prolonged endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014139:Endocytosis [Cell Function]
   827   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "tyrosine phosphorylation of the insulin receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.303: Taken together, these observations suggest that the reduced proteolysis of proinsulin in endosomes, and probably also at the plasma membrane, accounts for its slower hepatic clearance and prolonged ability to activate the insulin receptor. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the reduced proteolysis of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597304:Proteolysis [Molecular Function]

Phrase: "in endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "and"

Phrase: "probably also at the plasma membrane,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0007603:Plasma membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0032105:Plasma [Body Substance]
   753   C0596901:Membrane [Cell Component]
   753   C0750492:Probably [Idea or Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "accounts for its slower hepatic clearance"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205054:Hepatic [Body Location or Region]
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]
   753   C2981730:Account [Classification]
   719   C0439834:Slow [Qualitative Concept]

Phrase: "and"

Phrase: "prolonged ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the insulin receptor."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.304: The patterns of in vivo liver uptake of injected proinsulin and insulin have been compared in two previous studies (15, 16). 

Phrase: "The patterns of in vivo liver uptake of injected proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "compared in two previous studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205156:Previous [Temporal Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1552607:previous [Temporal Concept]
   760   C1707455:Compared [Activity]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.305: In one study, in which the liver was removed after injection of [131I]-labeled peptides, insulin uptake was maximal at 1 min and rapidly declined over 30 min, whereas proinsulin uptake was stable up to 10 min and declined more slowly; 

Phrase: "In one study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "in which"

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "removed after injection of [131I"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C0849355:Removed [Qualitative Concept]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]

Phrase: "]-labeled peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "insulin uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "maximal at 1 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "declined over 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "whereas"

Phrase: "proinsulin uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "stable up to 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205360:Stable [Qualitative Concept]
   760   C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "declined"

Phrase: "more slowly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0439834:Slowly [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.306: at maximum, 29% and 6% of the injected dose, respectively, were recovered in the liver (15). 

Phrase: "at maximum,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0806909:Maximum [Quantitative Concept]
  1000   C1552615:maximum [Quantitative Concept]
  1000   C2826546:MAXIMUM [Quantitative Concept]
   928 E C0205289:Maximal [Qualitative Concept]

Phrase: "29%"

Phrase: "and"

Phrase: "6% of the injected dose,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2986768:Injected Dose [Functional Concept]
   760   C0178602:Dose [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   726   C1720154:Inject [Functional Concept]

Phrase: "respectively,"

Phrase: "were"

Phrase: "recovered in the liver"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0521108:recovered [Qualitative Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   737 E C2004454:recover [Organism Function]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.307: In another study, which involved external scintigraphic analysis of the liver after injection of peptides labeled with 123I at the A14 position, insulin uptake attained 32% of injected dose after 3 min and declined with a half-life of 6 min, whereas proinsulin uptake reached 18% at 1 min and decreased with a half-life of 45 min (16). 

Phrase: "In another study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "which"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "external scintigraphic analysis of the liver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "after injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "labeled with 123I"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "at the A14 position,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "insulin uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "attained"

Phrase: "32% of injected dose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2986768:Injected Dose [Functional Concept]
   770   C0178602:Dose [Quantitative Concept]
   770   C0869039:Dose [Quantitative Concept]
   770   C1114758:Dose # [Clinical Attribute]
   737   C1720154:Inject [Functional Concept]

Phrase: "after 3 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "declined with a half-life of 6 min,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018517:Half-Life [Temporal Concept]
   744   C0376558:Life [Idea or Concept]
   744   C0702093:/min [Temporal Concept]
   744   C2825407:Half [Quantitative Concept]

Phrase: "whereas"

Phrase: "proinsulin uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "18% at 1 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "decreased with a half-life of 45 min (16"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   764   C0018517:Half-Life [Temporal Concept]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0376558:Life [Idea or Concept]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C0702093:/min [Temporal Concept]
   742   C2825407:Half [Quantitative Concept]
   708 E C0547047:Decrease [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.308: Our estimates of liver uptake of [125I]-proinsulin and [125I]-insulin (1.6 and 5.2% of injected dose per gram of liver, respectively) and half-lives (28 and 6 min) compare favorably with these results. 

Phrase: "Our estimates of liver uptake of [125I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0750572:estimates [Quantitative Concept]

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "5.2% of injected dose"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C2986768:Injected Dose [Functional Concept]
   760   C0178602:Dose [Quantitative Concept]
   760   C0439084:>5 [Quantitative Concept]
   760   C0728893:+5 [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   726   C1720154:Inject [Functional Concept]

Phrase: "per gram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439208:gram [Quantitative Concept]

Phrase: "of liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "respectively"

Phrase: ")"

Phrase: "and"

Phrase: "half-lives"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   966   C0018517:Half-Life [Temporal Concept]
   861   C0595998:lives [Finding]
   861   C1548795:Live [Qualitative Concept]
   861   C1634625:% live [Qualitative Concept]
   861   C2825407:Half [Quantitative Concept]
   861   C2982691:Live [Activity]
   827 E C0376558:Life [Idea or Concept]

Phrase: "(28"

Phrase: "and"

Phrase: "6 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "favorably with these results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]
Processing 00000000.tx.309: Previous studies have shown that, on cell fractionation, [125I]-insulin taken up by rat liver in vivo associates first with plasma membranes sedimenting in the N and P fractions and then with endosomes sedimenting in the P and L fractions (27, 36, 37). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "on cell fractionation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007593:Cell Fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "by rat liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: "first with plasma membranes"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0007603:Plasma Membranes [Cell Component]
   770   C0025255:Membranes [Tissue]
   770   C0032105:Plasma [Body Substance]
   770   C0205435:First [Quantitative Concept]
   770   C1279901:First [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "sedimenting in the N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0521447:Nuclear [Spatial Concept]
   737   C1550099:Sediment [Body Substance]

Phrase: "and"

Phrase: "P fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "then with endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034850:Endosomes [Cell Component]
   790   C1883708:Then [Temporal Concept]

Phrase: "sedimenting in the P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1550099:Sediment [Body Substance]

Phrase: "and"

Phrase: "L fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "(27,"

Phrase: "36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.310: In addition, although low or undetectable in vivo, a lysosomal association of internalized [125I]-insulin occurred in a cell-free system in the presence of cytosol and ATP (25, 28). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "although"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "or"

Phrase: "undetectable in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "a lysosomal association of internalized"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "occurred in a cell-free system"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   833   C0007625:Cell-Free System [Cell Component]
   790   C1183428:cell free [Cell]
   753   C0007634:Cell [Cell]
   753   C0332296:free [Functional Concept]
   753   C0449913:System [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1704653:Cell [Medical Device]
   753   C1709305:Occurred [Activity]
   753   C1880497:Free [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "ATP"

Phrase: "(25,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.311: Our results confirm these observations and show that the subcellular distribution of [125I]-proinsulin differs from that of [125I]-insulin in three respects: first, a reduced and slower association with the plasma membrane; 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the subcellular distribution of [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "differs from that of [125I"

Phrase: "]-insulin in three respects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ":"

Phrase: "first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "slower association with the plasma membrane"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: ";"
Processing 00000000.tx.312: second, a delayed and prolonged association with endosomes; 

Phrase: "second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "a delayed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205421:Delayed [Temporal Concept]
  1000   C3272602:Delayed [Qualitative Concept]

Phrase: "and"

Phrase: "prolonged association with endosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: ";"
Processing 00000000.tx.313: and third, a greater and more sustained lysosomal association, best demonstrable in a cell-free system. 

Phrase: "and"

Phrase: "third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "a greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "and"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "sustained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443318:Sustained [Functional Concept]
   966 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "lysosomal association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "best demonstrable in a cell-free system."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332265:Demonstrable [Functional Concept]
Processing 00000000.tx.314: Consistent with these observations, both the association of [125I]-proinsulin with cell surface insulin receptors and its internalization have been shown to be delayed in human fibroblasts overexpressing the insulin receptor (20). 

Phrase: "Consistent with these observations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "both"

Phrase: "the association of [125I"

Phrase: "]-proinsulin with cell surface insulin receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1718242:Proinsulin/Insulin [Quantitative Concept]
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "its internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871786:internalization [Mental Process]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "delayed in human fibroblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0016030:Fibroblasts [Cell]
   770   C0086418:Human [Human]
   770   C0205421:Delayed [Temporal Concept]
   770   C3272602:Delayed [Qualitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.315: [125I]-insulin taken up into PM and endosomal fractions in vivo has been shown to be converted to TCA-soluble and low-molecular-weight degradation products, which diffuse in the S fraction (24, 27, 36, 37). 

Phrase: "[125I"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "into PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "converted to TCA-soluble"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "low-molecular-weight degradation products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]

Phrase: "which"

Phrase: "diffuse in the S fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205219:Diffuse [Qualitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "(24,"

Phrase: "27,"

Phrase: "36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.316: In addition, when endosomal fractions containing in vivo internalized insulin were incubated under isoosmotic conditions, the ligand underwent further degradation, with a pH optimum of 56; 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "when"

Phrase: "endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "in vivo internalized insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "incubated under isoosmotic conditions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1439852:Incubated [Laboratory Procedure]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "the ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "underwent"

Phrase: "further degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "with a pH optimum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2698651:Optimum [Qualitative Concept]

Phrase: "of 56"

Phrase: ";"
Processing 00000000.tx.317: addition of ATP, by decreasing the internal endosomal pH, shifted this optimum to 78 (21, 24, 38, 39, 40, 41, 42). 

Phrase: "addition of ATP,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "by decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the internal endosomal pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "shifted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0333051:shifted [Functional Concept]
   966 E C2347509:Shift [Phenomenon or Process]

Phrase: "this optimum to 78"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2698651:Optimum [Qualitative Concept]

Phrase: "(21,"

Phrase: "24,"

Phrase: "38,"

Phrase: "39,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.318: The current studies extend these observations to [125I]-proinsulin but show that the extent and rate at which TCA-soluble radioactivity is generated in vivo, as well as in intact cell-free endosomes, are about three times lower than for [125I]-insulin. 

Phrase: "The current studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "these observations to [125I"

Phrase: "]-proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "and"

Phrase: "rate at which TCA-soluble radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "is"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "as well as in intact cell-free endosomes,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0682538:intact cell [Cell]
   770   C1183428:cell free [Cell]
   744   C0007634:Cell [Cell]
   744   C0034850:Endosomes [Cell Component]
   744   C0205170:Well [Qualitative Concept]
   744   C0205266:Intact [Qualitative Concept]
   744   C0332296:free [Functional Concept]
   744   C1269647:Cell [Cell]
   744   C1554187:Intact [Idea or Concept]
   744   C1704653:Cell [Medical Device]
   744   C1880497:Free [Qualitative Concept]
   744   C1948049:Cell [Spatial Concept]
   744   C1996904:Free [Qualitative Concept]
   744   C3146287:Well [Manufactured Object]

Phrase: "are"

Phrase: "about three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0441994:Lower [Spatial Concept]
   833   C1548802:Lower [Body Location or Region]
   833   C2003888:Lower [Activity]

Phrase: "for"

Phrase: "[125I"

Phrase: "]-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.319: Furthermore, a comparable and even-greater decrease in the rate of proinsulin degradation, as measured by RIA using anti-insulin and antiproinsulin antibodies, was observed in cell-free endosomes loaded with native peptides. 

Phrase: "Furthermore,"

Phrase: "a comparable"

Phrase: "and"

Phrase: "even-greater decrease in the rate of proinsulin degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "as"

Phrase: "measured by RIA"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0034580:RIA [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "antiproinsulin antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in cell-free endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034850:Endosomes [Cell Component]

Phrase: "loaded with native peptides."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0302891:Native [Functional Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.320: The slower degradation of proinsulin in endosomes probably accounts for its prolonged retention in these organelles in vivo and may explain why, as other peptides or proteins which also show a low rate of endosomal degradation (25, 28, 47), internalized proinsulin undergoes a greater and more sustained lysosomal association in vivo and in the cell-free system. 

Phrase: "The slower degradation of proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "in endosomes probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "accounts for its prolonged retention"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035280:Retention [Mental Process]
   760   C0333117:Retention [Functional Concept]
   760   C0439590:Prolonged [Temporal Concept]
   760   C1551359:account [Idea or Concept]
   760   C1753315:retention [Cell Function]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]

Phrase: "in these organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029219:Organelles [Cell Component]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "may"

Phrase: "explain"

Phrase: "why,"

Phrase: "as"

Phrase: "other peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a low rate of endosomal degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "(25,"

Phrase: "28,"

Phrase: "47"

Phrase: ")"

Phrase: ","

Phrase: "internalized proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "undergoes"

Phrase: "a greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "and"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "sustained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443318:Sustained [Functional Concept]
   966 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "lysosomal association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and in the cell-free system."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0007625:Cell-Free System [Cell Component]
   790   C1183428:cell free [Cell]
   753   C0007634:Cell [Cell]
   753   C0332296:free [Functional Concept]
   753   C0449913:System [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1515981:And [Idea or Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1704653:Cell [Medical Device]
   753   C1880497:Free [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]
   753   C1996904:Free [Qualitative Concept]
Processing 00000000.tx.321: Theoretically, the slower degradation of proinsulin in endosomes could result from a slower dissociation of the proinsulin-receptor complex at the low endosomal pH and/or from a decreased sensitivity of proinsulin to endosomal proteases. 

Phrase: "Theoretically,"

Phrase: "the slower degradation of proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "in endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "could"

Phrase: "result from a slower dissociation of the proinsulin-receptor complex"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C1523873:receptor complex [Cell Component]
   739   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   739   C0439855:Complex [Qualitative Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C1704241:Complex [Chemical Viewed Structurally]
   739   C2825142:Result [Finding]
   706   C0439834:Slow [Qualitative Concept]

Phrase: "at the low endosomal pH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0728725:Low pH [Finding]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and/or from a decreased sensitivity of proinsulin"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   770   C0020580:Decreased Sensitivity [Finding]
   770   C1706528:And/Or [Conceptual Entity]
   770   C1880261:DECREASED SENSITIVITY [Phenomenon or Process]
   770   C2348085:DECREASED SENSITIVITY [Phenomenon or Process]
   744   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0036667:Sensitivity [Quantitative Concept]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0312418:Sensitivity [Mental Process]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0427965:Sensitivity [Finding]
   744   C0442797:decreased [Qualitative Concept]
   744   C1511883:Sensitivity [Quantitative Concept]
   744   C1515981:And [Idea or Concept]
   744   C1522640:Sensitivity [Qualitative Concept]
   744   C2346484:SENSITIVITY [Phenomenon or Process]
   744   C2349185:Sensitivity [Qualitative Concept]
   711 E C0547047:Decrease [Quantitative Concept]

Phrase: "to endosomal proteases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]
Processing 00000000.tx.322: Our results do not support the former possibility and instead show that proinsulin degradation by hypotonically disrupted endosomes and soluble endosomal extracts, which occurs optimally at pH 4, is reduced by 3- to 5-fold relative to insulin degradation. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the former possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "and"

Phrase: "instead"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that proinsulin degradation by hypotonically disrupted endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "soluble endosomal extracts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "which"

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "optimally at pH 4,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2678549:PH-4 [Gene or Genome]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]

Phrase: "is"

Phrase: "reduced by 3-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "to 5-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "relative to insulin degradation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.323: This decrease is comparable to that observed in intact cell-free endosomes, supporting the view that the insulin- and proinsulin-degrading activity identified in soluble extracts is physiologically relevant (25, 29, 30). 

Phrase: "This decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "is"

Phrase: "comparable to that"

Phrase: "observed in intact cell-free endosomes,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0682538:intact cell [Cell]
   790   C1183428:cell free [Cell]
   753   C0007634:Cell [Cell]
   753   C0034850:Endosomes [Cell Component]
   753   C0205266:Intact [Qualitative Concept]
   753   C0332296:free [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1441672:Observed [Functional Concept]
   753   C1554187:Intact [Idea or Concept]
   753   C1704653:Cell [Medical Device]
   753   C1880497:Free [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]
   753   C1996904:Free [Qualitative Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that"

Phrase: "the insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proinsulin-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "identified in soluble extracts"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]
   737   C2828366:Extract [Substance]

Phrase: "is"

Phrase: "physiologically relevant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]

Phrase: "(25,"

Phrase: "29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.324: Furthermore, the relative degradation rates of insulin, intact proinsulin and proinsulin split conversion intermediates were similar in intact cell-free endosomes and soluble endosomal extracts (insulin > des-[64, 65]proinsulin > split-[3233]proinsulin > intact proinsulin). 

Phrase: "Furthermore,"

Phrase: "the relative degradation rates of insulin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "intact proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "proinsulin split conversion intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0205103:Intermediate [Spatial Concept]
   779   C1550465:intermediate [Idea or Concept]
   779   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "were"

Phrase: "similar in intact cell-free endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "soluble endosomal extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "(insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "> des-[64,"

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "]proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "> split-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1534709:Split [Functional Concept]
  1000   C1881714:SPLIT [Phenomenon or Process]

Phrase: "[3233"

Phrase: "]proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "> intact proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.325: The reasons why the pH optimum for insulin and proinsulin degradation is lower in disrupted endosomes (pH 44.5) (25, 29 and present study) than in intact cell-free endosomes (pH 56) (21, 24, 38, 39, 40, 41, 42 and present study) are not obvious. 

Phrase: "The reasons why"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392360:reasons [Idea or Concept]

Phrase: "the pH optimum for insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2698651:Optimum [Qualitative Concept]

Phrase: "and"

Phrase: "proinsulin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "lower in disrupted endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "(pH 44.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "(25,"

Phrase: "29"

Phrase: "and"

Phrase: "present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "than"

Phrase: "in intact cell-free endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034850:Endosomes [Cell Component]

Phrase: "(pH 56"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "(21,"

Phrase: "24,"

Phrase: "38,"

Phrase: "39,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41,"

Phrase: "42"

Phrase: "and"

Phrase: "present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "are"

Phrase: "not obvious."
Processing 00000000.tx.326: It is possible that, in freshly isolated endosomes incubated at low pH, endosomal integrity is not fully maintained, resulting in the extraluminal release of peptide and/or peptide-degrading activity. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that,"

Phrase: "in freshly isolated endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034850:Endosomes [Cell Component]

Phrase: "incubated at low pH,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0728725:Low pH [Finding]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0205251:low [Qualitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C1299352:Low [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1550472:low [Idea or Concept]

Phrase: "endosomal integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "is"

Phrase: "not fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: ","

Phrase: "resulting in the extraluminal release of peptide"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0332294:Resulting in [Functional Concept]
   748   C0030685:Release [Health Care Activity]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0678226:resulting [Functional Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1517059:Extraluminal [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "and/or"

Phrase: "peptide-degrading activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.327: In previous studies, degradation intermediates generated from [125I]-monoiodoinsulin in intact cell-free endosomes (42) and from native insulin in soluble endosomal extracts (25) have been isolated by RP-HPLC and characterized by radiosequencing and mass spectrometry, respectively. 

Phrase: "In previous studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "degradation intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "generated from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3146294:Generated [Activity]

Phrase: "[125I"

Phrase: "]-monoiodoinsulin in intact cell-free endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0063651:monoiodoinsulin [Amino Acid, Peptide, or Protein]

Phrase: "(42"

Phrase: ")"

Phrase: "and from native insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0302891:Native [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in soluble endosomal extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "(25"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "isolated by RP-HPLC"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1555029:Reverse [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "characterized by radiosequencing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "mass spectrometry,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.328: Based on these data, insulin degradation has been shown to proceed via an ordered sequential pathway, the PheB24-PheB25 bond being the major and earliest site of cleavage. 

Phrase: "Based on these data,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   802   C0242356:data base [Intellectual Product]
   802   C0993637:Data Base [Intellectual Product]
   770   C1511726:Data [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "proceed via an ordered sequential pathway,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C1548958:Sequential [Idea or Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705176:Ordered [Qualitative Concept]
   753   C1705178:Ordered [Activity]
   753   C1705294:Sequential [Qualitative Concept]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "the PheB24-PheB25 bond"

Phrase: "being"

Phrase: "the major"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205164:Major [Qualitative Concept]

Phrase: "and"

Phrase: "earliest site of cleavage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2945843:Site of [Qualitative Concept]
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]
Processing 00000000.tx.329: Using the mass spectrometry approach, we show here that, when incubated with a soluble endosomal extract, human proinsulin is cleaved at eight bonds in the C peptide but only at one, the Phe 24-Phe25 bond, in the insulin moiety. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mass spectrometry approach,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approach [Spatial Concept]
   734   C0037813:Mass Spectrometry [Laboratory Procedure]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that,"

Phrase: "when"

Phrase: "incubated with a soluble endosomal extract,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   753   C2828366:Extract [Substance]

Phrase: "human proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0086418:Human [Human]

Phrase: "is"

Phrase: "cleaved at eight bonds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205242:Cleaved [Spatial Concept]
   770   C0205454:Eight [Quantitative Concept]
   770   C0333853:Cleaved [Cell]

Phrase: "in the C peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "but"

Phrase: "only at one,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205171:Only [Quantitative Concept]
   790   C0205447:One [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "the Phe 24-Phe25 bond,"

Phrase: "in the insulin moiety."
Processing 00000000.tx.330: Under closely similar pH, time, and substrate concentration conditions, insulin has been shown to be cleaved at eight bonds in the B chain and one in the A chain (25). 

Phrase: "Under closely similar pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "substrate concentration conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "cleaved at eight bonds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205242:Cleaved [Spatial Concept]
   770   C0205454:Eight [Quantitative Concept]
   770   C0333853:Cleaved [Cell]

Phrase: "in the B chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "one in the A chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.331: This indicates that, despite similar conformations of proinsulin and insulin, the sensitivity of these bonds to endosomal proteases is reduced in proinsulin. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that,"

Phrase: "despite similar conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]

Phrase: "of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the sensitivity of these bonds"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to endosomal proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "is"

Phrase: "reduced in proinsulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.332: As in insulin, cleavage of the Phe24-Phe25 bond in proinsulin is probably an early event, because it is involved in the production of the 12 intermediates identified. 

Phrase: "As in insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cleavage of the Phe24-Phe25 bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "in proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "an early event,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "involved in the production of the 12 intermediates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0033268:production [Occupational Activity]
   744   C1314939:Involved [Functional Concept]
   711   C0205103:Intermediate [Spatial Concept]
   711   C1550465:intermediate [Idea or Concept]
   711   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.333: Although not detected here, additional cleavages in the insulin moiety of proinsulin would probably have occurred under more drastic conditions (longer incubation, lower substrate concentration), to account for the generation of low-molecular-weight TCA-soluble products from [125I]-proinsulin. 

Phrase: "Although"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "here,"

Phrase: "additional cleavages in the insulin moiety of proinsulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0010813:cleavage [Cell Function]
   711   C0596311:Cleavage [Phenomenon or Process]
   711   C1330957:cleavage [Cell Function]

Phrase: "would"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "have"

Phrase: "occurred under more drastic conditions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C1709305:Occurred [Activity]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "(longer incubation,"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "substrate concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: ","

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "account for the generation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0079411:Generation [Temporal Concept]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
   770   C3146294:Generation [Activity]

Phrase: "of low-molecular-weight TCA-soluble products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C1514468:Products [Entity]
   762 E C1704444:Product [Quantitative Concept]

Phrase: "from"

Phrase: "[125I"

Phrase: "]-proinsulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.334: Endosomes have been shown to harbor several acidic proteases, including cathepsin-B, cathepsin-D, and -site amyloid precursor protein-cleaving enzyme. 

Phrase: "Endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "have"

Phrase: "been"

Phrase: "shown to harbor several acidic proteases,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0001128:Acidic [Chemical]
   753   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0475311:Harbor [Manufactured Object]
   753   C1947941:Proteases [Enzyme]
   719   C1547282:Show [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cathepsin-B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cathepsin-D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "site amyloid precursor protein-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "cleaving"

Phrase: "enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.335: Based on a number of criteria, including the inhibitor profile of the degrading activity and the results of immunodepletion studies, the acidic protease cathepsin-D has been proposed as the enzyme that initiates insulin degradation in hepatic endosomes (30). 

Phrase: "Based on a number of criteria,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   767   C2981742:Base Number [Conceptual Entity]
   753   C0237753:*Number [Quantitative Concept]
   753   C0243161:criteria [Intellectual Product]
   753   C0449788:Number [Quantitative Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the inhibitor profile of the degrading activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1979963:Profile [Laboratory Procedure]
   748   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "the results of immunodepletion studies,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results studies [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "the acidic protease cathepsin-D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332805:CATHEPSIN D [Gene or Genome]
   812   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "proposed as the enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0014442:Enzyme [Enzyme,Organic Chemical]
   770   C1441414:PROPOSED [Idea or Concept]
   770   C1553874:Proposed [Qualitative Concept]
   770   C1578820:Proposed [Idea or Concept]

Phrase: "that"

Phrase: "initiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "insulin degradation in hepatic endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C3547574:insulin degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.336: That cathepsin-D may also initiate endosomal degradation of proinsulin is suggested by several observations. 

Phrase: "That cathepsin-D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "also"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "endosomal degradation of proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "suggested by several observations."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:observations [Research Activity]
   770   C0700325:observations [Health Care Activity]
   770   C3244290:observations [Functional Concept]
   737   C1705535:Suggest [Idea or Concept]
   737 E C1964257:Observation [Diagnostic Procedure]
Processing 00000000.tx.337: First, the Phe24-Phe25 bond cleaved in proinsulin is preferentially cleaved by this enzyme in insulin as well as in a number of synthetic substrates and proteins (reviewed in Ref. 25). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the Phe24-Phe25 bond"

Phrase: "cleaved in proinsulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205242:Cleaved [Spatial Concept]
   790   C0333853:Cleaved [Cell]

Phrase: "is"

Phrase: "preferentially"

Phrase: "cleaved by this enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014442:Enzyme [Enzyme,Organic Chemical]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]

Phrase: "in insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as well as in a number of synthetic substrates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0205170:Well [Qualitative Concept]
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C1883254:synthetic [Activity]
   742   C3146287:Well [Manufactured Object]
   708   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "reviewed in Ref. 25"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.338: Second, four of the eight bonds cleaved in C peptide, which contain an apolar residue on their carboxyl side, are also readily cleavable by cathepsin-D. 

Phrase: "Second, four of the eight bonds"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205436:Second [Quantitative Concept]
   753   C0205450:Four [Quantitative Concept]
   753   C0205454:Eight [Quantitative Concept]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]

Phrase: "cleaved in C peptide,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   819 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]

Phrase: "which"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an apolar residue on their carboxyl side,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "are"

Phrase: "also readily cleavable by cathepsin-D."
Processing 00000000.tx.339: Finally, like insulin degradation, proinsulin degradation by the soluble endosomal extract was totally inhibited by pepstatin-A, a cathepsin-D inhibitor. 

Phrase: "Finally,"

Phrase: "like insulin degradation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "proinsulin degradation by the soluble endosomal extract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "totally"

Phrase: "inhibited by pepstatin-A,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "a cathepsin-D inhibitor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]
Processing 00000000.tx.340: These observations do not exclude, however, the involvement of proteases other than cathepsin-D in the cleavage of bonds that do not contain apolar residues in C peptide, and/or in late cleavages in the A and B chains. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: ","

Phrase: "however,"

Phrase: "the involvement of proteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "other than cathepsin-D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "of bonds"

Phrase: "that"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "apolar residues in C peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and/or in late cleavages"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1706528:And/Or [Conceptual Entity]
   760   C0205087:Late [Temporal Concept]
   760   C1515981:And [Idea or Concept]
   726   C0010813:cleavage [Cell Function]
   726   C0596311:Cleavage [Phenomenon or Process]
   726   C1330957:cleavage [Cell Function]

Phrase: "in the A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "B chains."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:chains [Manufactured Object]
   861   C1524075:Chains [Idea or Concept]
Processing 00000000.tx.341: The participation of IDE in endosomal proteolysis of proinsulin should be considered (see below), in view of the partial inhibition of the endosomal insulin-degrading activity by 1,10-phenanthroline and bacitracin, at least when using the TCA-precipitation assay (Refs. 29 and 43, 44, 45 and present study). 

Phrase: "The participation of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679823:Participation [Functional Concept]

Phrase: "in endosomal proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597304:Proteolysis [Molecular Function]
   789 E C1947941:proteolytic [Enzyme]

Phrase: "of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "should"

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: ","

Phrase: "in view of the partial inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of the endosomal insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   875   C1145751:insulin activity [Molecular Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1561536:*Activity [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10-phenanthroline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "and"

Phrase: "bacitracin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "when"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TCA-precipitation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "(Refs. 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "and"

Phrase: "43,"

Phrase: "44,"

Phrase: "45"

Phrase: "and"

Phrase: "present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")."
Processing 00000000.tx.342: Indeed, IDE has been implicated in the degradation of insulin in early endosomes before acidification (40, 43, 45). 

Phrase: "Indeed,"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the degradation of insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C3547574:insulin degradation [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in early endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0887883:Early endosome [Cell Component]
   861   C0034850:Endosomes [Cell Component]

Phrase: "before acidification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522821:acidification [Cell Function]
  1000   C2987513:Acidification [Phenomenon or Process]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "43,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.343: In the present study, no insulin-sized components were identified in endosomes isolated after [125I]-proinsulin injection, nor were cleavages of the Arg31-Arg32 and Lys64-Arg65 bonds at the BC and AC junctions, respectively, detected in native proinsulin. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "no insulin-sized components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "identified in endosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034850:Endosomes [Cell Component]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "after"

Phrase: "[125I"

Phrase: "]-proinsulin injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "nor"

Phrase: "were"

Phrase: "cleavages of the Arg31-Arg32"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0010813:cleavage [Cell Function]
   726   C0596311:Cleavage [Phenomenon or Process]
   726   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "Lys64-Arg65 bonds at the BC"

Phrase: "and"

Phrase: "AC junctions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205144:Junction [Spatial Concept]
   827   C1706311:Junction [Medical Device]

Phrase: "respectively,"

Phrase: "detected in native proinsulin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0302891:Native [Functional Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.344: However, although not converted to mature insulin when expressed in normal hepatocytes and hepatoma cell lines (48, 49), human proinsulin has been shown to be processed to des-[31, 32]proinsulin when incubated with Triton X-100 solubilized liver endosomal extracts (50) and stably expressed in rat Fao hepatoma cells (51). 

Phrase: "However,"

Phrase: "although"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "converted to mature insulin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0205286:Mature [Temporal Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "when"

Phrase: "expressed in normal hepatocytes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205307:Normal [Qualitative Concept]
   770   C0227525:Hepatocytes [Cell]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "hepatoma cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   901   C0007600:Cell lines [Cell]
   901   C0677626:hepatoma cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0023903:Hepatoma [Neoplastic Process]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2239176:Hepatoma [Neoplastic Process]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "(48,"

Phrase: "49"

Phrase: ")"

Phrase: ","

Phrase: "human proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0086418:Human [Human]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "processed to des-[31,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0450355:31 [Intellectual Product]
   770   C1522240:Processed [Phenomenon or Process]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "32"

Phrase: "]proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "when"

Phrase: "incubated with Triton X-100 solubilized liver endosomal extracts"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   764   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   762   C0023899:Liver Extracts [Organic Chemical,Pharmacologic Substance]
   742   C0023884:Liver [Body Part, Organ, or Organ Component]
   742   C0242759:Triton [Geographic Area]
   742   C0736268:LIVER [Body Part, Organ, or Organ Component]
   742   C1278929:Liver [Body Part, Organ, or Organ Component]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C2346688:LIVER [Food]
   708   C2828366:Extract [Substance]

Phrase: "(50"

Phrase: ")"

Phrase: "and"

Phrase: "stably"

Phrase: "expressed in rat Fao hepatoma cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   756   C0677626:hepatoma cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0016457:FAO [Health Care Related Organization]
   753   C0023903:Hepatoma [Neoplastic Process]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C2239176:Hepatoma [Neoplastic Process]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.345: In these studies, proinsulin processing was attributed to furin, a subtilisin-like endoprotease which shows a preference for pairs of basic residues preceded by another basic residue at the -4 position and processes a number of proteins in liver (52). 

Phrase: "In these studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "proinsulin processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "was"

Phrase: "attributed to furin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0919550:FURIN [Gene or Genome]
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756   C1882133:Attribute [Qualitative Concept]

Phrase: "a subtilisin-like endoprotease"

Phrase: "which"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a preference for pairs of basic residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0558295:preference [Idea or Concept]
   748   C1549513:Preference [Idea or Concept]

Phrase: "preceded by another basic residue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332152:preceded [Temporal Concept]
   760   C1527178:Basic [Functional Concept]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "at the -4 position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "a number of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.346: Our inability to show cleavage of proinsulin at the Arg31-Arg32 bond despite the presence of furin in liver Golgi-endosomal fractions (53) may be explained by two reasons. 

Phrase: "Our inability to"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "cleavage of proinsulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]

Phrase: "at the Arg31-Arg32 bond"

Phrase: "despite the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "in liver Golgi-endosomal fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   886   C0982262:LIVER FRACTION [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "(53"

Phrase: ")"

Phrase: "may"

Phrase: "be"

Phrase: "explained by two reasons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205448:Two [Quantitative Concept]
   770   C0392360:reasons [Idea or Concept]
Processing 00000000.tx.347: First, endosomes were disrupted by hypotonic shock, conditions under which furin should not be extracted because it is a membrane-associated enzyme; 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "disrupted by hypotonic shock,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3661442:Hypotonic Shock [Natural Phenomenon or Process]
   770   C0036974:Shock [Pathologic Function]
   770   C0241938:Hypotonic [Pathologic Function]
   770   C0332454:Disrupted [Qualitative Concept]

Phrase: "conditions under which furin"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0012634:condition [Disease or Syndrome]
   770   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0348080:Condition [Qualitative Concept]
   770   C0919550:FURIN [Gene or Genome]
   770   C1705253:Condition [Conceptual Entity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "a membrane-associated enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.348: second, incubations were carried out in the absence of Ca2+, which is required for furin activity (52). 

Phrase: "second, incubations"

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in the absence of Ca2+,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0332197:absence [Quantitative Concept]
   753   C0439787:Out [Spatial Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0849355:Out [Qualitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "which"

Phrase: "is"

Phrase: "required for furin activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1150256:furin activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0919550:FURIN [Gene or Genome]
   770   C1514873:Required [Functional Concept]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.349: Taken together, the results of our in vivo and in vitro studies suggest that a reduced sensitivity of proinsulin to endosomal cathepsin-D may account, at least in part, for its slower hepatic clearance compared with insulin. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the results of our in vivo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1517589:In Vivo Result [Conceptual Entity]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "and"

Phrase: "in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a reduced sensitivity of proinsulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to endosomal cathepsin-D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "for its slower hepatic clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "compared with insulin."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1707455:Compared [Activity]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.350: Consistent with this, degradation rates of insulin, intact proinsulin, and split conversion intermediates in intact and hypotonically disrupted endosomes were found to vary in the same rank order as their hepatic clearances (16). 

Phrase: "Consistent with this,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "degradation rates of insulin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "intact proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "split conversion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439836:Conversion [Functional Concept]

Phrase: "intermediates in intact"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205103:Intermediate [Spatial Concept]
   790   C0205266:Intact [Qualitative Concept]
   790   C1550465:intermediate [Idea or Concept]
   790   C1554187:Intact [Idea or Concept]
   790   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "hypotonically disrupted endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "vary in the same rank order"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0445247:Same [Qualitative Concept]
   753   C0699794:Rank [Intellectual Product]
   753   C1705175:Order [Intellectual Product]
   753   C1705176:Order [Qualitative Concept]
   753   C1705177:Order [Classification]
   753   C1705178:Order [Activity]
   753   C1882348:Order [Qualitative Concept]

Phrase: "as their hepatic clearances"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.351: However, because the ability of PM and cytosolic fractions to degrade proinsulin in vitro is also reduced (and, in fact, proportionally more than that of the endosomal fraction), a lower sensitivity of proinsulin to proteases at these loci must also be considered. 

Phrase: "However,"

Phrase: "because"

Phrase: "the ability of PM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "cytosolic fractions to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "degrade"

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "("

Phrase: "and"

Phrase: ","

Phrase: "in fact,"

Phrase: "proportionally more than that of the endosomal fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1264633:Fraction of [Quantitative Concept]
           Fraction
   744   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "a lower sensitivity of proinsulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "at these loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "must"

Phrase: "also"

Phrase: "be"

Phrase: "considered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]
Processing 00000000.tx.352: One obvious candidate is IDE, an evolutionarily conserved neutral thiol-metalloendopeptidase, which seems to play a major role in cellular insulin degradation (43, 45). 

Phrase: "One obvious candidate"

Phrase: "is"

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "an evolutionarily conserved neutral thiol-metalloendopeptidase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a major role in cellular insulin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(43,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.353: Indeed, IDE is recovered mainly in the cytosol but has also been identified in isolated plasma membranes and at surface of cells overexpressing (or not) IDE (43, 45, 54). 

Phrase: "Indeed,"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "mainly in the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]

Phrase: "but"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "identified in isolated plasma membranes"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0007603:Plasma Membranes [Cell Component]
   760   C0025255:Membranes [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0205396:Identified [Qualitative Concept]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1550043:Identified [Finding]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1551388:Identified [Functional Concept]
   745   C2247585:isolation membrane [Cell Component]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "and at surface of cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   851   C0699040:Surface of cell [Cell Component]
           Cell surface
   760   C0007634:Cells [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1515981:And [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "("

Phrase: "or"

Phrase: "not) IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(43,"

Phrase: "45,"

Phrase: "54"

Phrase: ")."
Processing 00000000.tx.354: In addition, in the present study, the sensitivity of proinsulin to the degrading activity associated with plasma membrane and cytosol was reduced to the same extent as that to purified IDE (18, 43, 44, 45). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "in the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the sensitivity of proinsulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to the degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "associated with plasma membrane"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0007603:Plasma membrane [Cell Component]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0025255:Membrane [Tissue]
   770   C0032105:Plasma [Body Substance]
   770   C0596901:Membrane [Cell Component]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C1706182:Membrane [Manufactured Object]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "was"

Phrase: "reduced to the same extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392756:Reduced [Qualitative Concept]
   760   C0439792:Extent [Spatial Concept]
   760   C0445247:Same [Qualitative Concept]

Phrase: "as that"

Phrase: "to purified IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(18,"

Phrase: "43,"

Phrase: "44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.355: The slower development and longer duration of proinsulin hepatic effects in vivo (5, 6, 7) led us to compare insulin and proinsulin effects on insulin receptor expression and tyrosine phosphorylation in liver subcellular fractions. 

Phrase: "The slower development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "longer duration of proinsulin hepatic effects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C0439591:Long duration [Qualitative Concept]
   753   C0449238:Duration [Temporal Concept]
   753   C2926735:Duration [Pharmacologic Substance]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "7"

Phrase: ")"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proinsulin effects on insulin receptor expression"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "tyrosine phosphorylation in liver subcellular fractions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.356: As acute in vivo insulin treatment (24, 31, 46), proinsulin treatment led to a rapid and reversible endocytosis and tyrosine phosphorylation of the insulin receptor, but such effects differed with respect to dose- and time-dependence. 

Phrase: "As acute in vivo insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]

Phrase: "(24,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "46"

Phrase: ")"

Phrase: ","

Phrase: "proinsulin treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "led to a rapid"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C0439831:Rapid [Qualitative Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "reversible endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014139:Endocytosis [Cell Function]
   861   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "tyrosine phosphorylation of the insulin receptor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "but"

Phrase: "such effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "differed with respect to dose-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0178602:Dose [Quantitative Concept]
   760   C0679133:respect [Social Behavior]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "time-dependence."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0011546:Dependence [Mental Process]
   861   C0439857:Dependence [Mental or Behavioral Dysfunction]
   861   C2698668:DEPENDENCE [Regulation or Law]
   789 E C0851827:Dependent [Qualitative Concept]
   789 E C1701901:Dependent [Qualitative Concept]
   789 E C3244310:dependent [Functional Concept]
   761 E C1546937:Dependency [Idea or Concept]
Processing 00000000.tx.357: Consistent with the lower affinity of proinsulin for the insulin receptor, on a molar basis, proinsulin was about 1020 times less potent than insulin in its ability to increase endosomal receptor content and tyrosine phosphorylation. 

Phrase: "Consistent with the lower affinity of proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for the insulin receptor,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "on a molar basis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "about 1020 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "less potent than insulin"

Phrase: "in its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "endosomal receptor content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "tyrosine phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.358: In time studies, administration of an inframaximal dose of proinsulin led, relative to insulin, to an increased residence time of the insulin receptor in endosomes as judged on insulin binding activity and receptor -subunit expression, and to a prolonged tyrosine phosphorylation of the -subunit (both at the plasma membrane and in endosomes). 

Phrase: "In time studies,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
  1000   C0040227:Time Studies [Intellectual Product]
   861   C0040223:Time [Temporal Concept]
   861   C0947630:studies [Laboratory Procedure]
   861   C3541383:Time [Temporal Concept]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "administration of an inframaximal dose of proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001554:Administration [Occupational Activity]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "relative to insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "to an increased residence time"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   827   C0040223:Time [Temporal Concept]
   827   C0237096:residence [Spatial Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   755 E C1320928:Resident [Professional or Occupational Group]
   755 E C1549439:Resident [Intellectual Product]
   755 E C2347958:Resident [Human]
   743 E C1632851:Times [Quantitative Concept]
   727 E C0035182:Residencies [Educational Activity]

Phrase: "of the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "as"

Phrase: "judged on insulin binding activity"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   806   C1623517:insulin binding [Molecular Function]
   806   C2266866:Binding Activity [Molecular Function]
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0243122:binding [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0221191:Judge [Professional or Occupational Group]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "receptor -subunit expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0597360:receptor expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and to a prolonged tyrosine phosphorylation of the -subunit"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C1519726:Tyrosine Phosphorylation [Molecular Function]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0439590:Prolonged [Temporal Concept]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1515981:And [Idea or Concept]
   742   C1711351:Subunit [Quantitative Concept]

Phrase: "("

Phrase: "both at the plasma membrane"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0238767:Both [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706086:Both [Qualitative Concept]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "and in endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034850:Endosomes [Cell Component]
   790   C1515981:And [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.359: The most likely explanation of these observations is the slower clearance of proinsulin from blood plasma (4) and at these subcellular sites (present study), which, despite the low affinity of proinsulin for the insulin receptor, may keep the receptor occupied for a longer duration. 

Phrase: "The most likely explanation of these observations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "the slower clearance of proinsulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "from blood plasma"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
  1000   C0032105:Blood Plasma [Body Substance]
           Plasma
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "(4"

Phrase: ")"

Phrase: "and at these subcellular sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0205145:Sites [Spatial Concept]
   760   C1515981:And [Idea or Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "(present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "which,"

Phrase: "despite the low affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C1550472:low [Idea or Concept]

Phrase: "of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for the insulin receptor,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "keep"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Keep [Functional Concept]

Phrase: "the receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "occupied for a longer duration."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0439591:Long duration [Qualitative Concept]
   760   C0449238:Duration [Temporal Concept]
   760   C1548223:Occupied [Idea or Concept]
   760   C2926735:Duration [Pharmacologic Substance]
   726   C0205166:Long [Qualitative Concept]
   726   C1706317:Long [Qualitative Concept]
Processing 00000000.tx.360: Genetically engineered insulin analogs, covering a wide range of receptor affinities, have been shown to differ from native insulin in their abilities to be taken up by and cleared from rat liver in vivo (55). 

Phrase: "Genetically engineered insulin analogs,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0243071:analogs [Chemical Viewed Structurally]
   706 E C0679213:analogies [Idea or Concept]

Phrase: "covering"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0180153:covering [Medical Device]
  1000   C0439844:covering [Functional Concept]
   966 E C1707529:Cover [Medical Device]
   966 E C1999244:Cover [Functional Concept]

Phrase: "a wide range of receptor affinities,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "differ from native insulin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0302891:Native [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in their abilities to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Abilities [Organism Attribute]
   777 E C1299581:Able [Finding]

Phrase: "be"

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "by"

Phrase: "and"

Phrase: "cleared from rat liver"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0521097:cleared [Functional Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   737 E C2963144:Clear [Qualitative Concept]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.361: We have previously shown that the subcellular distribution and metabolic fate of [HisA8, HisB4, GluB10, HisB27]insulin, a high-affinity analog slowly cleared from the liver, somewhat resemble those of proinsulin (24, 25). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the subcellular distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "metabolic fate of [HisA8,"

Phrase: "HisB4,"

Phrase: "GluB10,"

Phrase: "HisB27"

Phrase: "]insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a high-affinity analog slowly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0243071:Analog [Chemical Viewed Structurally]
   712 E C0679213:analogies [Idea or Concept]

Phrase: "cleared from the liver,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0521097:cleared [Functional Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   737 E C2963144:Clear [Qualitative Concept]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "somewhat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2984079:Somewhat [Intellectual Product]

Phrase: "resemble"

Phrase: "those of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.362: Thus, relative to insulin, this analog showed a prolonged accumulation and slower processing in endosomes in vivo and in vitro, it underwent a greater cell-free endosome-lysosome transfer, it was more slowly degraded by soluble endosomal proteases, and it induced in vivo a more prolonged increase in endosomal insulin receptor content and tyrosine phosphorylation. 

Phrase: "Thus,"

Phrase: "relative to insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "this analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243071:Analog [Chemical Viewed Structurally]
   900 E C0679213:analogies [Idea or Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a prolonged accumulation"

Phrase: "and"

Phrase: "slower processing in endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "it"

Phrase: "underwent"

Phrase: "a greater cell-free endosome-lysosome transfer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0040671:Transfer [Mental Process]
   799   C1705822:Transfer [Activity]

Phrase: "it"

Phrase: "was"

Phrase: "more slowly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0439834:Slowly [Qualitative Concept]

Phrase: "degraded by soluble endosomal proteases,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C1749467:soluble [Cell Component]
   760   C1881707:DEGRADED [Phenomenon or Process]
   760   C1947941:Proteases [Enzyme]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "it"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "a more prolonged increase in endosomal insulin receptor content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0020459:INSULIN INCREASE [Disease or Syndrome]
   742   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "tyrosine phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.363: Along with the present results, these observations reinforce the concept that the endosomal processing of internalized ligands is an important determinant in ligand and receptor trafficking, as well as signal transduction, in liver cells.  

Phrase: "Along with the present results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "reinforce"

Phrase: "the concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concept [Idea or Concept]

Phrase: "that"

Phrase: "the endosomal processing of internalized ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709694:Processing [Activity]

Phrase: "is"

Phrase: "an important determinant in ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521761:Determinant [Functional Concept]

Phrase: "and"

Phrase: "receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: ","

Phrase: "as well as"

Phrase: "signal transduction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Signal Transduction [Cell Function]
   861   C1160185:transduction [Organism Function]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "in liver cells."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0227525:liver cells [Cell]
   928 E C2697585:Hepatocellular [Qualitative Concept]
   861   C0007634:Cells [Cell]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   805 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.364: Acknowledgments  The authors thank Khadija Tahiri and Eric Germain for expert assistance, Didier Chevenne for helpful comments, and Association Claude Bernard for financial support.  

Phrase: "Acknowledgments"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Khadija Tahiri"

Phrase: "and"

Phrase: "Eric Germain for expert assistance,"

Phrase: "Didier Chevenne for helpful comments,"

Phrase: "and"

Phrase: "Association Claude Bernard for financial support."
Processing 00000000.tx.365: Footnotes  Abbreviations: IDE, Insulin-degrading enzyme; 

Phrase: "Footnotes  Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.366: L, light mitochondrial (fraction); 

Phrase: "L, light mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "(fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.367: M, mitochondrial (fraction); 

Phrase: "M, mitochondrial"

Phrase: "(fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.368: N, nuclear (fraction); 

Phrase: "N, nuclear"

Phrase: "(fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.369: P, microsomal (fraction); 

Phrase: "P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "microsomal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1979928:Microsomal [Qualitative Concept]
   928 E C0026029:Microsome [Cell Component]

Phrase: "(fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.370: PEG, polyethyleneglycol; 

Phrase: "PEG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "polyethyleneglycol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.371: PM, plasma membrane (fraction); 

Phrase: "PM,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.372: RP-HPLC, reverse-phase HPLC; 

Phrase: "RP-HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: "reverse-phase HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.373: S, soluble; 

Phrase: "S, soluble"

Phrase: ";"
Processing 00000000.tx.374: TCA, trichloroacetic acid. 

Phrase: "TCA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "trichloroacetic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.375: Received December 17, 2002. 

Phrase: "Received December 17,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2002."
Processing 00000000.tx.376: Accepted for publication September 2, 2003.  

Phrase: "Accepted for publication September 2,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2003."
Processing 00000000.tx.377: References Top Abstract Introduction Materials and Methods Results Discussion References  Steiner DF, Oyer PE 1967 The biosynthesis of insulin and a probable precursor of insulin in a human islet cell adenoma. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Steiner DF,"

Phrase: "Oyer PE 1967"

Phrase: "The biosynthesis of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005572:biosynthesis [Functional Concept]
   770   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "a probable precursor of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709634:Precursor [Idea or Concept]

Phrase: "in a human islet cell adenoma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0022134:Islet Cell Adenoma [Neoplastic Process]
   923   C0242363:islet cell adenoma [Neoplastic Process]
   812   C0001430:Adenoma [Neoplastic Process]
   708   C0427861:human cell [Laboratory or Test Result]
Processing 00000000.tx.378: Proc Natl Acad Sci USA 57:473480 Steiner DF, James DE 1992 Cellular and molecular biology of the -cell. 

Phrase: "Proc Natl Acad Sci USA 57"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "473480 Steiner DF,"

Phrase: "James DE 1992 Cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0007634:Cellular [Cell]
   812   C0178539:Cellular [Functional Concept]
   741 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "molecular biology of the -cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   797   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   760   C0005532:Biology [Biomedical Occupation or Discipline]
   760   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.379: Diabetologia 35(Suppl 2):S41S48 Halban PA 1992 Proinsulin processing in the regulated and the constitutive secretory pathway. 

Phrase: "Diabetologia 35"

Phrase: "(Suppl 2"

Phrase: ")"

Phrase: ":"

Phrase: "S41S48 Halban PA 1992 Proinsulin processing in the regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "the constitutive secretory pathway."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159343:constitutive secretory pathway [Cell Function]
   901   C1159342:Secretory Pathway [Cell Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.380: Diabetologia 37(Suppl 2):S65S72 Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Anderson JH 1992 Biosynthetic human proinsulin. 

Phrase: "Diabetologia 37"

Phrase: "(Suppl 2"

Phrase: ")"

Phrase: ":"

Phrase: "S65S72 Galloway JA,"

Phrase: "Hooper SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Spradlin CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "Howey DC,"

Phrase: "Frank BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Bowsher RR,"

Phrase: "Anderson JH 1992 Biosynthetic human proinsulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0086418:Human [Human]
Processing 00000000.tx.381: Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. 

Phrase: "Review of chemistry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0282443:Review [Intellectual Product]
   790   C1552617:Review [Idea or Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo receptor binding,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0597358:Receptor Binding [Molecular Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "and"

Phrase: "human pharmacology studies,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   988   C1512514:Human Pharmacology Study [Research Activity]
   913   C0178693:human studies [Research Activity]
   865   C1831759:pharmacological studies [Diagnostic Procedure]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "clinical trial experience."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0237607:experience [Mental Process]
   827   C0596545:Experience [Mental Process]
   734   C0008976:Clinical Trial [Research Activity]
   734   C1096775:Clinical Trial [Intellectual Product]
Processing 00000000.tx.382: Diabetes Care 15:666692[Abstract] Revers RR, Henry R, Schmeiser L, Kolterman O, Cohen R, Bergenstal R, Polonsky K, Jaspan J, Rubenstein A, Frank B, Galloway J, Olefsky JM 1984 The effects of biosynthetic human proinsulin on carbohydrate metabolism. 

Phrase: "Diabetes Care 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: ":"

Phrase: "666692"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Revers RR,"

Phrase: "Henry R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Schmeiser L, Kolterman O,"

Phrase: "Cohen R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bergenstal R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Polonsky K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Jaspan J,"

Phrase: "Rubenstein A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "Frank B,"

Phrase: "Galloway J,"

Phrase: "Olefsky JM 1984"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022337:JM [Geographic Area]

Phrase: "The effects of biosynthetic human proinsulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on carbohydrate metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302820:Carbohydrate Metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.383: Diabetes 33:762770[Abstract] Lavelle-Jones M, Scott MH, Kolterman O, Rubenstein AH, Olefsky JM, Moossa AR 1987 Selective suppression of hepatic glucose output by human proinsulin in the dog. 

Phrase: "Diabetes 33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "762770"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lavelle-Jones M, Scott MH,"

Phrase: "Kolterman O,"

Phrase: "Rubenstein AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Olefsky JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Moossa AR 1987 Selective suppression of hepatic glucose output"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0728721:suppression [Mental Process]

Phrase: "by human proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0086418:Human [Human]

Phrase: "in the dog."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dog [Mammal]
  1000   C1280551:Dog [Mammal]
Processing 00000000.tx.384: Am J Physiol 252 [Endocrinol Metab 15]:E230E236 Glauber HS, Revers RR, Henry R, Schmeiser L, Wallace P, Kolterman OG, Cohen RM, Rubenstein AH, Galloway JA, Frank BH, Olefsky JM 1986 In vivo deactivation of proinsulin action on glucose disposal and hepatic glucose production in normal man. 

Phrase: "Am"

Phrase: "J Physiol 252"

Phrase: "[Endocrinol Metab 15"

Phrase: "]"

Phrase: ":"

Phrase: "E230E236 Glauber HS,"

Phrase: "Revers RR,"

Phrase: "Henry R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Schmeiser L, Wallace P,"

Phrase: "Kolterman OG,"

Phrase: "Cohen RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Rubenstein AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Galloway JA,"

Phrase: "Frank BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Olefsky JM 1986 In vivo deactivation of proinsulin action"

Phrase: "on glucose disposal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707797:Disposal [Activity]

Phrase: "and"

Phrase: "hepatic glucose production in normal man."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0860800:glucose normal [Finding]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0033268:production [Occupational Activity]
   753   C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.385: Diabetes 35:311317[Abstract] Nissley SP, Rechler MM, Moses AC, Short PA, Podskalny JM 1977 Proinsulin binds to a growth peptide receptor and stimulates DNA synthesis in chick embryo fibroblasts. 

Phrase: "Diabetes 35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "311317"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Nissley SP,"

Phrase: "Rechler MM,"

Phrase: "Moses AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Short PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Podskalny JM 1977 Proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to a growth peptide receptor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0206473:Peptide Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0220844:growth [Physiologic Function]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "stimulates"

Phrase: "DNA synthesis in chick embryo fibroblasts."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0598312:DNA Synthesis [Genetic Function]
   790   C1328870:DNA synthesis [Laboratory Procedure]
   790   C1817262:DNA synthesis [Genetic Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.386: Endocrinology 101:708716[Medline] Jehle PM, Lutz MP, Fussgaenger RD 1996 High affinity binding sites for proinsulin in human IM-9 lymphoblasts. 

Phrase: "Endocrinology 101"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "708716"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jehle PM,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0007603:Plasma membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0032105:Plasma [Body Substance]
   827   C0596901:Membrane [Cell Component]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "Lutz MP,"

Phrase: "Fussgaenger RD 1996 High affinity binding sites for proinsulin"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   764   C0005456:Binding Sites [Receptor]
   742   C0205145:Sites [Spatial Concept]
   742   C0205250:High [Qualitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1299351:High [Qualitative Concept]
   742   C1510827:Affinity [Natural Phenomenon or Process]
   742   C2700149:HIGH [Intellectual Product]
   731 E C0682969:Binding Site [Amino Acid Sequence]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "in human IM-9 lymphoblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0229613:Lymphoblasts [Cell]
   812   C1167770:Lymphoblasts [Laboratory Procedure]
Processing 00000000.tx.387: Diabetologia 39:421432[CrossRef][Medline] Jehle PM, Fussgaenger RD, Angelus NK, Jungwirth RJ, Saile B, Lutz MP 1999 Proinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors. 

Phrase: "Diabetologia 39"

Phrase: ":"

Phrase: "421432"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jehle PM,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0007603:Plasma membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0032105:Plasma [Body Substance]
   827   C0596901:Membrane [Cell Component]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "Fussgaenger RD,"

Phrase: "Angelus NK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022688:NK [Cell]

Phrase: "Jungwirth RJ,"

Phrase: "Saile B,"

Phrase: "Lutz MP 1999 Proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "stimulates"

Phrase: "growth of small intestinal crypt-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0021841:growth intestines [Neoplastic Process]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "like cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "acting via specific receptors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205369:Specific [Qualitative Concept]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   770   C1552740:specific [Intellectual Product]
   737   C0079613:ACT [Therapeutic or Preventive Procedure]
Processing 00000000.tx.388: Am J Physiol 276 [Endocrinol Metab 39]:E262E268 Freychet P 1974 The interactions of proinsulin with insulin receptors on the plasma membrane of the liver. 

Phrase: "Am"

Phrase: "J Physiol 276"

Phrase: "[Endocrinol Metab 39"

Phrase: "]"

Phrase: ":"

Phrase: "E262E268 Freychet P 1974"

Phrase: "The interactions of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "with insulin receptors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "on the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "of the liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.389: J Clin Invest 54:10201031[Medline] Peavy DE, Brunner MR, Duckworth WC, Hooker CS, Frank BH 1985 Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "54"

Phrase: ":"

Phrase: "10201031"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Peavy DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Brunner MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Hooker CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Frank BH 1985 Receptor binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "biological potency of several split forms"

Phrase: "(conversion intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: ")"

Phrase: "of human proinsulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0086418:Human [Human]
Processing 00000000.tx.390: Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats. 

Phrase: "Studies in cultured IM-9 lymphocytes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro in rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.391: J Biol Chem 260:1398913994[Abstract/Free FullText] Stoll RW, Touber JL, Menahan LA, Williams RH 1970 Clearance of porcine insulin, proinsulin, and connective peptide by the isolated rat liver. 

Phrase: "J Biol Chem 260"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1398913994"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stoll RW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035978:RW [Geographic Area]
   861   C2700310:RW [Fish]

Phrase: "Touber JL,"

Phrase: "Menahan LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Williams RH 1970 Clearance of porcine insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449297:Clearance [Qualitative Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "connective peptide by the isolated rat liver."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.392: Proc Soc Exp Biol Med 133:894896 Rubenstein AH, Pottenger LA, Mako M, Getz GS, Steiner DF 1972 The metabolism of proinsulin and insulin by the liver. 

Phrase: "Proc Soc Exp Biol Med 133"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1417055:EXP [Gene or Genome]
   799   C1418943:PROC [Gene or Genome]

Phrase: ":"

Phrase: "894896 Rubenstein AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1836672:AH [Disease or Syndrome]

Phrase: "Pottenger LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Mako M, Getz GS,"

Phrase: "Steiner DF 1972"

Phrase: "The metabolism of proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "insulin by the liver."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.393: J Clin Invest 51:912921[Medline] Izzo JL, Roncone AM, Helton DL, Izzo MJ 1978 Disposition of 131I proinsulin in the rat. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "51"

Phrase: ":"

Phrase: "912921"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Izzo JL,"

Phrase: "Roncone"

Phrase: "AM"

Phrase: ","

Phrase: "Helton DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Izzo MJ 1978 Disposition of 131I proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0743223:Disposition [Idea or Concept]
   748   C1705555:Disposition [Idea or Concept]

Phrase: "in the rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.394: Comparisons with 131I insulin. 

Phrase: "Comparisons with 131I insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707455:Comparison [Activity]
Processing 00000000.tx.395: Diabetes 27:400410[Medline] Sodoyez-Goffaux F, Sodoyez JC, Koch M, De Vos CJ, Frank BH 1988 Scintigraphic distribution of 123I labelled proinsulin, split conversion intermediates and insulin in rats. 

Phrase: "Diabetes 27"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "400410"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sodoyez-Goffaux F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Sodoyez JC,"

Phrase: "Koch M, De Vos CJ,"

Phrase: "Frank BH 1988 Scintigraphic distribution of 123I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "labelled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0181496:Label [Manufactured Object]
   966   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "split conversion intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "insulin in rats."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.396: Diabetologia 31:848854[Medline] Kitabchi AE, Stentz FB 1972 Degradation of insulin and proinsulin by various organ homogenates of rat. 

Phrase: "Diabetologia 31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "848854"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kitabchi AE,"

Phrase: "Stentz FB 1972 Degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "proinsulin by various organ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "homogenates of rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:Rat, NOS [Mammal]
   790   C0034721:Rat [Mammal]
Processing 00000000.tx.397: Diabetes 21:10911101[Medline] Burghen GA, Kitabchi AE, Brush JS 1972 Characterization of a rat liver protease with specificity for insulin. 

Phrase: "Diabetes 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "10911101"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Burghen GA,"

Phrase: "Kitabchi AE,"

Phrase: "Brush JS 1972 Characterization of a rat liver protease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]

Phrase: "with specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "for insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.398: Endocrinology 91:633642[Medline] Podlecki DA, Frank BH, Olefsky JM 1984 In vitro characterization of biosynthetic human proinsulin. 

Phrase: "Endocrinology 91"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "633642"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Podlecki DA,"

Phrase: "Frank BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Olefsky JM 1984 In vitro characterization of biosynthetic human proinsulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880022:Characterization [Activity]
Processing 00000000.tx.399: Diabetes 33:111118[Abstract] Levy JR, Ullrich A, Olefsky JM 1988 Endocytotic uptake, processing and retroendocytosis of human biosynthetic proinsulin by rat fibroblasts transfected with the human insulin receptor gene. 

Phrase: "Diabetes 33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "111118"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Levy JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Ullrich A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "Olefsky JM 1988 Endocytotic uptake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0243144:Uptake [Physiologic Function]
   804   C0347980:% uptake [Quantitative Concept]

Phrase: "processing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]
   966 E C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "retroendocytosis of human biosynthetic proinsulin"

Phrase: "by rat fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "transfected with the human insulin receptor gene."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C1334133:Insulin Receptor Gene [Gene or Genome]
           INSULIN RECEPTOR
   814   C1448132:insulin receptor, human [Amino Acid, Peptide, or Protein,Receptor]
   778   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   778   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   778   C1335671:Receptor Gene [Gene or Genome]
   774   C0314604:Human gene [Gene or Genome]
   774   C1337112:Insulin Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086418:Human [Human]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.400: J Clin Invest 81:13701377[Medline] Desbuquois B, Janicot M, Dupuis A 1990 Degradation of insulin in isolated liver endosomes is functionally linked to ATP-dependent endosomal acidification. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "81"

Phrase: ":"

Phrase: "13701377"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Desbuquois B,"

Phrase: "Janicot M, Dupuis A 1990 Degradation of insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1820119:Mitochondrial Degradation [Cell Function]
   767   C3547574:insulin degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "in isolated liver endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034850:Endosomes [Cell Component]

Phrase: "is"

Phrase: "functionally"

Phrase: "linked to ATP-dependent endosomal acidification."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1522821:acidification [Cell Function]
   753   C1701901:Dependent [Qualitative Concept]
   753   C2987513:Acidification [Phenomenon or Process]
   753   C3244310:dependent [Functional Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]
Processing 00000000.tx.401: Eur J Biochem 193:501512[Abstract] Bowsher RR, Wolny JD, Frank BH 1992 A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum. 

Phrase: "Eur J Biochem 193"

Phrase: ":"

Phrase: "501512"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bowsher RR,"

Phrase: "Wolny JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Frank BH 1992 A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332197:absence [Quantitative Concept]
   812   C1689985:Absence [Anatomical Abnormality]
   741 E C2699517:ABSENT [Finding]

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "sensitive radioimmunoassay for the measurement of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0034580:Radioimmunoassay [Laboratory Procedure]

Phrase: "in human serum."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0086418:Human [Human]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
Processing 00000000.tx.402: Diabetes 41:10841090[Abstract] Kemmler W, Peterson JD, Steiner DF 1971 Studies on the conversion of proinsulin to insulin. 

Phrase: "Diabetes 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "10841090"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kemmler W,"

Phrase: "Peterson JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Steiner DF 1971 Studies on the conversion of proinsulin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0947630:studies [Laboratory Procedure]
   708 E C0557651:Study [Manufactured Object]
   708 E C2603343:Study [Research Activity]

Phrase: "to insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.403: I. 

Phrase: "I."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.404: Conversion in vitro with trypsin and carboxypeptidase B. 

Phrase: "Conversion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439836:Conversion [Functional Concept]

Phrase: "in vitro with trypsin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "carboxypeptidase B."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054756:Carboxypeptidase B [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0007075:Carboxypeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3265462:Carboxypeptidase [Pharmacologic Substance]
Processing 00000000.tx.405: J Biol Chem 246:67866791[Abstract/Free FullText] Authier F, Di Guglielmo GM, Danielsen GM, Bergeron JJM 1998 Uptake and metabolic fate of [HisA8, HisB4, GluB10, HisB27]insulin in rat liver in vivo. 

Phrase: "J Biol Chem 246"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "67866791"

Phrase: "[Abstract/Free FullText"

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Di Guglielmo GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Danielsen GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Bergeron JJM 1998 Uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "metabolic fate of [HisA8,"

Phrase: "HisB4,"

Phrase: "GluB10,"

Phrase: "HisB27"

Phrase: "]insulin in rat liver"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.406: Biochem J 332:421430[Medline] Authier F, Danielsen GM, Kouach M, Briand G, Chauvet G 2001 Identification of insulin domains important for binding to and degradation by endosomal acidic insulinase. 

Phrase: "Biochem J 332"

Phrase: ":"

Phrase: "421430"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Danielsen GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Kouach M, Briand G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "Chauvet G 2001 Identification of insulin domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "important for binding"

Phrase: "to"

Phrase: "and"

Phrase: "degradation by endosomal acidic insulinase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.407: Endocrinology 142:276289[Abstract/Free FullText] Hubbard AL, Wall DA, Ma A 1983 Isolation of rat hepatocyte plasma membranes. 

Phrase: "Endocrinology 142"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "276289"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hubbard AL,"

Phrase: "Wall DA,"

Phrase: "Ma A 1983 Isolation of rat hepatocyte plasma membranes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   745   C2247585:isolation membrane [Cell Component]
   742   C0204727:Isolation [Therapeutic or Preventive Procedure]
   742   C0205409:Isolation [Functional Concept]
   742   C0220862:isolation [Laboratory Procedure]
Processing 00000000.tx.408: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.409: Presence of the three major domains. 

Phrase: "Presence of the three major domains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.410: J Cell Biol 96:217229[Abstract] Khan MN, Savoie S, Bergeron JJM, Posner BI 1986 Characterization of rat liver endosomal fractions. 

Phrase: "J Cell Biol 96"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "217229"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Khan MN,"

Phrase: "Savoie S, Bergeron JJM,"

Phrase: "Posner BI 1986 Characterization of rat liver endosomal fractions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]
Processing 00000000.tx.411: In vivo activation of insulin-stimulable receptor kinase in these structures. 

Phrase: "In vivo activation of insulin-stimulable receptor kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1514758:Receptor Activation [Cell Function]
   744   C1879547:Activation [Activity]

Phrase: "in these structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]
Processing 00000000.tx.412: J Biol Chem 261:84628472[Abstract/Free FullText] Chauvet G, Tahiri K, Authier F, Desbuquois B 1998 Endosome-lysosome transfer of insulin and glucagon in a liver cell-free system. 

Phrase: "J Biol Chem 261"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "84628472"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chauvet G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Tahiri K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois B 1998 Endosome-lysosome transfer of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0040671:Transfer [Mental Process]
   744   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "glucagon in a liver cell-free system."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0030280:Glucagon Cell [Cell]
   748   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   748   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.413: Eur J Biochem 254:527537[Abstract] Authier F, Rachubinski RA, Posner BI, Bergeron JJM 1994 Endosomal proteolysis of insulin by an acidic thiol-metalloprotease unrelated to insulin degrading enzyme. 

Phrase: "Eur J Biochem 254"

Phrase: ":"

Phrase: "527537"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Rachubinski RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1994 Endosomal proteolysis of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597304:Proteolysis [Molecular Function]

Phrase: "by an acidic thiol-metalloprotease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "unrelated to insulin degrading enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0445356:Unrelated [Finding]
   760   C1704623:Unrelated [Qualitative Concept]
Processing 00000000.tx.414: J Biol Chem 269:30103016[Abstract/Free FullText] Authier F, Mtioui M, Fabrega S, Kouach M, Briand G 2002 Endosomal proteolysis of internalized insulin at the C-terminal region of the B chain by cathepsin D. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "30103016"

Phrase: "[Abstract/Free FullText"

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Mtioui M, Fabrega S, Kouach M, Briand G 2002 Endosomal proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0597304:Proteolysis [Molecular Function]
   717 E C1947941:proteolytic [Enzyme]

Phrase: "of internalized insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "at the C-terminal region"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205088:Terminal [Temporal Concept]
   827   C0205147:Region [Spatial Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of the B chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "by cathepsin D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.415: J Biol Chem 277:94379446[Abstract/Free FullText] Desbuquois B, Lopez S, Burlet H 1982 Ligand-induced translocation of insulin receptors in intact rat liver. 

Phrase: "J Biol Chem 277"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "94379446"

Phrase: "[Abstract/Free FullText"

Phrase: "] Desbuquois B,"

Phrase: "Lopez S, Burlet H 1982 Ligand-induced translocation of insulin receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0040715:Translocation [Cell or Molecular Dysfunction]
   738   C2987521:Translocation [Activity]

Phrase: "in intact rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.416: J Biol Chem 257:1085210860[Abstract/Free FullText] Desbuquois B, Aurbach GD 1971 Use of polyethyleneglycol to separate free and antibody-bound peptide hormones in radioimmunoassays. 

Phrase: "J Biol Chem 257"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1085210860"

Phrase: "[Abstract/Free FullText"

Phrase: "] Desbuquois B,"

Phrase: "Aurbach GD 1971 Use of polyethyleneglycol to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "antibody-bound peptide hormones in radioimmunoassays."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0597192:Peptide Hormones [Amino Acid, Peptide, or Protein,Hormone]
   773 E C1149477:peptide hormone [Molecular Function]
   753   C0019932:Hormones [Hormone]
   750   C0436152:Hormone radioimmunoassay [Laboratory Procedure]
Processing 00000000.tx.417: J Clin Endocrinol Metab 33:732738[Medline] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. 

Phrase: "J Clin Endocrinol Metab 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "732738"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lowry OH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "Rosebrough NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Farr AL,"

Phrase: "Randall RJ 1951 Protein measurement with the Folin phenol reagent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0202202:Protein measurement [Laboratory Procedure]
   757   C0202446:Phenol measurement [Laboratory Procedure]
   739   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.418: J Biol Chem 193:265275[Free FullText] Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye protein binding. 

Phrase: "J Biol Chem 193"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "265275"

Phrase: "[Free FullText"

Phrase: "] Bradford MM 1976 A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332197:absence [Quantitative Concept]
   812   C1689985:Absence [Anatomical Abnormality]
   741 E C2699517:ABSENT [Finding]

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "sensitive method for the quantitation of microgram quantities of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C1547724:Quantity method [Idea or Concept]
   739   C0025663:Method [Intellectual Product]
   739   C0449851:Method [Functional Concept]
   739   C0871511:METHOD [Intellectual Product]

Phrase: "utilizing"

Phrase: "the principle of dye protein binding."
Processing 00000000.tx.419: Anal Biochem 72:248254[CrossRef][Medline] Beaufay H, Amar-Costesec A, Feytmans E, Thins-Sempoux D, Wibo M, Robbi M, Berthet J 1974 Analytical study of microsomes and isolated subcellular membranes from rat liver. 

Phrase: "Anal Biochem 72"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "248254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Beaufay H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Amar-Costesec A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332197:absence [Quantitative Concept]
   827   C1689985:Absence [Anatomical Abnormality]
   755 E C2699517:ABSENT [Finding]

Phrase: "Feytmans"

Phrase: "E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0034850:Endosome [Cell Component]

Phrase: "Thins-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205168:Thin [Qualitative Concept]

Phrase: "Sempoux D,"

Phrase: "Wibo M, Robbi M, Berthet J 1974 Analytical study of microsomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0557651:Study [Manufactured Object]
   738   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "isolated subcellular membranes from rat liver."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   773   C0682532:subcellular membrane [Cell Component]
   753   C0025255:Membranes [Tissue]
   731   C2247585:isolation membrane [Cell Component]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.420: I. 

Phrase: "I."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.421: Biochemical methods. 

Phrase: "Biochemical methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.422: J Cell Biol 61:188200[Abstract/Free FullText] Bergeron JJM, Searle N, Khan MN, Posner BI 1986 Differential and analytical subfractionation of rat liver components internalizing insulin and prolactin. 

Phrase: "J Cell Biol 61"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "188200"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bergeron JJM,"

Phrase: "Searle N, Khan MN,"

Phrase: "Posner BI 1986 Differential"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0443199:Differential [Qualitative Concept]
   812   C1705242:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "analytical subfractionation of rat liver components"

Phrase: "internalizing"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "prolactin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033371:Prolactin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1744644:prolactin [Molecular Function]
Processing 00000000.tx.423: Biochemistry 25:17561764[Medline] Desbuquois B, Willeput J, Huet de Froberville A 1979 Receptor-mediated internalization of insulin in intact rat liver. 

Phrase: "Biochemistry 25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: ":"

Phrase: "17561764"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Desbuquois B,"

Phrase: "Willeput J,"

Phrase: "Huet de Froberville A 1979 Receptor-mediated internalization of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   775   C3271694:insulin receptor internalization [Phenomenon or Process]
   757   C0599281:receptor internalization [Phenomenon or Process]
   739   C0871786:internalization [Mental Process]

Phrase: "in intact rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.424: A biochemical study. 

Phrase: "A biochemical study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205474:Biochemical [Functional Concept]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.425: FEBS Lett 106:338344[CrossRef][Medline] Pease RJ, Smith GD, Peters TJ 1985 Degradation of endocytosed insulin in rat liver is mediated by low density vesicles. 

Phrase: "FEBS Lett 106"

Phrase: ":"

Phrase: "338344"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pease RJ,"

Phrase: "Smith GD,"

Phrase: "Peters TJ 1985 Degradation of endocytosed insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "in rat liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "is"

Phrase: "mediated by low density vesicles."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0178587:density [Quantitative Concept]
   760   C0205251:low [Qualitative Concept]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C1622418:vesicle [Cell Component]
Processing 00000000.tx.426: Biochem J 228:137146[Medline] Doherty JJ, Kay DG, Lai WH, Posner BI, Bergeron JJM 1990 Selective degradation of insulin within rat liver endosomes. 

Phrase: "Biochem J 228"

Phrase: ":"

Phrase: "137146"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Doherty JJ,"

Phrase: "Kay DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Lai WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1990 Selective degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "within rat liver endosomes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034850:Endosomes [Cell Component]
   734   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
Processing 00000000.tx.427: J Cell Biol 110:3542[Abstract] Hamel FG, Mahoney MJ, Duckworth WC 1991 Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification. 

Phrase: "J Cell Biol 110"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "3542"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Mahoney MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Duckworth WC 1991 Degradation of intraendosomal insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "by insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "without acidification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522821:acidification [Cell Function]
  1000   C2987513:Acidification [Phenomenon or Process]
Processing 00000000.tx.428: Diabetes 40:436443[Abstract] Clot JP, Janicot M, Fouque F, Desbuquois B, Haumont PY, Lederer F 1990 Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies. 

Phrase: "Diabetes 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "436443"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

Phrase: "Clot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
  1000   C0302148:Clot [Acquired Abnormality]

Phrase: "JP,"

Phrase: "Janicot M, Fouque F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois B,"

Phrase: "Haumont PY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030428:PY [Geographic Area]
   861   C3538810:PY [Idea or Concept]

Phrase: "Lederer F 1990 Characterization of insulin degradation products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "generated in liver endosomes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0034850:Endosomes [Cell Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   770   C3146294:Generated [Activity]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: ":"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro studies."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.429: Mol Cell Endocrinol 72:175185[CrossRef][Medline] Seabright PJ, Smith GD 1996 The characterization of endosomal insulin degradation intermediates and their sequence of production. 

Phrase: "Mol Cell Endocrinol 72"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "175185"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seabright PJ,"

Phrase: "Smith GD 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: "The characterization of endosomal insulin degradation intermediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "their sequence of production."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.430: Biochem J 320:947956[Medline] Duckworth WC 1988 Insulin degradation: mechanisms, products, and significance. 

Phrase: "Biochem J 320"

Phrase: ":"

Phrase: "947956"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC 1988 Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C3547574:insulin degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.431: Endocr Rev 9:319345[Abstract] Sonne O 1988 Receptor-mediated endocytosis and degradation of insulin. 

Phrase: "Endocr Rev 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "319345"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sonne O 1988 Receptor-mediated endocytosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0597361:Receptor Mediated Endocytosis [Cell Function]
   799   C0014139:Endocytosis [Cell Function]
   799   C0086597:mediated [Social Behavior]
   799   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "degradation of insulin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C3547574:insulin degradation [Molecular Function]
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]
Processing 00000000.tx.432: Physiol Rev 68:11291196[Free FullText] Duckworth WC, Bennett RG, Hamel FG 1998 Insulin degradation: progress and potential. 

Phrase: "Physiol Rev 68"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450387:68 [Intellectual Product]
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "11291196"

Phrase: "[Free FullText"

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG 1998 Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C3547574:insulin degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "and"

Phrase: "potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.433: Endocr Rev 19:608624[Abstract/Free FullText] Khan MN, Baquiran G, Brule C, Burgess J, Foster B, Bergeron JJM, Posner BI 1989 Internalization and activation of the rat liver insulin receptor kinase in vivo. 

Phrase: "Endocr Rev 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "608624"

Phrase: "[Abstract/Free FullText"

Phrase: "] Khan MN,"

Phrase: "Baquiran G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Brule C,"

Phrase: "Burgess J,"

Phrase: "Foster B,"

Phrase: "Bergeron JJM,"

Phrase: "Posner BI 1989 Internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "activation of the rat liver insulin receptor kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1514758:Receptor Activation [Cell Function]
   744   C1879547:Activation [Activity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.434: J Biol Chem 264:1293112940[Abstract/Free FullText] Mullock BM, Branch WJ, Van Schaik M, Gilbert LK, Luzio JP 1989 Reconstitution of an endosome-lysosome interaction in a cell-free system. 

Phrase: "J Biol Chem 264"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1293112940"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mullock BM,"

Phrase: "Branch WJ,"

Phrase: "Van Schaik M, Gilbert LK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0038088:LK [Geographic Area]
   804   C2681928:LK [Gene or Genome]

Phrase: "Luzio JP 1989 Reconstitution of an endosome-lysosome interaction"

Phrase: "in a cell-free system."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C0007625:Cell-Free System [Cell Component]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.435: J Cell Biol 108:20932099[Abstract] Short DK, Okada S, Yamauchi K, Pessin JE 1998 Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice. 

Phrase: "J Cell Biol 108"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "20932099"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Short DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "Okada S, Yamauchi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1708601:K' [Quantitative Concept]

Phrase: "Pessin JE 1998 Adenovirus-mediated transfer of a modified human proinsulin gene"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   766   C1062667:Human adenovirus A [Virus]
   751   C0001490:Human adenovirus [Virus]
   751   C1517499:Gene Transfer [Molecular Biology Research Technique]
   736   C0001483:Adenovirus, NOS [Virus]
   736   C0001486:Adenovirus [Disease or Syndrome]
   736   C0040671:Transfer [Mental Process]
   736   C0086597:mediated [Social Behavior]
   736   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   736   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   736   C1705822:Transfer [Activity]

Phrase: "reverses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "hyperglycemia in diabetic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0162418:Hyperglycemic Mice [Mammal]
   770   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.436: Am J Physiol 275 (Endocrinol Metab 38): E748E756 Mitanchez D, Chen R, Massias JF, Porteu A, Mignon A, Bertagna X, Kahn A 1998 Regulated expression of mature human insulin in the liver of transgenic mice. 

Phrase: "Am"

Phrase: "J Physiol 275"

Phrase: "(Endocrinol Metab 38"

Phrase: ")"

Phrase: ":"

Phrase: "E748E756 Mitanchez D,"

Phrase: "Chen R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Massias JF,"

Phrase: "Porteu A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "Mignon A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "Bertagna X,"

Phrase: "Kahn A 1998 Regulated expression of mature human insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "of transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.437: FEBS Lett 421:285289[CrossRef][Medline] Brennan SO, Peach RJ 1991 The processing of human proinsulin and chicken proalbumin by rat hepatic vesicles suggests a convertase specific for X-Y-Arg-Arg or Arg-X-Y-Arg sequences. 

Phrase: "FEBS Lett 421"

Phrase: ":"

Phrase: "285289"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brennan SO,"

Phrase: "Peach RJ 1991"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0330659:Peach [Plant]
   827   C0949824:Peach [Food]
   827   C0972391:PEACH [Pharmacologic Substance]
   827   C1337216:PEACH [Food]

Phrase: "The processing of human proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "chicken proalbumin by rat hepatic vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0032923:Proalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a convertase"

Phrase: "specific for X-Y-Arg-Arg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "or"

Phrase: "Arg-X-Y-Arg sequences."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]
   708   C0653858:Arg-Arg [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.438: J Biol Chem 266:2150421508[Abstract/Free FullText] Vollenweider F, Irminger JC, Gross DJ, Villa-Komaroff L, Halban PA 1992 Processing of proinsulin by transfected hepatoma (FAO) cells. 

Phrase: "J Biol Chem 266"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2150421508"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vollenweider F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Irminger JC,"

Phrase: "Gross DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Villa-Komaroff L, Halban PA 1992 Processing of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709694:Processing [Activity]

Phrase: "by transfected hepatoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023903:Hepatoma [Neoplastic Process]
   861   C2239176:Hepatoma [Neoplastic Process]

Phrase: "(FAO) cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.439: J Biol Chem 267:1462914636[Abstract/Free FullText] Nakayama K 1997 Furin: a mammalian subtilisin/kex2P-like endoprotease involved in processing of a wide variety of precursor proteins. 

Phrase: "J Biol Chem 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1462914636"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nakayama K 1997 Furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0919550:FURIN [Gene or Genome]

Phrase: ":"

Phrase: "a mammalian subtilisin/kex2P-"

Phrase: "like endoprotease"

Phrase: "involved in processing of a wide variety of precursor proteins."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   743   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0033666:protein processing [Molecular Function]
   741   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0332464:Wide [Spatial Concept]
   739   C1314939:Involved [Functional Concept]
   739   C1709634:Precursor [Idea or Concept]
   739   C1709694:Processing [Activity]
   739   C1883525:Variety [Conceptual Entity]
   739   C2346866:Variety [Conceptual Entity]
Processing 00000000.tx.440: Biochem J 327:625635[Medline] Alarcon C, Chetham B, Lincoln B, Kahn CR, Siddle K, Rhodes CJ 1994 A kex2-related endopeptidase activity present in rat liver specifically processes the insulin proreceptor. 

Phrase: "Biochem J 327"

Phrase: ":"

Phrase: "625635"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Alarcon C,"

Phrase: "Chetham B,"

Phrase: "Lincoln B,"

Phrase: "Kahn CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Siddle K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Rhodes CJ 1994 A kex2-related endopeptidase activity present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0150312:Present [Quantitative Concept]
   791   C0449450:Present [Idea or Concept]

Phrase: "in rat liver specifically processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1184743:Process [Body Part, Organ, or Organ Component]
   779   C1522240:Process [Phenomenon or Process]

Phrase: "the insulin proreceptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063612:insulin proreceptor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.441: Biochem J 301:257265[Medline] Seta KA, Roth RA 1997 Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling. 

Phrase: "Biochem J 301"

Phrase: ":"

Phrase: "257265"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seta KA,"

Phrase: "Roth RA 1997 Overexpression of insulin degrading enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514559:Overexpression [Genetic Function]

Phrase: ":"

Phrase: "cellular localization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1660642:cellular localisation [Cell Function]
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "effects on insulin signaling."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.442: Biochem Biophys Res Commun 231:167171[CrossRef][Medline] Jensen I, Kruse V, Larsen UD 1991 Scintigraphic studies in rats. 

Phrase: "Biochem Biophys Res Commun 231"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "167171"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jensen I,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Kruse V,"

Phrase: "Larsen UD 1991 Scintigraphic studies in rats."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]
Processing 00000000.tx.443: Kinetics of insulin analogues covering wide range of receptor affinities. 

Phrase: "Kinetics of insulin analogues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022702:Kinetics [Natural Phenomenon or Process]
   770   C0220865:kinetics [Functional Concept]
   770   C2825046:Kinetics [Occupation or Discipline]

Phrase: "covering"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0180153:covering [Medical Device]
  1000   C0439844:covering [Functional Concept]
   966 E C1707529:Cover [Medical Device]
   966 E C1999244:Cover [Functional Concept]

Phrase: "wide range of receptor affinities."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]
Processing 00000000.tx.444: Diabetes 40:628632[Abstract] This Article Abstract Full Text (PDF) All Versions of this Article: 144/12/5308 most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Desbuquois, B. 

Phrase: "Diabetes 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "628632"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "144/12/5308 most recent Author Manuscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "(PDF) Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441061:Shopping cart [Manufactured Object]
   799   C0179636:Cart [Manufactured Object]
   799   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Request Copyright Permission Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706852:Article [Intellectual Product]

Phrase: "by Desbuquois,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.445: Articles by Authier, F. 

Phrase: "Articles by Authier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.446: Articles citing this Article PubMed PubMed Citation Articles by Desbuquois, B. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Desbuquois,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.447: Articles by Authier, F. 

Phrase: "Articles by Authier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.448: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Endocrinology Endocrine Reviews J. 

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Endocrinology Endocrine Reviews J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   735   C0039224:Table [Manufactured Object]
   735   C1706073:Table [Medical Device]
   735   C1706074:Table [Intellectual Product]
Processing 00000000.tx.449: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.450: End. 

Phrase: "End."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.451: & Metab. 

Phrase: "& Metab."
Processing 00000000.tx.452: Molecular Endocrinology Recent Prog. 

Phrase: "Molecular Endocrinology Recent Prog."
Processing 00000000.tx.453: Horm. 

Phrase: "Horm."
Processing 00000000.tx.454: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.455: All Endocrine Journals

Phrase: "All Endocrine Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

